Eesti Haigekassa ravimite loetelu
Vastu võetud 24.09.2002 nr 112
Määrus kehtestatakse «Ravikindlustuse seaduse» (RT I 2002, 62, 377) paragrahvi 43 lõike 1 alusel.
§ 1. Reguleerimisala
Määrus kehtestab Eesti Haigekassa ravimite loetelu, mis on toodud käesoleva määruse lisas ning mille korral võtab haigekassa üle tasu maksmise kohustuse kindlustatud isiku ambulatoorseks raviks vajalike ravimite jaemüügi eest.
§ 2. Ravimite piirhind
Kuni ravimite piirhinna kehtestamiseni loetakse piirhinnaks jaemüügi hind.
§ 3. Määruse jõustumine
Käesolev määrus jõustub 1. oktoobril 2002. a.
Minister Siiri OVIIR |
Kantsler Maarja MÄNDMAA |
Sotsiaalministri 24. septembri 2002. a määruse nr 112 «Eesti Haigekassa
ravimite loetelu» lisa |
EESTI HAIGEKASSA RAVIMITE LOETELU
Nr | Toimeained | ATC kood | Ravim | Müügiloa hoidja | 50% soodustus | Märkused | 75% soodustus | Diagnoosid | Märkused | 100% soodustus | Diagnoosid | Märkused |
1 | adapaleen | D10AD03 | DIFFERIN 0,1% CREAM kreem 0,1% 30g N1 | Galderma | 50% | |||||||
2 | adapaleen | D10AD03 | DIFFERIN 0,1% CREAM kreem 0,1% 5g N1 | Galderma | 50% | |||||||
3 | adapaleen | D10AD03 | DIFFERIN 0,1% GEL geel 0,1% 30g N1 | Galderma | 50% | |||||||
4 | adapaleen | D10AD03 | DIFFERIN 0,1% GEL geel 0,1% 5g N1 | Galderma | 50% | |||||||
5 | alendroonhape | M05BA04 | FOSAMAX 70 MG ÜKS KORD NÄDALAS tablett 70mg N2 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
6 | alendroonhape | M05BA04 | FOSAMAX 70 MG ÜKS KORD NÄDALAS tablett 70mg N4 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
7 | alendroonhape | M05BA04 | FOSAMAX tablett 10mg N14 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
8 | alendroonhape | M05BA04 | FOSAMAX tablett 10mg N28 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
9 | alendroonhape | M05BA04 | FOSAMAX tablett 5mg N14 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
10 | alendroonhape | M05BA04 | FOSAMAX tablett 5mg N28 | MSD | 50% | 75% | M80* | *rv endokrinoloogil | ||||
11 | alfakaltsidool | A11CC03 | ALPHA D3-TEVA kapsel 0,25mcg 1TK N30 | Teva | 50% | 75% | N18* | *rv nefroloogil | ||||
12 | alfakaltsidool | A11CC03 | ALPHA D3-TEVA kapsel 1mcg N10 | Teva | 50% | 75% | N18* | *rv nefroloogil | ||||
13 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 0,25mcg N100 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
14 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 0,25mcg N30 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
15 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 1mcg N10 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
16 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 1mcg N100 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
18 | alfakaltsidool | A11CC03 | ONE-ALPHA kapsel 1mcg N30 | Leo | 50% | 75% | N18* | *rv nefroloogil | ||||
19 | alfusosiin | G04CA01 | XATRAL retardtablett 5mg N28 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
20 | alfusosiin | G04CA01 | XATRAL retardtablett 5mg N56 | LABORATOIRES SYNT- HELABO/ |
50% | |||||||
17 | alfusosiin | G04CA01 | XATRAL SR retardtablett 10mg N10 | Sanofi-Synthelabo France | 50% | |||||||
21 | alfusosiin | G04CA01 | XATRAL SR retardtablett 10mg N30 | Sanofi-Synthelabo France | 50% | |||||||
22 | allopurinool | M04AA01 | ALLOPURINOL ALPHARMA TABLETS 100 MG tablett 100mg N100 | ALPHARMA | 50% | 75% | M10; N20-N23 | |||||
25 | allopurinool | M04AA01 | ALLOPURINOL ALPHARMA TABLETS 100 MG tablett 100mg N50 | ALPHARMA | 50% | 75% | M10; N20-N23 | |||||
26 | allopurinool | M04AA01 | ALLOPURINOL NYCOMED tablett 100mg N50 | Nycomed SEFA | 50% | 75% | M10; N20-N23 | |||||
23 | allopurinool | M04AA01 | ALLOPURINOL NYCOMED tablett 300mg N50 | Nycomed SEFA | 50% | 75% | M10; N20-N23 | |||||
24 | alumiiniumkloriid-hüdroksiid kompleks | A12CX81 | PHOSPHONORM kapsel 300mg N100 | Medice | 50% | |||||||
29 | amantadiin | N04BB01 | AMANTADIN- RATIOPHARM TABLETTEN tablett 100mg N100 | ratiopharm | 50% | 100% | G20* | *rev neuroloogil | ||||
30 | amantadiin | N04BB01 | AMANTADIN- RATIOPHARM TABLETTEN tablett 100mg N20 | ratiopharm | 50% | 100% | G20* | *rev neuroloogil | ||||
31 | amantadiin | N04BB01 | AMANTADIN- RATIOPHARM TABLETTEN tablett 100mg N50 | ratiopharm | 50% | 100% | G20* | *rev neuroloogil | ||||
32 | amantadiin | N04BB01 | PK-MERZ TABLETS tablett 100mg N30 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
33 | amantadiin | N04BB01 | PK-MERZ TABLETS tablett 100mg N90 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
34 | aminogluteetimiid | L02BG01 | ORIMETENE tablett 250mg N100 | Novartis Pharma | 50% | |||||||
35 | amiodaroon | C01BD01 | AMIODARONE ALPHARMA tablett 200 mg N30 | ALPHARMA | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
36 | amiodaroon | C01BD01 | CORDARONE 200 MG tablett 200mg N30 | Sanofi | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
37 | amisulpiriid | N05AL05 | SOLIAN tablett 100mg N30 | Sanofi-Synthelabo France | 50% | |||||||
38 | amisulpiriid | N05AL05 | SOLIAN tablett 200mg N150 | LABORATOIRES SYNT-HELABO/ | 50% | |||||||
39 | amisulpiriid | N05AL05 | SOLIAN tablett 200mg N30 | LABORATOIRES SYNT-HELABO/ | 50% | |||||||
40 | amisulpiriid | N05AL05 | SOLIAN tablett 400mg N30 | Sanofi-Synthelabo France | 50% | |||||||
41 | amisulpiriid | N05AL05 | SOLIAN tablett 50mg N30 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
42 | amitriptüliin | N06AA09 | AMITRIPTILINS-GRINDEKS 10 MG tablett 10mg N50 | Grindeks | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
44 | amitriptüliin | N06AA09 | AMITRIPTILINS-GRINDEKS 25 MG tablett 25mg N50 | Grindeks | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
45 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 10 MG tablett 10mg N100 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
46 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 10 MG tablett 10mg N50 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
47 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 25 MG tablett 25mg N100 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
27 | amitriptüliin | N06AA09 | AMITRIPTYLIN NYCOMED 25 MG tablett 25mg N50 | Nycomed SEFA | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
28 | amitriptüliin | N06AA09 | SAROTEN RETARD retardkapsel 50mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
43 | amitriptüliin | N06AA09 | SAROTEN tablett 10mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
48 | amitriptüliin | N06AA09 | SAROTEN tablett 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
49 | amlodipiin | C08CA01 | NORMODIPINE tablett 10mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
50 | amlodipiin | C08CA01 | NORMODIPINE tablett 5mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
51 | amlodipiin | C08CA01 | NORVASC tablett 10mg N100 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
52 | amlodipiin | C08CA01 | NORVASC tablett 10mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
53 | amlodipiin | C08CA01 | NORVASC tablett 5mg N100 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
54 | amlodipiin | C08CA01 | NORVASC tablett 5mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
56 | amoksitsilliin | J01CA04 | AMOCILEKS kapsel 250mg N20 | Grindeks | 50% | 75% | J13-J15; H66 | |||||
57 | amoksitsilliin | J01CA04 | AMOCILEKS kapsel 500mg N10 | Grindeks | 50% | 75% | J13-J15; H66 | |||||
58 | amoksitsilliin | J01CA04 | AMOXICILLIN 1000 STADA tablett 1g N10 | Stada | 50% | 75% | J13-J15; H66 | |||||
59 | amoksitsilliin | J01CA04 | AMOXICILLIN 1000 STADA tablett 1g N20 | Stada | 50% | 75% | J13-J15; H66 | |||||
60 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 tablett 1000mg N10 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
55 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 tablett 1000mg N20 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
61 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 250 TS suspensioonigraanulid 50mgml 100ml N1 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
62 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 500 tablett 500mg N10 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
63 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 500 tablett 500mg N20 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
64 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 750 tablett 750mg N10 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
65 | amoksitsilliin | J01CA04 | AMOXICILLIN- RATIOPHARM 750 tablett 750mg N20 | ratiopharm | 50% | 75% | J13-J15; H66 | |||||
66 | amoksitsilliin | J01CA04 | BACTOX 125MG/5ML pulber suspensiooniks 25mgml 60ml N1 | Innotech | 50% | 75% | J13-J15; H66 | |||||
67 | amoksitsilliin | J01CA04 | BACTOX 250MG/5ML pulber suspensiooniks 50mgml 60ml N1 | Innotech | 50% | 75% | J13-J15; H66 | |||||
68 | amoksitsilliin | J01CA04 | BACTOX 500MG/5ML pulber suspensiooniks 100mgml 60ml N1 | Innotech | 50% | 75% | J13-J15; H66 | |||||
69 | amoksitsilliin | J01CA04 | BACTOX pulber suspensiooniks 1g N6 | Laboratoire Innotech int | 50% | 75% | J13-J15; H66 | |||||
70 | amoksitsilliin | J01CA04 | ERAMOX tablett 500mg N10 | Nycomed SEFA | 50% | 75% | J13-J15; H66 | |||||
71 | amoksitsilliin | J01CA04 | ERAMOX tablett 500mg N100 | Nycomed SEFA | 50% | 75% | J13-J15; H66 | |||||
73 | amoksitsilliin | J01CA04 | ERAMOX tablett 500mg N30 | Nycomed SEFA | 50% | 75% | J13-J15; H66 | |||||
74 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 250mg N14 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
75 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 250mg N20 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
76 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 500mg N14 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
77 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 500mg N20 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
78 | amoksitsilliin | J01CA04 | FLEMOXIN SOLUTAB lahustuv tablett 500mg N30 | Yamanouchi | 50% | 75% | J13-J15; H66 | |||||
79 | amoksitsilliin | J01CA04 | HICONCIL 100 MG/ML graanulid tilkade valm. 100mgml 10ml N1 | KRKA, d.d. | 50% | 75% | J13-J15; H66 | |||||
80 | amoksitsilliin | J01CA04 | HICONCIL 125 MG/5 ML suspensioonigraanulid 25mgml 60ml N1 | KRKA, d.d. | 50% | 75% | J13-J15; H66 | |||||
81 | amoksitsilliin | J01CA04 | HICONCIL 250 MG/5 ML suspensioonigraanulid 50mgml 100ml N1 | KRKA, d.d. | 50% | 75% | J13-J15; H66 | |||||
82 | amoksitsilliin | J01CA04 | OSPAMOX 125 MG/5 ML suspensioonigraanulid 25mgml 60ml N1 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
83 | amoksitsilliin | J01CA04 | OSPAMOX 250 MG/5 ML suspensioonigraanulid 50mgml 60ml N1 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
84 | amoksitsilliin | J01CA04 | OSPAMOX kapsel 250mg N10 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
85 | amoksitsilliin | J01CA04 | OSPAMOX kapsel 250mg N12 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
86 | amoksitsilliin | J01CA04 | OSPAMOX tablett 1000mg N10 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
87 | amoksitsilliin | J01CA04 | OSPAMOX tablett 1000mg N100 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
88 | amoksitsilliin | J01CA04 | OSPAMOX tablett 1000mg N12 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
89 | amoksitsilliin | J01CA04 | OSPAMOX tablett 500mg N10 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
90 | amoksitsilliin | J01CA04 | OSPAMOX tablett 500mg N12 | Biochemie GmbH | 50% | 75% | J13-J15; H66 | |||||
91 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 250mg N12 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
92 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 250mg N24 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
93 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 500mg N12 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
94 | amoksitsilliin | J01CA04 | UPSAMOX kapsel 500mg N24 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
72 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 25mgml 100ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
95 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 25mgml 60ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
96 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 50mgml 100ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
97 | amoksitsilliin | J01CA04 | UPSAMOX suspensioonigraanulid 50mgml 60ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15; H66 | |||||
98 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 1000 MG FILM COATED TABLETS tablett 875mg+125mg N10 | LEK d.d | 50% | |||||||
99 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 1000 MG FILM COATED TABLETS tablett 875mg+125mg N14 | LEK d.d | 50% | |||||||
100 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 457MG/5ML POWDER FOR ORAL SUSPENSION suspensioon 400mg+57mg 5ml 35ml N1 | LEK d.d | 50% | |||||||
101 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 457MG/5ML POWDER FOR ORAL SUSPENSION suspensioon 400mg+57mg 5ml 70ml N1 | LEK d.d | 50% | |||||||
102 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 625 MG FILM COATED TABLETS tablett 500mg+125mg N10 | LEK d.d | 50% | |||||||
103 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV 2X 625 MG FILM COATED TABLETS tablett 500mg+125mg N14 | LEK d.d | 50% | |||||||
104 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV FORTE suspensiooni- graanulid 50mg+12,5mgml 100ml N1 |
LEK d.d | 50% | |||||||
105 | amoksitsilliin+klavulaanhape | J01CR02 | AMOKSIKLAV tilgad 50mg+12,5mgml 20ml N1 | LEK d.d | 50% | |||||||
106 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN suspensioonigraanulid 80mg+11,4mgml 70ml N1 | GlaxoSmithKline | 50% | |||||||
107 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 500mg+125mg N14 | GlaxoSmith Kline |
50% | |||||||
108 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 875mg+125mg N12 | GlaxoSmith Kline |
50% | |||||||
109 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 875mg+125mg N14 | GlaxoSmith Kline |
50% | |||||||
110 | amoksitsilliin+klavulaanhape | J01CR02 | AUGMENTIN tablett 875mg+125mg N2 | GlaxoSmith Kline |
50% | |||||||
111 | amoksitsilliin+klavulaanhape | J01CR02 | BETAKLAV tablett 500 mg+125 mg N14 | KRKA, d.d. | 50% | |||||||
112 | amoksitsilliin+klavulaanhape | J01CR02 | BETAKLAV tablett 500 mg+125 mg N21 | KRKA, d.d. | 50% | |||||||
113 | amoksitsilliin+klavulaanhape | J01CR02 | BETAKLAV pulber suspensiooni valmistamiseks 250 mg+62,5 mg/5 ml 13,6 g | KRKA, d.d. | 50% | |||||||
114 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 156,25 MG/5 ML pulber suspensiooniks 25mg+6,25mg/ml 100ml N1 | Biochemie GmbH | 50% | |||||||
115 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 156,25 MG/5 ML pulber suspensiooniks 25mg+6,25mg/ml 60ml N1 | Biochemie GmbH | 50% | |||||||
116 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 156,25 MG/5 ML pulber suspensiooniks 25mg+6,25mg/ml 75ml N1 | Biochemie GmbH | 50% | |||||||
117 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 312,5 MG/5ML pulber suspensiooniks 50mg+12,5mg/ml 100ml N1 | Biochemie GmbH | 50% | |||||||
118 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 312,5 MG/5ML pulber suspensiooniks 50mg+12,5mg/ml 60ml N1 | Biochemie GmbH | 50% | |||||||
119 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 312,5 MG/5ML pulber suspensiooniks 50mg+12,5mg/ml 75ml N1 | Biochemie GmbH | 50% | |||||||
120 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N10 | Biochemie GmbH | 50% | |||||||
121 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N100 | Biochemie GmbH | 50% | |||||||
122 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N12 | Biochemie GmbH | 50% | |||||||
123 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N14 | Biochemie GmbH | 50% | |||||||
124 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N15 | Biochemie GmbH | 50% | |||||||
125 | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N16 | Biochemie GmbH | 50% | |||||||
125a | amoksitsilliin+klavulaanhape | J01CR02 | CURAM 625 MG tablett 500mg+125mg N20 | Biochemie GmbH | 50% | |||||||
126 | amorolfiin | D01AE16 | LOCERYL kreem 0,25% 20g N1 | Galderma | 50% | |||||||
126a | amorolfiin | D01AE16 | LOCERYL küünelakk 5% 2.5ml N1 | Galderma | 50% | |||||||
127 | amorolfiin | D01AE16 | LOCERYL küünelakk 5% 5ml N1 | Galderma | 50% | |||||||
128 | ampitsilliin | J01CA01 | PENTREXYL kapsel 250mg N12 | Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
129 | ampitsilliin | J01CA01 | PENTREXYL kapsel 500mg N12 | Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
130 | ampitsilliin | J01CA01 | PENTREXYL suspensioonigraanulid 25mgml 60ml N1 | Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
130a | ampitsilliin | J01CA01 | PENTREXYL suspensiooni- graanulid 50mgml 100ml N1 |
Bristol- Myers Squibb |
50% | 75% | J13-J15 | |||||
131 | ampitsilliin | J01CA01 | PENTREXYL suspensioonigraanulid 50mgml 60ml N1 | Bristol-Myers Squibb | 50% | 75% | J13-J15 | |||||
131a | ampitsilliin | J01CA01 | STANDACILLIN kapsel 500mg N10 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
132 | ampitsilliin | J01CA01 | STANDACILLIN kapsel 500mg N1000 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
133 | ampitsilliin | J01CA01 | STANDACILLIN kapsel 500mg N12 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
134 | anastrosool | L02BG03 | ARIMIDEX tablett 1mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
135 | artemeeter+lumefantriin | P01BX80 | RIAMET tablett 20mg+120mg N16 | Novartis Pharma | 50% | |||||||
136 | artemeeter+lumefantriin | P01BX80 | RIAMET tablett 20mg+120mg N24 | Novartis Pharma | 50% | |||||||
137 | asatiopriin | L04AX01 | IMURAN TABLETS 25 MG tablett 25mg N100 | Glaxo Wellcome | 50% | 75% | K50*; K51*; K73*; K74*; L10**; L12**; L13.0**; L40***; M07***; M05****; M06****; M08****; M45****; M46****; (M30-M33)****; M35****; (N00-N008)***** | *rv gastroentero- loogil; **rv dermatovenero- loogil; ***rv dermatovenero- loogil ja reumatoloogil; ****rv reumato- loogil; *****rv nefroloogil ja pediaatril |
100% | G70*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
138 | asatiopriin | L04AX01 | IMURAN TABLETS 50 MG tablett 50mg N100 | Glaxo Wellcome | 50% | 75% | K50*; K51*; K73*; K74*; L10**; L12**; L13.0**; L40***; M07***; M05****; M06****; M08****; M45****; M46****; (M30-M33)****; M35****; (N00-N008)***** | *rv gastroentero- loogil; **rv dermatovenero- loogil; ***rv dermatovenero- loogil ja reumatoloogil; ****rv reumato- loogil; *****rv nefroloogil ja pediaatril |
100% | G70*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
138a | aselaiinhape | D10AX03 | SKINOREN kreem 20% 30g N1 | Schering AG | 50% | |||||||
139 | aselastiin | S01GX80 | ALLERGODIL silmatilgad 0,05% 6ml N1 | Asta Medica | 50% | |||||||
139A | asitromütsiin | J01FA10 | SUMAMED FORTE suspensioonigraanulid 40mg/ml 40ml N1 | Pliva | 50% | |||||||
140 | asitromütsiin | J01FA10 | SUMAMED kapsel 250mg N6 | Pliva | 50% | |||||||
141 | asitromütsiin | J01FA10 | SUMAMED suspensioonigraanulid 20mg/ml 20ml N1 | Pliva | 50% | |||||||
142 | asitromütsiin | J01FA10 | SUMAMED tablett 500mg N3 | Pliva | 50% | |||||||
142a | atenolool | C07AB03 | ATENODEKS 100 MG TABLETES tablett 100mg N28 | Grindeks | 50% | 75% | I10-I13; I15; I20 | |||||
143 | atenolool | C07AB03 | ATENODEKS 25 MG TABLETES tablett 25mg N20 | Grindeks | 50% | 75% | I10-I13; I15; I20 | |||||
144 | atenolool | C07AB03 | ATENODEKS 50 MG TABLETES tablett 50mg N28 | Grindeks | 50% | 75% | I10-I13; I15; I20 | |||||
144a | atenolool | C07AB03 | ATENOLAN tablett 100mg N20 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
146 | atenolool | C07AB03 | ATENOLAN tablett 100mg N50 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
149 | atenolool | C07AB03 | ATENOLAN tablett 50mg N20 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
149a | atenolool | C07AB03 | ATENOLAN tablett 50mg N50 | Lannacher | 50% | 75% | I10-I13; I15; I20 | |||||
147 | atenolool | C07AB03 | ATENOLOL ALPHARMA TABLETS 50 MG tablett 50mg N30 | ALPHARMA | 50% | 75% | I10-I13; I15; I20 | |||||
147a | atenolool | C07AB03 | ATENOLOL NYCOMED 50 MG tablett 50mg N30 | Nycomed SEFA | 50% | 75% | I10-I13; I15; I20 | |||||
150 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 100 tablett 100mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
151 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 100 tablett 100mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
152 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 100 tablett 100mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
145 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 25 tablett 25mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
148 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 25 tablett 25mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
148a | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 25 tablett 25mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
153 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
154 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 50 tablett 50mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
155 | atenolool | C07AB03 | ATENOLOL-RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I20 | |||||
155a | atenolool | C07AB03 | ATENOSAN tablett 100mg N28 | Sanofi | 50% | 75% | I10-I13; I15; I20 | |||||
156 | atenolool | C07AB03 | ATENOSAN tablett 50mg N28 | Sanofi | 50% | 75% | I10-I13; I15; I20 | |||||
157 | atenolool | C07AB03 | TENORMIN tablett 100mg N28 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I20 | |||||
157a | atenolool | C07AB03 | TENORMIN tablett 50mg N28 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I20 | |||||
158 | atorvastatiin | C10AA05 | SORTIS tablett 10mg N100 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
159 | atorvastatiin | C10AA05 | SORTIS tablett 10mg N30 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
160 | atorvastatiin | C10AA05 | SORTIS tablett 10mg N50 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
161 | atorvastatiin | C10AA05 | SORTIS tablett 20mg N100 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
162 | atorvastatiin | C10AA05 | SORTIS tablett 20mg N30 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
163 | atorvastatiin | C10AA05 | SORTIS tablett 20mg N50 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
164 | atorvastatiin | C10AA05 | SORTIS tablett 40mg N100 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
165 | atorvastatiin | C10AA05 | SORTIS tablett 40mg N30 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
166 | atorvastatiin | C10AA05 | SORTIS tablett 40mg N50 | Pfizer H.C.P | 50% | 75% | E78* | *(2) | ||||
167 | atropiin | S01FA01 | ISOPTO ATROPINE silmatilgad 1% 5 ml N1 | Alcon | 50% | |||||||
170 | atsetüülsalit- süülhape+ metoklop- ramiid |
N02BA92 | MIGPRIV pulber lahuseks 900mg+10mg N6 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
171 | atsetüül- tsüsteiin |
R05CB01 | ACC 600 HOT graanulid lahuseks 600mg 1annus N6 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
174 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N10 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
172 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N100 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
173 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N20 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
168 | atsetüül- tsüsteiin |
R05CB01 | ACC LONG lahustuv tablett 600mg N50 | Hexal AG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
169 | atsetüül- tsüsteiin |
R05CB01 | ACETYLCYSTEIN 600 STADA TABS tablett 600mg N10 | Stada | 50% | 100% | E84* | *rev pulmonoloogil | ||||
175 | atsetüül- tsüsteiin |
R05CB01 | ACETYLCYSTEIN 600 STADA TABS tablett 600mg N20 | Stada | 50% | 100% | E84* | *rev pulmonoloogil | ||||
176 | atsetüül- tsüsteiin |
R05CB01 | ACETYLCYSTEIN 600 STADA TABS tablett 600mg N50 | Stada | 50% | 100% | E84* | *rev pulmonoloogil | ||||
177 | atsitretiin | D05BB02 | NEOTIGASON kapsel 10mg N30 | Roche | 50% | 75% | L40*; L86*; M07*; Q80*; Q82.8* | *rv dermatovenero- loogil |
||||
178 | atsükloviir | D06BB03 | ACYCLOVIR STADA, CREAM kreem 5% 20g N1 | Stada | 50% | |||||||
179 | atsükloviir | D06BB03 | SUPRAVIRAN kreem 5% 20g N1 | Grünenthal GmbH | 50% | |||||||
180 | atsükloviir | J05AB01 | ACIC 200 tablett 200mg N100 | Hexal AG | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
181 | atsükloviir | J05AB01 | ACIC 200 tablett 200mg N25 | Hexal AG | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
182 | atsükloviir | J05AB01 | ACICLOVIR tablett 200 mg N20 | Balkanpharma- Troyan |
50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
183 | atsükloviir | J05AB01 | ACICLOVIR tablett 400 mg N10 | Balkanpharma- Troyan |
50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
184 | atsükloviir | J05AB01 | ACICLOVIR ALPHARMA TABLETS 200 MG tablett 200mg N30 | ALPHARMA | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
185 | atsükloviir | J05AB01 | ACICLOVIR ALPHARMA TABLETS 400 MG tablett 400mg N30 | ALPHARMA | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
186 | atsükloviir | J05AB01 | ACICLOVIR ALPHARMA TABLETS 800 MG tablett 800mg N35 | ALPHARMA | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
187 | atsükloviir | J05AB01 | ACYCLOVIR TFT tablett 200mg N25 | TFT | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
188 | atsükloviir | J05AB01 | ACYCLOVIR TFT tablett 200mg N30 | TFT | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
189 | atsükloviir | J05AB01 | PROVIRSAN tablett 200mg N30 | PRO. MED. CS. PRAHA a.s. | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
190 | atsükloviir | J05AB01 | ZOVIRAX TABLETS 200 MG tablett 200mg N25 | Glaxo Wellcome | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
191 | atsükloviir | J05AB01 | VIROLEX tablett 200mg N20 | KRKA, d.d. | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
192 | atsükloviir | J05AB01 | XOROX tablett 200mg N25 | Kwizda | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
193 | atsükloviir | J05AB01 | XOROX tablett 400mg N60 | Kwizda | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
194 | atsükloviir | J05AB01 | XOROX tablett 800mg N35 | Kwizda | 50% | 100% | (D60-D64)*; T86** | *rv hematoloogil; **rv patsienti jälgival ja ravival arstil | ||||
195 | atsükloviir | S01AD03 | ZOVIRAX OPHTHALMIC OINTMENT 3% silmasalv 3% 4.5g N1 | Glaxo Wellcome | 50% | |||||||
196 | atsükloviir | S01AD03 | VIROLEX silmasalv 3% 4.5g N1 | KRKA, d.d. | 50% | |||||||
197 | atsükloviir | S01AD03 | XOROX silmasalv 3% 4.5g N1 | Kwizda | 50% | |||||||
198 | auranofiin | M01CB03 | RIDAURA tablett 3mg N100 | Goldshield | 50% | 75% | M05*; M06*; M08*; M45*; M46* | *rv reumatoloogil | ||||
199 | batsiratsiin+ neomütsiin |
D06AX80 | BANEOCIN OINTMENT salv 250TÜ+mg+5TÜ+mgg 20g N1 | Biochemie GmbH | 50% | |||||||
200 | batsiratsiin+ neomütsiin |
D06AX80 | BANEOCIN POWDER puistepulber 250TÜ+mg+5TÜ+mgg 10g N1 | Biochemie GmbH | 50% | |||||||
201 | beetahistiin | N07CA01 | BETASERC tablett 16mg N60 | Solvay Pharmaceuticals | 50% | |||||||
202 | beetahistiin | N07CA01 | BETASERC tablett 8mg N100 | Solvay Pharmaceuticals | 50% | |||||||
203 | beetametasoon | D07AC01 | BETNOVATE CREAM kreem 0,1% 15g N1 | Glaxo Wellcome | 50% | |||||||
204 | beetametasoon | D07AC01 | BETNOVATE OINTMENT salv 0,1% 15g N1 | Glaxo Wellcome | 50% | |||||||
205 | beetametasoon | D07AC01 | CELESTODERM-V kreem 1mgg 30g N1 | Schering-Plough | 50% | |||||||
206 | beetametasoon | D07AC01 | CELESTODERM-V kreem 1mgg 50g N1 | Schering-Plough | 50% | |||||||
207 | beetametasoon | D07AC01 | CELESTODERM-V salv 1mgg 30g N1 | Schering-Plough | 50% | |||||||
208 | beetametasoon+fusiidhape | D07CC80 | FUCICORT kreem 0,1%+2% 15g N1 | Leo | 50% | |||||||
209 | beetametasoon+neomütsiin | D07CC81 | BETNOVATE N CREAM kreem 0,1%+0,5% 15g N1 | Glaxo Wellcome | 50% | |||||||
210 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC lahus 0,05%+2% 30ml N1 | Schering-Plough | 50% | |||||||
211 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC lahus 0,05%+2% 50ml N1 | Schering-Plough | 50% | |||||||
212 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC salv 0,05%+3% 20g N1 | Schering-Plough | 50% | |||||||
213 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC salv 0,05%+3% 30g N1 | Schering-Plough | 50% | |||||||
215 | beetametasoon+salitsüülhape | D07BC80 | DIPROSALIC salv 0,05%+3% 50g N1 | Schering-Plough | 50% | |||||||
219 | bekaplermiin | D03AX06 | REGRANEX geel 0,01% 15g N1 | Cilag | 50% | |||||||
220 | beklometasoon | R01AD01 | BECLONASAL FORTE AQUA ninasprei 0,1mg/annuses 30ml N1 | Orion | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
223 | beklometasoon | R01AD01 | BECONASE AQUEOUS NASAL SPRAY 50 MCG ninasprei 50mcg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
224 | beklometasoon | R03BA01 | BECLOFORTE inhal aeros 0,25mg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
214 | beklometasoon | R03BA01 | BECLOMET EASYHALER inhalatsioonipulber 200mcg/annuses 200annust N1 | Orion | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
216 | beklometasoon | R03BA01 | BECLOMET inhal aeros 0,05mg/annuses 200annust N1 | Orion | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
217 | beklometasoon | R03BA01 | BECOTIDE BECODISKS inhalatsioonipulber 0,1mg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
218 | beklometasoon | R03BA01 | BECOTIDE BECODISKS inhalatsioonipulber 0,2mg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
221 | beklometasoon | R03BA01 | BECOTIDE inhal aeros 0,05mg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
222 | beklometasoon | R03BA01 | ECOBEC 100 MCG EASI-BREATHE inhal aeros 100mcg/annus 200annust N1 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
225 | beklometasoon | R03BA01 | ECOBEC 100 MCG EASI-BREATHE inhal aeros 100mcg/annus 200annust N3 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
226 | beklometasoon | R03BA01 | ECOBEC 100 MCG inhal aeros 100mcg/annus 200annust N1 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
227 | beklometasoon | R03BA01 | ECOBEC 250 MCG EASI-BREATHE inhal aeros 250mcg/annus N200 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
228 | beklometasoon | R03BA01 | ECOBEC 250 MCG inhal aeros 250mcg/annus 200annust N1 | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
229 | beklometasoon | R03BA01 | NASOBEC sprei 50 mcg/1 annuses 200 annust 30 ml | IVAX - CR a.s. | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv pediaatril ja pulmonoloogil |
||||
230 | bensatiinbensüülpenitsilliin | J01CE08 | RETARPEN 2.4 injektsioonisubstants 2,4miljTÜ N1 | Biochemie GmbH | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
231 | bensatiinbensüülpenitsilliin | J01CE08 | RETARPEN 2.4 injektsioonisubstants 2,4miljTÜ N50 | Biochemie GmbH | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
232 | bensüülpenitsilliin | J01CE01 | PENICILLIN G injektsioonisubstants 1000000TÜ N10 | Balkanpharma-Razgrad | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
233 | bensüülpenitsilliin | J01CE01 | PENICILLIN G injektsioonisubstants 1000000TÜ N100 | Balkanpharma-Razgrad | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
234 | bensüülpenitsilliin | J01CE01 | PENICILLIN G injektsioonisubstants 1000000TÜ N50 | Balkanpharma-Razgrad | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
235 | bensüülpenitsilliin | J01CE01 | PENICILLIN G SODIUM “BIOCHEMIE” 1000000 IU VIAL injektsioonisubstants 1000000TÜ N1 | Biochemie GmbH | 50% | 100% | (A50-A53)* | *rv dermatove- neroloogil |
||||
236 | betaksolool | S01ED02 | BETOPTIC S silmasuspensioon 0,25% 5ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
237 | betaksolool | S01ED02 | BETOPTIC silmatilgad 0,5% 5 ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
238 | bikalutamiid | L02BB03 | CASODEX 150 tablett 150mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
239 | bikalutamiid | L02BB03 | CASODEX tablett 50mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
240 | biperideen | N04AA02 | AKINETON tablett 2mg N100 | Abbott GmbH & Co. KG | 50% | 100% | G20* | *rev neuroloogil | ||||
241 | biperideen | N04AA02 | AKINETON tablett 2mg N50 | Abbott GmbH & Co. KG | 50% | 100% | G20* | *rev neuroloogil | ||||
242 | brinsolamiid | S01EC04 | AZOPT silmatilgad 1% 5ml N1 | Alcon Inc. | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
243 | brivudiin | J05AB82 | VIZORAX tablett 125 mg N1 | Berlin-Chemie | 50% | |||||||
244 | brivudiin | J05AB82 | VIZORAX tablett 125 mg N7 | Berlin-Chemie | 50% | |||||||
245 | brivudiin | J05AB82 | VIZORAX tablett 125 mg N35 | Berlin-Chemie | 50% | |||||||
246 | bromokriptiin | G02CB01 | BROMERGON 10 MG TABLETS tablett 10mg N30 | LEK d.d | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
247 | bromokriptiin | G02CB01 | BROMERGON 2,5 MG TABLETS tablett 2,5mg N30 | LEK d.d | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
248 | bromokriptiin | G02CB01 | BROMOCRIPTIN-RICHTER tablett 2,5mg N30 | Richter | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
249 | bromokriptiin | G02CB01 | PARLODEL tablett 2,5mg N100 | Novartis Pharma | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
250 | bromokriptiin | G02CB01 | PARLODEL tablett 2,5mg N30 | Novartis Pharma | 50% | 100% | E22*; E24*;
G20** |
*rev endokrinoloogil; **rev neuroloogil | ||||
251 | budesoniid | A07EA06 | ENTOCORT 3 MG retardkapsel 3mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
252 | budesoniid | A07EA06 | ENTOCORT 3 MG retardkapsel 3mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
253 | budesoniid | A07EA06 | ENTOCORT lahustuv tabl+ lahusti 2mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K50-K51)* | *rv gastroenteroloogil | ||||
254 | budesoniid | D07AC09 | APULEIN 0,025% CREAM kreem 0,025% 15g N1 | Richter | 50% | |||||||
255 | budesoniid | D07AC09 | APULEIN 0,025% OINTMENT salv 0,025% 15g N1 | Richter | 50% | |||||||
256 | budesoniid | R01AD05 | RHINOCORT AQUA 32 MCG/DOSE ninasprei 32mcg/annuses 10ml N120 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
257 | budesoniid | R01AD05 | RHINOCORT AQUA 50 MCG/DOSE ninasprei 50mcg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
258 | budesoniid | R01AD05 | RHINOCORT AQUA 64 MCG/DOSE ninasprei 64mcg/annuses 10ml N120 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
259 | budesoniid | R01AD05 | TAFEN NASAL ninasprei 50mcg/annuses 200annust N1 | LEK d.d | 50% | 75% | J45* | *rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
260 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 100mcg/annuses 200 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
261 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 200mcg/annus 100 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
262 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 200mcg/annus 200 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
263 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 400mcg/annus 50 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
264 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 400mcg/annus 100 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
265 | budesoniid | R03BA02 | EASI-CORT inhalatsioonipulber 400mcg/annus 200 annust | IVAX - CR a.s. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
266 | budesoniid | R03BA02 | PULMICORT inhal aeros 50mcg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
267 | budesoniid | R03BA02 | PULMICORT SUSPENSION FOR NEBULISATION 0,125 MG/ML nebulisaatori susp. 0,125mg/ml 2ml N20 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
268 | budesoniid | R03BA02 | PULMICORT SUSPENSION FOR NEBULISATION 0,25 MG/ML nebulisaatori susp. 0,25mg/ml 2ml N20 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
269 | budesoniid | R03BA02 | PULMICORT SUSPENSION FOR NEBULISATION 0,5 MG/ML nebulisaatori susp. 0,5mg/ml 2 ml N20 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
270 | budesoniid | R03BA02 | PULMICORT TURBUHALER inhalatsioonipulber 0,1mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
271 | budesoniid | R03BA02 | PULMICORT TURBUHALER inhalatsioonipulber 0,2mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
272 | budesoniid | R03BA02 | PULMICORT TURBUHALER inhalatsioonipulber 0,4mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
273 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 160mcg+4,5mcg/annus 120annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
274 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 160mcg+4,5mcg/annus 60annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
275 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 80mcg+4,5mcgannus 120annus N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
276 | budesoniid+formoterool | R03AK83 | SYMBICORT TURBUHALER inhalatsioonipulber 80mcg+4,5mcgannus 60annus N1 | AstraZeneca UK Ltd. | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil | ||||
277 | busereliin | L02AE01 | SUPRECUR ninasprei 0,15mg/annuses 10g N2 | Aventis Pharma Deutschland | 50% | |||||||
278 | busereliin | L02AE01 | SUPREFACT DEPOT implantaat 6,3mg 2 N1 | Aventis Pharma Deutschland | 50% | |||||||
279 | buspiroon | N05BE01 | BUSPAR tablett 10mg N60 | Bristol-Myers Squibb | 50% | |||||||
280 | busulfaan | L01AB01 | MYLERAN TABLETS tablett 2mg N100 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
281 | butenafiin | D01AE82 | MENTAX kreem 1% 10g N1 | KAKEN PHARMACEUTICAL Co., | 50% | |||||||
282 | butüülskopolamiin | A03BB01 | BUSCOPAN drazhee 10mg N20 | Boehringer Ingelheim | 50% | |||||||
283 | butüülskopolamiin | A03BB01 | BUSCOPAN suposiit 10mg N10 | Boehringer Ingelheim | 50% | |||||||
284 | candesartaan | C09CA80 | ATACAND tablett 16mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
285 | candesartaan | C09CA80 | ATACAND tablett 16mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
286 | candesartaan | C09CA80 | ATACAND tablett 4mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
287 | candesartaan | C09CA80 | ATACAND tablett 4mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
288 | candesartaan | C09CA80 | ATACAND tablett 8mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
289 | candesartaan | C09CA80 | ATACAND tablett 8mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
290 | daltepariin | B01AB04 | FRAGMIN süstelahus 10000TÜ 0.4ml N5 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
291 | daltepariin | B01AB04 | FRAGMIN süstelahus 12500TÜ 0.5ml N5 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
292 | daltepariin | B01AB04 | FRAGMIN süstelahus 12500TÜ anti Xa/ml 0.2ml N10 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
293 | daltepariin | B01AB04 | FRAGMIN süstelahus 25000TÜ anti Xa/ml 0.2ml N10 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
294 | daltepariin | B01AB04 | FRAGMIN süstelahus 7500TÜ 0.3ml N10 | Pharmacia Enterprises | 50% | 75% | O99.8 | |||||
295 | danasool | G03XA01 | DANOL kapsel 100mg N100 | Sanofi | 50% | 75% | N80* | *rv günekoloogil | ||||
296 | danasool | G03XA01 | DANOL kapsel 200mg N100 | Sanofi | 50% | 75% | N80* | *rv günekoloogil | ||||
297 | deksametasoon | H02AB02 | DEXAMETASON tablett 0,5mg N100 | Orion | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
298 | deksametasoon | H02AB02 | DEXAMETASON tablett 0,5mg N30 | Orion | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
299 | deksametasoon | H02AB02 | DEXAMETHASON 4 MG/ML süstelahus 4mgml 1ml N25 | KRKA, d.d. | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
300 | deksametasoon | H02AB02 | DEXAMETHASONE tablett 0,5mg N10 | KRKA, d.d. | 50% | 75% | L10*; L12*; L13.0* | *rv dermatoveneroloogil | 100% | (C00-D48)*; E23**;
E25**; E27**; E89.3**; E89.6**; T86*** |
*rv onkoloogil ja hematoloogil; **rev endokrinoloogil; ***rv patsienti jälgival ja ravival arstil | |
301 | deksametasoon | S01BA01 | MAXIDEX OINTMENT silmasalv 1mg/g 3.5g N1 | Alcon n.v. | 50% | |||||||
302 | deksametasoon | S01BA01 | MAXIDEX silmasuspensioon 0,1% 5 ml N1 | Alcon | 50% | |||||||
303 | deksametasoon | S01BA01 | OFTAN DEXA silmatilgad 0,1% 5 ml N1 | Santen | 50% | |||||||
304 | deksametasoon+gramitsidiin+framütsetiin | S03CA01 | SOFRADEX silma- ja kõrvatilgad 0,05%+0,005%+0,5% 8 ml N1 | Aventis Pharma Ltd. | 50% | |||||||
305 | deksametasoon+klooramfenikool | S01CA82 | OFTAN DEXA-CHLORA silmasalv 0,1%+0,2% 3.5g N1 | Santen | 50% | |||||||
306 | deksametasoon+klooramfenikool | S01CA82 | OFTAN DEXA-CHLORA silmatilgad 0,1%+0,2% 10 ml N1 | Santen | 50% | |||||||
307 | deksametasoon+neomütsiin+polümüksiin B | S01CA80 | MAXITROL silmasuspensioon 6000TÜ/ml+0,1%+3500TÜ/ml 5 ml N1 | Alcon | 50% | |||||||
308 | deksametasoon+tobramütsiin | S01CA81 | TOBRADEX silmasuspensioon 0,1%+0,3% 5 ml N1 | Alcon | 50% | |||||||
309 | deksketoprofeen | M01AE17 | DOLMEN tablett 25mg N10 | Berlin-Chemie | 50% | |||||||
310 | deksketoprofeen | M01AE17 | DOLMEN tablett 25mg N30 | Berlin-Chemie | 50% | |||||||
311 | deksketoprofeen | M01AE17 | DOLMEN tablett 25mg N50 | Berlin-Chemie | 50% | |||||||
312 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 30 ml | Schering-Plough | 50% | |||||||
313 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 50 ml | Schering-Plough | 50% | |||||||
314 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 60 ml | Schering-Plough | 50% | |||||||
315 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 100 ml | Schering-Plough | 50% | |||||||
316 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 120 ml | Schering-Plough | 50% | |||||||
317 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 150 ml | Schering-Plough | 50% | |||||||
318 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 225 ml | Schering-Plough | 50% | |||||||
319 | Desloratadiin | R06AX27 | AERIUS siirup 0,5 mg/ml 300 ml | Schering-Plough | 50% | |||||||
320 | Desloratadiin | R06AX27 | AERIUS tablett 5mg N10 | Schering-Plough | 50% | |||||||
321 | Desloratadiin | R06AX27 | AERIUS tablett 5mg N2 | Schering-Plough | 50% | |||||||
322 | Desloratadiin | R06AX27 | AERIUS tablett 5mg N30 | Schering-Plough | 50% | |||||||
323 | desmopressiin | H01BA02 | MINIRIN ninasprei 10mcg/annuses 2.5ml N1 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
324 | desmopressiin | H01BA02 | MINIRIN ninasprei 10mcg/annuses 5ml N1 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
325 | desmopressiin | H01BA02 | MINIRIN tablett 0,1mg N15 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
326 | desmopressiin | H01BA02 | MINIRIN tablett 0,1mg N30 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
327 | desmopressiin | H01BA02 | MINIRIN tablett 0,1mg N90 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
328 | desmopressiin | H01BA02 | MINIRIN tablett 0,2mg N15 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
329 | desmopressiin | H01BA02 | MINIRIN tablett 0,2mg N30 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
330 | desmopressiin | H01BA02 | MINIRIN tablett 0,2mg N90 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
331 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 1ml N10 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
332 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 1ml N5 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
333 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 2ml N10 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
334 | desmopressiin | H01BA02 | OCTOSTIM süstelahus 15mcg/ml 2ml N5 | Ferring AB | 50% | 100% | E23* | *rev endokrinoloogil | ||||
335 | desogestreel | G03AC09 | CERAZETTE tablett 0,075mg N168 | N.V. ORGANON | 50% | 75% | Z30 | |||||
336 | desogestreel | G03AC09 | CERAZETTE tablett 0,075mg N28 | N.V. ORGANON | 50% | 75% | Z30 | |||||
337 | desogestreel | G03AC09 | CERAZETTE tablett 0,075mg N84 | N.V. ORGANON | 50% | 75% | Z30 | |||||
338 | desogestreel+etünüülöstradiool | G03AA09 | JENETTEN drazhee 0,15mg+0,03mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
339 | desogestreel+etünüülöstradiool | G03AA09 | MARVELON tablett 0,15mg+0,03mg N126 | N.V. ORGANON | 50% | 75% | Z30 | |||||
340 | desogestreel+etünüülöstradiool | G03AA09 | MARVELON tablett 0,15mg+0,03mg N21 | N.V. ORGANON | 50% | 75% | Z30 | |||||
341 | desogestreel+etünüülöstradiool | G03AA09 | MARVELON tablett 0,15mg+0,03mg N63 | N.V. ORGANON | 50% | 75% | Z30 | |||||
342 | desogestreel+etünüülöstradiool | G03AA09 | MERCILON tablett 0,15mg+0,02mg N21 | N.V. ORGANON | 50% | 75% | Z30 | |||||
343 | desogestreel+etünüülöstradiool | G03AA09 | MERCILON tablett 0,15mg+0,02mg N63 | N.V. ORGANON | 50% | 75% | Z30 | |||||
344 | desogestreel+etünüülöstradiool | G03AA09 | NOVYNETTE tablett 0,15mg+0,02mg N21 | Richter | 50% | 75% | Z30 | |||||
345 | desogestreel+etünüülöstradiool | G03AA09 | NOVYNETTE tablett 0,15mg+0,02mg N63 | Richter | 50% | 75% | Z30 | |||||
346 | desogestreel+etünüülöstradiool | G03AA09 | REGULON tablett 0,15mg+0,03mg N21 | Richter | 50% | 75% | Z30 | |||||
347 | desogestreel+etünüülöstradiool | G03AA09 | REGULON tablett 0,15mg+0,03mg N63 | Richter | 50% | 75% | Z30 | |||||
348 | desogestreel+etünüülöstradiool | G03AA09 | VILONET tablett 0,15mg+0,03mg N21 | Wyeth-Pharma | 50% | 75% | Z30 | |||||
349 | kloormadinoon+etünüülöstradiool | G03AA80 | BELARA filmtabletid 2 mg+30 mcg N21 | Grünenthal GmbH | 50% | 75% | Z30 | |||||
350 | kloormadinoon+etünüülöstradiool | G03AA80 | BELARA filmtabletid 2 mg+30 mcg N3X21 | Grünenthal GmbH | 50% | 75% | Z30 | |||||
351 | desogestreel+etünüülöstradiool | G03AB05 | GRACIAL tablett N22 | N.V. ORGANON | 50% | 75% | Z30 | |||||
352 | desogestreel+etünüülöstradiool | G03AB05 | TRIMIRON tablett N21 | N.V. ORGANON | 50% | 75% | Z30 | |||||
353 | diasepaam | N05BA01 | DIAZEPAM DESITIN rektaaltuub 10mg N5 | Desitin | 50% | |||||||
354 | diasepaam | N05BA01 | DIAZEPAM DESITIN rektaaltuub 5mg N5 | Desitin | 50% | |||||||
355 | didanosiin | J05AB07 | VIDEX EC 125 MG gastroresistentne kapsel 125mg N30 | Bristol-Myers Squibb | 50% | |||||||
356 | didanosiin | J05AB07 | VIDEX EC 200 MG gastroresistentne kapsel 200mg N30 | Bristol-Myers Squibb | 50% | |||||||
357 | didanosiin | J05AB07 | VIDEX EC 250 MG gastroresistentne kapsel 250mg N30 | Bristol-Myers Squibb | 50% | |||||||
358 | didanosiin | J05AB07 | VIDEX EC 400 MG gastroresistentne kapsel 400mg N30 | Bristol-Myers Squibb | 50% | |||||||
359 | didanosiin | J05AB07 | VIDEX tablett 100mg N60 | Bristol-Myers Squibb | 50% | |||||||
360 | didanosiin | J05AB07 | VIDEX tablett 150mg N60 | Bristol-Myers Squibb | 50% | |||||||
361 | didanosiin | J05AB07 | VIDEX tablett 200mg N60 | Bristol-Myers Squibb | 50% | |||||||
362 | didanosiin | J05AB07 | VIDEX tablett 25mg N60 | Bristol-Myers Squibb | 50% | |||||||
363 | didanosiin | J05AB07 | VIDEX tablett 50mg N60 | Bristol-Myers Squibb | 50% | |||||||
364 | dienogest+etünüülöstradiool | G03AA81 | JEANINE tablett 2mg+0,03mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
365 | dienogest+etünüülöstradiool | G03AA81 | JEANINE tablett 2mg+0,03mg N63 | Jenapharm | 50% | 75% | Z30 | |||||
366 | dienogest+östradiool | G03FA15 | KLIMODIEN kaetud tablett 2mg N3x28 | Schering AG | 50% | |||||||
367 | dienogest+östradiool | G03FA15 | KLIMODIEN kaetud tablett 2mg N28 | Schering AG | 50% | |||||||
368 | difenhüdramiin | R06AA02 | DIMEDROL tablett 50mg tabl N10 | TFT | 50% | |||||||
369 | digoksiin | C01AA05 | DIGOXIN NYCOMED 0,25 MG tablett 0,25mg N50 | Nycomed SEFA | 50% | 75% | I50 | |||||
370 | digoksiin | C01AA05 | DIGOXIN NYCOMED 62,5 MCG tablett 62,5mcg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
371 | digoksiin | C01AA05 | DIGOXIN TFT tablett 0,25mg N25 | TFT | 50% | 75% | I50 | |||||
372 | digoksiin | C01AA05 | DIGOXIN TFT tablett 0,25mg N50 | TFT | 50% | 75% | I50 | |||||
373 | digoksiin | C01AA05 | LANOXIN tablett 0,25mg N100 | Glaxo Wellcome | 50% | 75% | I50 | |||||
374 | dihüdroergotamiin | N02CA01 | NEOMIGRAN ninasprei 4mg/ml 1ml N1 | Novartis Pharma | 50% | |||||||
375 | dihüdrokodeiin | N02AA08 | DHC CONTINUS retardtablett 120mg N56 | Mundipharma Austria | 50% | |||||||
376 | dihüdrokodeiin | N02AA08 | DHC CONTINUS retardtablett 60mg N56 | Mundipharma Austria | 50% | |||||||
377 | dihüdrokodeiin | N02AA08 | DHC CONTINUS retardtablett 90mg N56 | Mundipharma Austria | 50% | |||||||
378 | dihüdrotahhüsterool | A11CC02 | TACHYSTIN LIQUIDUM suukaudne lahus 1mg/ml 20ml N1 | ANKERPHARM | 50% | 100% | E20*; E89.2* | *rv endokrinoloogil | ||||
379 | diklofenak | M01AB05 | CATAFLAM tablett 25mg N20 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
380 | diklofenak | M01AB05 | CATAFLAM tablett 25mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
381 | diklofenak | M01AB05 | CATAFLAM tablett 50mg N20 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
382 | diklofenak | M01AB05 | CATAFLAM tablett 50mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
383 | diklofenak | M01AB05 | DICLAC 100 suposiit 100mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
384 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
385 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N100 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
386 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
387 | diklofenak | M01AB05 | DICLAC 150 ID retardtablett 150mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
388 | diklofenak | M01AB05 | DICLAC 50 suposiit 50mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
389 | diklofenak | M01AB05 | DICLAC 50 suposiit 50mg N5 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
390 | diklofenak | M01AB05 | DICLAC 50 TABL tablett 50mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
391 | diklofenak | M01AB05 | DICLAC 50 TABL tablett 50mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
392 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N10 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
393 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N100 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
394 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
395 | diklofenak | M01AB05 | DICLAC 75 ID retardtablett 75mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
396 | diklofenak | M01AB05 | DICLAC RETARD retardtablett 100mg N100 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
397 | diklofenak | M01AB05 | DICLAC RETARD retardtablett 100mg N20 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
398 | diklofenak | M01AB05 | DICLAC RETARD retardtablett 100mg N50 | Hexal AG | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
399 | diklofenak | M01AB05 | DICLOBERL RETARD retardkapsel 100mg N50 | Berlin-Chemie | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
400 | diklofenak | M01AB05 | DICLOFENAC 100 STADA RETARD retardtablett 100mg N20 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
401 | diklofenak | M01AB05 | DICLOFENAC 25 STADA Gastroresistentne tablett 25mg N100 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
402 | diklofenak | M01AB05 | DICLOFENAC 25 STADA Gastroresistentne tablett 25mg N20 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
403 | diklofenak | M01AB05 | DICLOFENAC 25 STADA Gastroresistentne tablett 25mg N50 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
404 | diklofenak | M01AB05 | DICLOFENAC 50 STADA enterotablett 50mg N100 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
405 | diklofenak | M01AB05 | DICLOFENAC 50 STADA enterotablett 50mg N20 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
406 | diklofenak | M01AB05 | DICLOFENAC 50 STADA enterotablett 50mg N50 | Stada | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
407 | diklofenak | M01AB05 | DICLOFENAC DUO BMS retardkapsel 75mg N30 | Bristol-Myers Squibb | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
408 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 25 enterotablett 25mg N20 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
409 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 25 enterotablett 25mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
410 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 50 enterotablett 50mg N20 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
411 | diklofenak | M01AB05 | DICLOFENAC- RATIOPHARM 50 enterotablett 50mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
412 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM 100 suposiit 100mg N10 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
413 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM 50 suposiit 50mg N10 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
414 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM 50 suposiit 50mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
415 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N10 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
416 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N100 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
417 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N20 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
418 | diklofenak | M01AB05 | DICLOFENAC-RATIOPHARM UNO retardtablett 150mg N50 | ratiopharm | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
419 | diklofenak | M01AB05 | DICLOMELAN 50 mg tablett 50mg N10 | Lannacher | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
420 | diklofenak | M01AB05 | DICLOMELAN RETARD 100 mg retardtablett 100mg N30 | Lannacher | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
421 | diklofenak | M01AB05 | DICLOMELAN suposiit 100mg N6 | Lannacher | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
422 | diklofenak | M01AB05 | INFLAMAC 50 gastroresistentne kapsel 50mg N20 | Spirig | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
423 | diklofenak | M01AB05 | INFLAMAC 75 SR retardkapsel 75mg N20 | Spirig | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
424 | diklofenak | M01AB05 | NAKLOFEN DUO kapsel 75mg N20 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
425 | diklofenak | M01AB05 | NAKLOFEN ENTEROTABLETT enterotablett 50mg N20 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
426 | diklofenak | M01AB05 | NAKLOFEN RETARD retardtablett 100mg N20 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
427 | diklofenak | M01AB05 | NAKLOFEN SUPOSIIT suposiit 50mg N10 | KRKA, d.d. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
428 | diklofenak | M01AB05 | OLFEN-100 RECTOCAPS rektaalkapsel 100 mg N 5 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
429 | diklofenak | M01AB05 | OLFEN-100 SR DEPOCAPS retardkapsel 100mg N20 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
430 | diklofenak | M01AB05 | OLFEN-25 LACTAB enterotablett 25mg N30 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
431 | diklofenak | M01AB05 | OLFEN-50 LACTAB enterotablett 50mg N20 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
432 | diklofenak | M01AB05 | OLFEN-50 RECTOCAPS rektaalkapsel 50 mg N10 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
433 | diklofenak | M01AB05 | OLFEN-75 SR DEPOTABS retardtablett 75mg N30 | MEPHA Ltd. | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
434 | diklofenak | M01AB05 | SANFINAC tablett 25mg N100 | Sanofi | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
435 | diklofenak | M01AB05 | SANFINAC tablett 50mg N100 | Sanofi | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
436 | diklofenak | M01AB05 | VERAL 100 MG suposiit 100mg N10 | Slovakofarma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
437 | diklofenak | M01AB05 | VERAL 50 MG enterotablett 50mg N20 | Slovakofarma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
438 | diklofenak | M01AB05 | VERAL 50 MG enterotablett 50mg N50 | Slovakofarma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
439 | diklofenak | M01AB05 | VOLTAREN 100 suposiit 100mg N5 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
440 | diklofenak | M01AB05 | VOLTAREN 25 enterotablett 25mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
441 | diklofenak | M01AB05 | VOLTAREN 25 suposiit 25mg N10 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
442 | diklofenak | M01AB05 | VOLTAREN 50 enterotablett 50mg N20 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
443 | diklofenak | M01AB05 | VOLTAREN 50 suposiit 50mg N10 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
444 | diklofenak | M01AB05 | VOLTAREN RETARD retardtablett 100mg N10 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
445 | diklofenak | M01AB05 | VOLTAREN RETARD retardtablett 100mg N30 | Novartis Pharma | 50% | 75% | L40; M07; M05; M06; M08; M15-M19; M30-M33; M35; M45; M46; | |||||
446 | diklofenak | M02AA15 | DICLAC 5% GEL geel 5% 100g N1 | Hexal AG | 50% | |||||||
447 | diklofenak | M02AA15 | DICLAC 5% GEL geel 5% 50g N1 | Hexal AG | 50% | |||||||
448 | diklofenak | M02AA15 | FELORAN geel 1% 60g 60g N1 | Balkanpharma-Troyan | 50% | |||||||
449 | diklofenak | M02AA15 | NAKLOFEN geel 1% 60g N1 | KRKA, d.d. | 50% | |||||||
450 | diklofenak | M02AA15 | OLFEN GEL geel 1% 20g N1 | MEPHA Ltd. | 50% | |||||||
451 | diklofenak | M02AA15 | OLFEN GEL geel 1% 50g N1 | MEPHA Ltd. | 50% | |||||||
452 | diklofenak | M02AA15 | OLFEN ROLL-ON roll-on geel 1% 50ml N1 | MEPHA Ltd. | 50% | |||||||
453 | diklofenak | M02AA15 | ORTOFEN salv 2% 30g N1 | TFT | 50% | |||||||
454 | diklofenak | M02AA15 | VERAL geel 1% 55g N1 | Slovakofarma | 50% | |||||||
455 | diklofenak | M02AA15 | VOLTAREN EMULGEL geel 1% 20g N1 | Novartis Consumer Health | 50% | |||||||
456 | diklofenak | M02AA15 | VOLTAREN EMULGEL geel 1% 50g N1 | Novartis Consumer Health | 50% | |||||||
457 | diklofenak | S01BC03 | NACLOF silmatilgad 0,1% 5 ml N1 | H. Faure | 50% | |||||||
458 | diklofenak+misoprostool | M01AB80 | ARTHROTEC tablett 50mg+0,2mg N100 | Pharmacia Enterprises | 50% | |||||||
459 | diklofenak+misoprostool | M01AB80 | ARTHROTEC tablett 50mg+0,2mg N20 | Pharmacia Enterprises | 50% | |||||||
460 | diklofenak+misoprostool | M01AB80 | ARTHROTEC tablett 50mg+0,2mg N60 | Pharmacia Enterprises | 50% | |||||||
461 | diltiaseem | C08DB01 | ALTIAZEM RR retardkapsel 180mg N20 | Lusofarmaco | 50% | |||||||
462 | diltiaseem | C08DB01 | DILRENE 300 MG S.R. retardkapsel 300mg N28 | Sanofi | 50% | |||||||
463 | diltiaseem | C08DB01 | DILTIAZEM tablett 60mg N30 | Pliva | 50% | |||||||
464 | diltiaseem | C08DB01 | DILTIAZEM tablett 90mg N30 | Pliva | 50% | |||||||
465 | diltiaseem | C08DB01 | DILTIKARD DEPOT 120 MG retardkapsel 120mg N28 | Nycomed SEFA | 50% | |||||||
466 | diltiaseem | C08DB01 | DILTIKARD DEPOT 180 MG retardkapsel 180mg N28 | Nycomed SEFA | 50% | |||||||
467 | diltiaseem | C08DB01 | DILTIKARD DEPOT 240 MG retardkapsel 240mg N28 | Nycomed SEFA | 50% | |||||||
468 | diltiaseem | C08DB01 | DILTISAN tablett 60mg N100 | Sanofi | 50% | |||||||
469 | doksasosiin | C02CA04 | CARDURA tablett 1mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
470 | doksasosiin | C02CA04 | CARDURA tablett 2mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
471 | doksasosiin | C02CA04 | CARDURA tablett 4mg N30 | Pfizer H.C.P. Corporation | 50% | |||||||
472 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 1 MG tablett 1mg N100 | ratiopharm | 50% | |||||||
473 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 1 MG tablett 1mg N20 | ratiopharm | 50% | |||||||
474 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 1 MG tablett 1mg N50 | ratiopharm | 50% | |||||||
475 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 2 MG tablett 2mg N100 | ratiopharm | 50% | |||||||
476 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 2 MG tablett 2mg N20 | ratiopharm | 50% | |||||||
477 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 2 MG tablett 2mg N50 | ratiopharm | 50% | |||||||
478 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 4 MG tablett 4mg N100 | ratiopharm | 50% | |||||||
479 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 4 MG tablett 4mg N20 | ratiopharm | 50% | |||||||
480 | doksasosiin | C02CA04 | DOXAZOSIN-RATIOPHARM 4 MG tablett 4mg N50 | ratiopharm | 50% | |||||||
481 | doksasosiin | C02CA04 | KAMIREN tablett 1mg N20 | KRKA, d.d. | 50% | |||||||
482 | doksasosiin | C02CA04 | KAMIREN tablett 1mg N30 | KRKA, d.d. | 50% | |||||||
483 | doksasosiin | C02CA04 | KAMIREN tablett 2mg N20 | KRKA, d.d. | 50% | |||||||
484 | doksasosiin | C02CA04 | KAMIREN tablett 2mg N30 | KRKA, d.d. | 50% | |||||||
485 | doksasosiin | C02CA04 | KAMIREN tablett 4mg N20 | KRKA, d.d. | 50% | |||||||
486 | doksasosiin | C02CA04 | KAMIREN tablett 4mg N30 | KRKA, d.d. | 50% | |||||||
487 | doksasosiin | C02CA04 | ZOXON 1 tablett 1mg N15 | LÉCIVA a.s. | 50% | |||||||
488 | doksasosiin | C02CA04 | ZOXON 1 tablett 1mg N30 | LÉCIVA a.s. | 50% | |||||||
489 | doksasosiin | C02CA04 | ZOXON 2 tablett 2mg N10 | LÉCIVA a.s. | 50% | |||||||
490 | doksasosiin | C02CA04 | ZOXON 2 tablett 2mg N30 | LÉCIVA a.s. | 50% | |||||||
491 | doksasosiin | C02CA04 | ZOXON 4 tablett 4mg N30 | LÉCIVA a.s. | 50% | |||||||
492 | doksütsükliin | J01AA02 | DOXITIN tablett 100mg N10 | Vitabalans | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
493 | doksütsükliin | J01AA02 | DOXITIN tablett 100mg N8 | Vitabalans | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
494 | doksütsükliin | J01AA02 | DOXY M-RATIOPHARM 100 tablett 100mg N10 | ratiopharm | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
495 | doksütsükliin | J01AA02 | DOXY M-RATIOPHARM 100 tablett 100mg N20 | ratiopharm | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
496 | doksütsükliin | J01AA02 | DOXYCYCLIN 100 STADA TABS tablett 100mg N10 | Stada | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
497 | doksütsükliin | J01AA02 | DOXYCYCLIN 100 STADA TABS tablett 100mg N20 | Stada | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
498 | doksütsükliin | J01AA02 | DOXYCYCLIN 200 STADA TABS tablett 200mg N10 | Stada | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
499 | doksütsükliin | J01AA02 | DOXYHEXAL tablett 100mg N10 | Hexal AG | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
500 | doksütsükliin | J01AA02 | DOXYHEXAL tablett 100mg N20 | Hexal AG | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
501 | doksütsükliin | J01AA02 | DOXYLAN tablett 100mg N10 | Lannacher | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
502 | doksütsükliin | J01AA02 | DOXYLAN tablett 100mg N5 | Lannacher | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
503 | doksütsükliin | J01AA02 | VIBRAMYCIN kapsel 100mg N10 | Pfizer H.C.P. Corporation | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
504 | doksütsükliin | J01AA02 | VIBRAMYCIN siirup 10mgml 60ml N1 | Pfizer H.C.P. Corporation | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
505 | domperidoon | A03FA03 | MOTILIUM tablett 10mg N10 | Janssen | 50% | |||||||
506 | domperidoon | A03FA03 | MOTILIUM tablett 10mg N30 | Janssen | 50% | |||||||
507 | donepesiil | N06DA02 | ARICEPT tablett 10mg N28 | Pfizer H.C.P. Corporation | 50% | |||||||
508 | donepesiil | N06DA02 | ARICEPT tablett 5mg N28 | Pfizer H.C.P. Corporation | 50% | |||||||
509 | dornaas alfa | R05CB13 | PULMOZYME inhalatsioonilahus 1mg/ml 2.5ml N6 | Roche | 50% | 100% | E84* | *rev pulmono- loogil |
||||
510 | dorsolamiid | S01EC03 | TRUSOPT silmatilgad 2% 5 ml N1 | MSD | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
511 | drospirenoon+etünüülöstradiool | G03AA12 | YARINA tablett 3mg+0,03mg N21 | Schering AG | 50% | 75% | Z30 | |||||
512 | drotaveriin | A03AD02 | NO-SPA tablett 40mg N100 | Chinoin | 50% | |||||||
513 | drotaveriin | A03AD02 | NO-SPA tablett 40mg N20 | Chinoin | 50% | |||||||
514 | düdrogesteroon | G03DB01 | DUPHASTON tablett 10mg N20 | Solvay Pharmaceuticals BV | 50% | |||||||
515 | ebastiin | R06AX22 | KESTINE tablett 10mg N30 | Nycomed SEFA | 50% | |||||||
516 | ebastiin | R06AX22 | KESTINE tablett 20mg N10 | Nycomed SEFA | 50% | |||||||
517 | ebastiin | R06AX22 | KESTINE tablett 20mg N100 | Nycomed SEFA | 50% | |||||||
518 | ebastiin | R06AX22 | KESTINE tablett 20mg N30 | Nycomed SEFA | 50% | |||||||
519 | Efavirenzum | J05AG03 | STOCRIN kapsel 200 mg N90 | MSD | 50% | |||||||
520 | Efavirenzum | J05AG03 | STOCRIN kapsel 100mg N30 | MSD | 50% | |||||||
521 | Efavirenzum | J05AG03 | STOCRIN kapsel 50mg N30 | MSD | 50% | |||||||
522 | Efavirenzum | J05AG03 | STOCRIN suukaudne lahus 30mg/ml 180ml N1 | MSD | 50% | |||||||
523 | ekonasool | D01AC03 | ECOMI kreem 1%/g 30g N1 | Geymonat | 50% | |||||||
524 | ekonasool | D01AC03 | PEVARYL kreem 1%/g 15g N1 | Cilag | 50% | |||||||
525 | ekonasool | D01AC03 | PEVARYL kreem 1%/g 30g N1 | Cilag | 50% | |||||||
526 | ekonasool | D01AC03 | PEVARYL lipogeel 1%/g 15g N1 | Cilag | 50% | |||||||
527 | ekonasool | D01AC03 | PEVARYL sprei 1%/ml 30ml N1 | Cilag | 50% | |||||||
528 | ekonasool | G01AF05 | GYNO-PEVARYL 150 COMBIPACK oovul+kreem 150mg/g N1 | Cilag | 50% | |||||||
529 | ekonasool | G01AF05 | GYNO-PEVARYL 50 vaginaaloovul 50mg N15 | Cilag | 50% | |||||||
530 | ekonasool | G01AF05 | GYNO-PEVARYL oovul 150mg N3 | Cilag | 50% | |||||||
531 | eksemestaan | L02BG06 | AROMASIN tablett 25mg N30 | Pharmacia Enterprises | 50% | |||||||
532 | Emedastiin | S01GX06 | EMADINE silmatilgad 0,05% 10ml N1 | Alcon UK | 50% | |||||||
533 | Emedastiin | S01GX06 | EMADINE silmatilgad 0,05% 5ml N1 | Alcon UK | 50% | |||||||
534 | enalapriil | C09AA02 | BERLIPRIL 5 tablett 5mg N100 | Berlin-Chemie | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
535 | enalapriil | C09AA02 | BERLIPRIL 5 tablett 5mg N30 | Berlin-Chemie | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
536 | enalapriil | C09AA02 | BERLIPRIL 5 tablett 5mg N50 | Berlin-Chemie | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
537 | enalapriil | C09AA02 | EDNYT tablett 10mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
538 | enalapriil | C09AA02 | EDNYT tablett 10mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
539 | enalapriil | C09AA02 | EDNYT tablett 2,5mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
540 | enalapriil | C09AA02 | EDNYT tablett 2,5mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
541 | enalapriil | C09AA02 | EDNYT tablett 20mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
542 | enalapriil | C09AA02 | EDNYT tablett 20mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
543 | enalapriil | C09AA02 | EDNYT tablett 5mg N28 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
544 | enalapriil | C09AA02 | EDNYT tablett 5mg N30 | Richter | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
545 | enalapriil | C09AA02 | ENAHEXAL 10 MG tablett 10mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
546 | enalapriil | C09AA02 | ENAHEXAL 10 MG tablett 10mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
547 | enalapriil | C09AA02 | ENAHEXAL 10 MG tablett 10mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
548 | enalapriil | C09AA02 | ENAHEXAL 20 MG tablett 20mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
549 | enalapriil | C09AA02 | ENAHEXAL 20 MG tablett 20mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
550 | enalapriil | C09AA02 | ENAHEXAL 20 MG tablett 20mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
551 | enalapriil | C09AA02 | ENAHEXAL 5 MG tablett 5mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
552 | enalapriil | C09AA02 | ENAHEXAL 5 MG tablett 5mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
553 | enalapriil | C09AA02 | ENAHEXAL 5 MG tablett 5mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
554 | enalapriil | C09AA02 | ENALAPRIL ALPHARMA TABLETS 10MG tablett 10mg N28 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
555 | enalapriil | C09AA02 | ENALAPRIL ALPHARMA TABLETS 5 MG tablett 5mg N28 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
556 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 10MG tablett 10mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
557 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 10MG tablett 10mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
558 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 10MG tablett 10mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
559 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 20MG tablett 20mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
560 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 20MG tablett 20mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
561 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 20MG tablett 20mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
562 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 5MG tablett 5mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
563 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 5MG tablett 5mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
564 | enalapriil | C09AA02 | ENALAPRIL- RATIOPHARM 5MG tablett 5mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
565 | enalapriil | C09AA02 | ENAP 10 tablett 10mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
566 | enalapriil | C09AA02 | ENAP 2,5 tablett 2,5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
567 | enalapriil | C09AA02 | ENAP 20 tablett 20mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
568 | enalapriil | C09AA02 | ENAP 5 tablett 5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
569 | enalapriil | C09AA02 | ENATEC 10 tablett 10mg N28 | MEPHA Ltd. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
570 | enalapriil | C09AA02 | ENATEC 20 tablett 20mg N28 | MEPHA Ltd. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
571 | enalapriil | C09AA02 | ENATEC 5 tablett 5mg N30 | MEPHA Ltd. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
572 | enalapriil | C09AA02 | INVORIL tablett 10mg N10 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
573 | enalapriil | C09AA02 | INVORIL tablett 10mg N100 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
574 | enalapriil | C09AA02 | INVORIL tablett 10mg N30 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
575 | enalapriil | C09AA02 | INVORIL tablett 5mg N10 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
576 | enalapriil | C09AA02 | INVORIL tablett 5mg N100 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
577 | enalapriil | C09AA02 | INVORIL tablett 5mg N30 | Ranbaxy | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
578 | enalapriil | C09AA02 | RENITEC 10 MG tablett 10mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
579 | enalapriil | C09AA02 | RENITEC 10 MG tablett 10mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
580 | enalapriil | C09AA02 | RENITEC 10 MG tablett 10mg N100 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
581 | enalapriil | C09AA02 | RENITEC 5 MG tablett 5mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
582 | enalapriil | C09AA02 | RENITEC 5 MG tablett 5mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
583 | enalapriil | C09AA02 | RENITEC FORTE tablett 20mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
584 | enalapriil | C09AA02 | RENITEC FORTE tablett 20mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
585 | enalapriil | C09AA02 | RENITEC START tablett N25 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
586 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 10mg+25mg N10 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
587 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 10mg+25mg N30 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
588 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 20mg+12,5mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
589 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | CO-RENITEC tablett 20mg+12,5mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
590 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | ENAP-H tablett 10mg+25mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
591 | enalapriil+ hüdrokloro- tiasiid |
C09BA02 | ENAP-HL tablett 10mg+12,5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
592 | enalapriil+hüdroklorotiasiid | C09BA02 | RENITEC PLUS tablett 20mg+6mg N14 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
593 | enalapriil+hüdroklorotiasiid | C09BA02 | RENITEC PLUS tablett 20mg+6mg N28 | MSD | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
594 | entakapoon | N04BX02 | COMTESS tablett 200mg N100 | Orion | 50% | |||||||
595 | entakapoon | N04BX02 | COMTESS tablett 200mg N30 | Orion | 50% | |||||||
596 | entakapoon | N04BX02 | COMTESS tablett 200mg N350 | Orion | 50% | |||||||
597 | entakapoon | N04BX02 | COMTESS tablett 200mg N60 | Orion | 50% | |||||||
598 | eprosartaan | C09CA02 | TEVETEN tablett 400mgTabl N14 | Solvay Pharmaceuticals BV | 50% | |||||||
599 | eprosartaan | C09CA02 | TEVETEN tablett 400mgTabl N28 | Solvay Pharmaceuticals BV | 50% | |||||||
600 | eprosartaan | C09CA02 | TEVETEN tablett 400mgTabl N56 | Solvay Pharmaceuticals BV | 50% | |||||||
601 | eprosartaan | C09CA02 | TEVETEN tablett 600mg 1Tabl N14 | Solvay Pharmaceuticals BV | 50% | |||||||
602 | eprosartaan | C09CA02 | TEVETEN tablett 600mg 1Tabl N28 | Solvay Pharmaceuticals BV | 50% | |||||||
603 | eprosartaan | C09CA02 | TEVETEN tablett 600mg 1Tabl N56 | Solvay Pharmaceuticals BV | 50% | |||||||
604 | Epoetin beta | B03XA80 | NEORECORMON 50 000 MULTIDOSE injektsioonisubstants 50000IU N1 | Roche | 50% | |||||||
605 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 10000TÜ 0.3ml N1 | Roche | 50% | |||||||
606 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 10000TÜ 0.3ml N6 | Roche | 50% | |||||||
607 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 2000TÜ 0.3ml N1 | Roche | 50% | |||||||
608 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 2000TÜ 0.3ml N6 | Roche | 50% | |||||||
609 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 4000TÜ 0.3ml N1 | Roche | 50% | |||||||
610 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 4000TÜ 0.3ml N6 | Roche | 50% | |||||||
611 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 5000TÜ 0.3ml N1 | Roche | 50% | |||||||
612 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 5000TÜ 0.3ml N6 | Roche | 50% | |||||||
613 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 500TÜ 0.3ml N1 | Roche | 50% | |||||||
614 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 500TÜ 0.3ml N6 | Roche | 50% | |||||||
615 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 6000TÜ 0.3ml 0.3ml N1 | Roche | 50% | |||||||
616 | Epoetin beta | B03XA80 | NEORECORMON süstelahus 6000TÜ 0.3ml 0.3ml N6 | Roche | 50% | |||||||
617 | erütromütsiin | D10AF02 | AKNEFUG EL lahus paikseks kasut. 10mgml 60ml N1 | Wolff | 50% | |||||||
618 | erütromütsiin | J01FA01 | ERYTHROMYCIN NYCOMED tablett 500mg N10 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
619 | erütromütsiin | J01FA01 | ERYTHROMYCIN- RATIOPHARM TS suspensioonigraanulid 40mgml 16g N1 | ratiopharm | 50% | 75% | J13-J15 | |||||
620 | erütromütsiin | J01FA01 | ERYTHROMYCIN- RATIOPHARM TS suspensioonigraanulid 40mgml 9.6g N1 | ratiopharm | 50% | 75% | J13-J15 | |||||
621 | erütromütsiin | J01FA01 | ILOSONE suspensioon 25mgml 100ml N1 | Eli Lilly Export S.A. | 50% | 75% | J13-J15 | |||||
622 | erütromütsiin | J01FA01 | ILOSONE suspensioon 50mgml 100ml N1 | Eli Lilly Export S.A. | 50% | 75% | J13-J15 | |||||
623 | erütromütsiin | J01FA01 | ILOSONE tablett 500mg N10 | Eli Lilly Export S.A. | 50% | 75% | J13-J15 | |||||
624 | erütropoetiin | B03XA01 | EPREX 10 000 süstelahus 10000TÜ/ml 1ml N6 | Cilag | 50% | |||||||
625 | erütropoetiin | B03XA01 | EPREX 2000 süstelahus 4000TÜ/ml 0.5ml N6 | Cilag | 50% | |||||||
626 | erütropoetiin | B03XA01 | EPREX 4000 süstelahus 10000TÜ/ml 0.4ml N6 | Cilag | 50% | |||||||
627 | erütropoetiin | B03XA01 | EPREX 5000 süstelahus 5000IU 0.5ml N6 | Cilag | 50% | |||||||
628 | erütropoetiin | B03XA01 | EPREX 6000 süstelahus 6000IU 0.6ml N6 | Cilag | 50% | |||||||
629 | erütropoetiin | B03XA01 | EPREX 7000 süstelahus 7000IU 0.7ml N6 | Cilag | 50% | |||||||
630 | erütropoetiin | B03XA01 | EPREX 8000 süstelahus 8000IU 0.8ml N6 | Cilag | 50% | |||||||
631 | erütropoetiin | B03XA01 | RECORMON injektsioonisubstants 1000TÜ N10 | Roche | 50% | |||||||
632 | erütropoetiin | B03XA01 | RECORMON injektsioonisubstants 2000TÜ N10 | Roche | 50% | |||||||
633 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N14 | AstraZeneca UK Ltd. | 50% | |||||||
634 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N140 | AstraZeneca UK Ltd. | 50% | |||||||
635 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N28 | AstraZeneca UK Ltd. | 50% | |||||||
636 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N3 | AstraZeneca UK Ltd. | 50% | |||||||
637 | Esomeprasool | A02BC05 | NEXIUM tablett 20mg N7 | AstraZeneca UK Ltd. | 50% | |||||||
638 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N14 | AstraZeneca UK Ltd. | 50% | |||||||
639 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N140 | AstraZeneca UK Ltd. | 50% | |||||||
640 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N28 | AstraZeneca UK Ltd. | 50% | |||||||
641 | Esomeprasool | A02BC05 | NEXIUM tablett 40mg 1Tabl N7 | AstraZeneca UK Ltd. | 50% | |||||||
642 | estsitalopraam | N06AB10 | CIPRALEX tablett 5 mg N14 | Lundbeck | 50% | |||||||
643 | estsitalopraam | N06AB10 | CIPRALEX tablett 5 mg N28 | Lundbeck | 50% | |||||||
644 | estsitalopraam | N06AB10 | CIPRALEX tablett 10 mg N14 | Lundbeck | 50% | |||||||
645 | estsitalopraam | N06AB10 | CIPRALEX tablett 10 mg N28 | Lundbeck | 50% | |||||||
646 | estsitalopraam | N06AB10 | CIPRALEX tablett 15 mg N28 | Lundbeck | 50% | |||||||
647 | estsitalopraam | N06AB10 | CIPRALEX tablett 20 mg N28 | Lundbeck | 50% | |||||||
648 | etidroonhape | M05BA01 | PLEOSTAT tablett 400mg N14 | KRKA, d.d. | 50% | |||||||
649 | etidroonhape | M05BA01 | PLEOSTAT tablett 400mg N56 | KRKA, d.d. | 50% | |||||||
650 | etonogestreel | G03AC08 | IMPLANON implantaat 68mg N1 | N.V. ORGANON | 50% | |||||||
651 | etoposiid | L01CB01 | VEPESID kapsel 100mg N10 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
652 | etoposiid | L01CB01 | VEPESID kapsel 100mg N60 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
653 | etoposiid | L01CB01 | VEPESID kapsel 50mg N20 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
654 | etoposiid | L01CB01 | VEPESID kapsel 50mg N60 | Bristol-Myers Squibb | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
655 | etorikoksiib | M01AH80 | ARCOXIA tablett 60 mg N14 | MSD | 50% | |||||||
656 | etorikoksiib | M01AH80 | ARCOXIA tablett 60 mg N28 | MSD | 50% | |||||||
657 | etorikoksiib | M01AH80 | ARCOXIA tablett 90 mg N14 | MSD | 50% | |||||||
658 | etorikoksiib | M01AH80 | ARCOXIA tablett 90 mg N28 | MSD | 50% | |||||||
659 | etorikoksiib | M01AH80 | ARCOXIA tablett 120 mg N14 | MSD | 50% | |||||||
660 | etorikoksiib | M01AH80 | ARCOXIA tablett120 mg N28 | MSD | 50% | |||||||
661 | famitsükloviir | J05AB09 | FAMVIR tablett 125mg N10 | Novartis Pharma | 50% | |||||||
662 | famitsükloviir | J05AB09 | FAMVIR tablett 125mg N30 | Novartis Pharma | 50% | |||||||
663 | famitsükloviir | J05AB09 | FAMVIR tablett 250mg N15 | Novartis Pharma | 50% | |||||||
664 | famitsükloviir | J05AB09 | FAMVIR tablett 250mg N21 | Novartis Pharma | 50% | |||||||
665 | famitsükloviir | J05AB09 | FAMVIR tablett 500mg N14 | Novartis Pharma | 50% | |||||||
666 | famitsükloviir | J05AB09 | FAMVIR tablett 500mg N21 | Novartis Pharma | 50% | |||||||
667 | famotidiin | A02BA03 | FAMOSAN tablett 20mg N20 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
668 | famotidiin | A02BA03 | FAMOSAN tablett 40mg N10 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
669 | famotidiin | A02BA03 | FAMOTIDIN 20-SL kaetud tablett 20mg N30 | Slovakofarma | 50% | |||||||
670 | famotidiin | A02BA03 | FAMOTIDIN 40-SL kaetud tablett 40mg N10 | Slovakofarma | 50% | |||||||
671 | famotidiin | A02BA03 | QUAMATEL tablett 20mg N28 | Richter | 50% | |||||||
672 | famotidiin | A02BA03 | QUAMATEL tablett 40mg N14 | Richter | 50% | |||||||
673 | famotidiin | A02BA03 | ULFAMID tablett 20mg N10 | KRKA, d.d. | 50% | |||||||
674 | famotidiin | A02BA03 | ULFAMID tablett 20mg N20 | KRKA, d.d. | 50% | |||||||
675 | famotidiin | A02BA03 | ULFAMID tablett 40mg N10 | KRKA, d.d. | 50% | |||||||
676 | feksofenadiin | R06AX26 | TELFAST 120MG tablett 120mg N100 | Aventis Pharma Deutschland | 50% | |||||||
677 | feksofenadiin | R06AX26 | TELFAST 120MG tablett 120mg N30 | Aventis Pharma Deutschland | 50% | |||||||
678 | feksofenadiin | R06AX26 | TELFAST 180MG tablett 180mg N100 | Aventis Pharma Deutschland | 50% | |||||||
679 | feksofenadiin | R06AX26 | TELFAST 180MG tablett 180mg N30 | Aventis Pharma Deutschland | 50% | |||||||
680 | felodipiin | C08CA02 | PLENDIL retardtablett 10mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
681 | felodipiin | C08CA02 | PLENDIL retardtablett 10mg N30 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
682 | felodipiin | C08CA02 | PLENDIL retardtablett 2,5mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
683 | felodipiin | C08CA02 | PLENDIL retardtablett 2,5mg N30 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
684 | felodipiin | C08CA02 | PLENDIL retardtablett 5mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
685 | felodipiin | C08CA02 | PLENDIL retardtablett 5mg N30 | AstraZeneca UK Ltd. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
686 | felodipiin | C08CA02 | PRESID retardtablett 10mg N100 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
687 | felodipiin | C08CA02 | PRESID retardtablett 10mg N30 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
688 | felodipiin | C08CA02 | PRESID retardtablett 2,5mg N100 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
689 | felodipiin | C08CA02 | PRESID retardtablett 2,5mg N30 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
690 | felodipiin | C08CA02 | PRESID retardtablett 5mg N100 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
691 | felodipiin | C08CA02 | PRESID retardtablett 5mg N30 | IVAX - CR a.s. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
692 | fenobarbitaal | N03AA02 | PHENAEMAL 0,1 tablett 100mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
693 | fenobarbitaal | N03AA02 | PHENAEMALETTEN tablett 15mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
694 | fenofibraat | C10AB05 | LIPANTHYL kapsel 200mg N30 | LABORATOIRES FOURNIER S.A | 50% | |||||||
695 | fenoksümetüülpenitsilliin | J01CE02 | OSPEN 500 tablett 500 000 TÜ N12 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
696 | fenoksümetüülpenitsilliin | J01CE02 | OSPEN 1000 tablett 1 000 000 TÜ N12 | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
697 | fenoksümetüülpenitsilliin | J01CE02 | OSPEN 400 000 IU/5 ml Oral Suspensionsiirup 400 000 TÜ/5 ml 60 ml | Biochemie GmbH | 50% | 75% | J13-J15 | |||||
698 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N10 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
699 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N100 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
700 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N20 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
701 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 1 000 000 TÜ tablett 1000000TÜ N30 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
702 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 500 000 TÜ tablett 500000TÜ N20 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
703 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 500 000 TÜ tablett 500000TÜ N30 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
704 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN NOVUM 85 000TÜ/ML graanulid lahuseks 85000TÜ/ml 100ml N1 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
705 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN tablett 1000000TÜ N12 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
706 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN tablett 300000TÜ N18 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
707 | fenoksümetüülpenitsilliin | J01CE02 | VEPICOMBIN tablett 500000TÜ N18 | Nycomed SEFA | 50% | 75% | J13-J15 | |||||
708 | fenoksümetüülpenitsilliin | J01CE02 | V-PENICILIN 250MG SLOVAKOFARMA tablett 250mg N30 | Slovakofarma | 50% | 75% | J13-J15 | |||||
709 | fenoksümetüülpenitsilliin | J01CE02 | V-PENICILIN 500MG SLOVAKOFARMA tablett 500mg N30 | Slovakofarma | 50% | 75% | J13-J15 | |||||
710 | fenoterool | R03AC04 | BEROTEC 100 annustatud aerosool 100mcg/annuses 300annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
711 | fenoterool | R03AC04 | BEROTEC 200 annustatud aerosool 200mcg/annuses 200annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
712 | fenoterool | R03AC04 | BEROTEC 200 annustatud aerosool 200mcg/annuses 300annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
713 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 0,5mg 2ml 2ml N20 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
714 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 0,5mg 2ml 2ml N60 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
715 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 1,25mg 2ml 2ml N20 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
716 | fenoterool | R03AC04 | BEROTEC inhalatsioonilahus 1,25mg 2ml 2ml N60 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
717 | fenoterool | R03AC04 | BEROTEC N 100 MCG inhal aeros 100mcg/annuses 200annust | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
718 | fenoterool+ipratroopiumbromiid | R03AK80 | BERODUAL annustatud aerosool 50mcg+20mcg/annuses 300annust N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
719 | fenoterool+ ipratroopium- bromiid |
R03AK80 | BERODUAL inhalatsioonilahus 0,5mg+0,25mg/ml 20ml N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
720 | fenoterool+ ipratroopium- bromiid |
R03AK80 | BERODUAL N annustatud aerosool 50mcg+20mcgannus 200annus N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
721 | fentanüül | N02AB03 | DUROGESIC TTS 100mcg/h N5 | Janssen | 50% | |||||||
722 | fentanüül | N02AB03 | DUROGESIC TTS 25mcg/h N5 | Janssen | 50% | |||||||
723 | fentanüül | N02AB03 | DUROGESIC TTS 50mcg/h N5 | Janssen | 50% | |||||||
724 | fenütoiin | N03AB02 | PHENHYDAN tablett 100mg N100 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
725 | fenütoiin | N03AB02 | PHENHYDAN tablett 100mg N200 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
726 | fenütoiin | N03AB02 | PHENHYDAN tablett 100mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
727 | fenüülbutasoon | M02AA01 | BUTADION salv 5% 20g N1 | Richter | 50% | |||||||
728 | finasteriid | G04CB01 | PENESTER tablett 5mg N30 | LÉCIVA a.s. | 50% | |||||||
729 | finasteriid | G04CB01 | PROSCAR 5 MG tablett 5mg N28 | MSD | 50% | |||||||
730 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 100mg N100 | 3M Health Care | 50% | |||||||
731 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 100mg N20 | 3M Health Care | 50% | |||||||
732 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 50mg N100 | 3M Health Care | 50% | |||||||
733 | flekainiidatsetaat | C01BC04 | TAMBOCOR tablett 50mg N20 | 3M Health Care | 50% | |||||||
734 | fludarabiin | L01BB05 | FLUDARA ORAL tablett 10mg N15 | Schering AG | 50% | |||||||
735 | fludarabiin | L01BB05 | FLUDARA ORAL tablett 10mg N20 | Schering AG | 50% | |||||||
736 | flukonasool | J02AC01 | DIFLAZON 100 kapsel 100mg N28 | KRKA, d.d. | 50% | |||||||
737 | flukonasool | J02AC01 | DIFLAZON 150 kapsel 150mg N1 | KRKA, d.d. | 50% | |||||||
738 | flukonasool | J02AC01 | DIFLAZON 200 kapsel 200mg N20 | KRKA, d.d. | 50% | |||||||
739 | flukonasool | J02AC01 | DIFLAZON 200 kapsel 200mg N7 | KRKA, d.d. | 50% | |||||||
740 | flukonasool | J02AC01 | DIFLAZON 50 kapsel 50mg N7 | KRKA, d.d. | 50% | |||||||
741 | flukonasool | J02AC01 | DIFLUCAN 100MG kapsel 100mg N7 | Pfizer H.C.P. Corporation | 50% | |||||||
742 | flukonasool | J02AC01 | DIFLUCAN 150MG kapsel 150mg N1 | Pfizer H.C.P. Corporation | 50% | |||||||
743 | flukonasool | J02AC01 | DIFLUCAN 50MG kapsel 50mg N7 | Pfizer H.C.P. Corporation | 50% | |||||||
744 | flukonasool | J02AC01 | FLUCONAZOL 150 SLOVAKOFARMA kapsel 150mg N1 | Slovakofarma | 50% | |||||||
745 | flukonasool | J02AC01 | FLUCONAZOL 150 SLOVAKOFARMA kapsel 150mg N2 | Slovakofarma | 50% | |||||||
746 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N10 | Slovakofarma | 50% | |||||||
747 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N14 | Slovakofarma | 50% | |||||||
748 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N20 | Slovakofarma | 50% | |||||||
749 | flukonasool | J02AC01 | FLUCONAZOL 50 SLOVAKOFARMA kapsel 50mg N7 | Slovakofarma | 50% | |||||||
750 | flukonasool | J02AC01 | MYCOMAX 100 kapsel 100mg N28 | LÉCIVA a.s. | 50% | |||||||
751 | flukonasool | J02AC01 | MYCOMAX 100 kapsel 100mg N7 | LÉCIVA a.s. | 50% | |||||||
752 | flukonasool | J02AC01 | MYCOMAX 100 kapsel 100mg N70 | LÉCIVA a.s. | 50% | |||||||
753 | flukonasool | J02AC01 | MYCOMAX 200 kapsel 200mg N7 | LÉCIVA a.s. | 50% | |||||||
754 | flukonasool | J02AC01 | MYCOMAX kapsel 150mg N1 | LÉCIVA a.s. | 50% | |||||||
755 | flukonasool | J02AC01 | MYCOMAX kapsel 50mg N28 | LÉCIVA a.s. | 50% | |||||||
756 | flukonasool | J02AC01 | MYCOMAX kapsel 50mg N7 | LÉCIVA a.s. | 50% | |||||||
757 | flukonasool | J02AC01 | MYCOMAX kapsel 50mg N70 | LÉCIVA a.s. | 50% | |||||||
758 | flukonasool | J02AC01 | MYCOMAX SIR siirup 5mg/ml 100ml N1 | LÉCIVA a.s. | 50% | |||||||
759 | flukonasool | J02AC01 | MYCOSYST 100 MG kapsel 100mg N28 | Richter | 50% | |||||||
760 | flukonasool | J02AC01 | MYCOSYST 150 MG kapsel 150mg N1 | Richter | 50% | |||||||
761 | flukonasool | J02AC01 | MYCOSYST 150 MG kapsel 150mg N2 | Richter | 50% | |||||||
762 | flukonasool | J02AC01 | MYCOSYST 50 MG kapsel 50mg N7 | Richter | 50% | |||||||
763 | fluoksetiin | N06AB03 | DEPRENON kapsel 20mg N20 | Slovakofarma | 50% | |||||||
764 | fluoksetiin | N06AB03 | DEPRIMAKS kapsel 20mg N14 | Grindeks | 50% | |||||||
765 | fluoksetiin | N06AB03 | FLUVAL kapsel 20mg N14 | KRKA, d.d. | 50% | |||||||
766 | fluoksetiin | N06AB03 | FLUVAL kapsel 20mg N28 | KRKA, d.d. | 50% | |||||||
767 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N100 | Hexal AG | 50% | |||||||
768 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N14 | Hexal AG | 50% | |||||||
769 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N20 | Hexal AG | 50% | |||||||
770 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N28 | Hexal AG | 50% | |||||||
771 | fluoksetiin | N06AB03 | FLUX kapsel 20mg N50 | Hexal AG | 50% | |||||||
772 | fluoksetiin | N06AB03 | FRAMEX kapsel 20mg N14 | Richter | 50% | |||||||
773 | fluoksetiin | N06AB03 | FRAMEX kapsel 20mg N28 | Richter | 50% | |||||||
774 | fluoksetiin | N06AB03 | MAGRILAN kapslid 20 mg N30 | Medochemie Ltd. | 50% | |||||||
775 | fluoksetiin | N06AB03 | NYCOFLOX kapsel 20mg N100 | Nycomed SEFA | 50% | |||||||
776 | fluoksetiin | N06AB03 | NYCOFLOX kapsel 20mg N30 | Nycomed SEFA | 50% | |||||||
777 | fluoksetiin | N06AB03 | NYCOFLOX kapsel 20mg N60 | Nycomed SEFA | 50% | |||||||
778 | fluoksetiin | N06AB03 | PROZAC kapsel 20mg N14 | Eli Lilly Export S.A. | 50% | |||||||
779 | fluoksetiin | N06AB03 | PROZAC kapsel 20mg N28 | Eli Lilly Export S.A. | 50% | |||||||
780 | fluoksetiin | N06AB03 | PROZAC kapsel 20mg N7 | Eli Lilly Export S.A. | 50% | |||||||
781 | fluoksetiin | N06AB03 | PROZAC LIQUID suukaudne lahus 4mg/ml 70ml N1 | Eli Lilly Export S.A. | 50% | |||||||
782 | fluoksetiin | N06AB03 | SALIPAX kapsel 20mg N10 | MEPHA Ltd. | 50% | |||||||
783 | fluoksetiin | N06AB03 | SALIPAX kapsel 20mg N30 | MEPHA Ltd. | 50% | |||||||
784 | fluotsinoloon | D07AC04 | SYNALAR kreem 0,025% 15g N1 | Bioglan | 50% | |||||||
785 | fluotsinoloon | D07AC04 | SYNALAR kreem 0,025% 30g N1 | Bioglan | 50% | |||||||
786 | fluotsinoniid | D07AC08 | METOSYN kreem 0,05% 15g N1 | Bioglan | 50% | |||||||
787 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 100mg/ml 1ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
788 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 100mg/ml 1ml N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
789 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 20mg/ml 1ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
790 | flupentiksool | N05AF01 | FLUANXOL DEPOT süstelahus 20mg/ml 1ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
791 | flupentiksool | N05AF01 | FLUANXOL tablett 1mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
792 | flupentiksool | N05AF01 | FLUANXOL tablett 1mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
793 | flupentiksool | N05AF01 | FLUANXOL tilgad 100mg/ml 10ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
794 | flutamiid | L02BB01 | PROFAMID tablett 250mg N84 | Orion | 50% | |||||||
795 | flutikasoon- propionaat |
D07AC17 | CUTIVATE CREAM 0,05% kreem 0,05% 15g N1 | Glaxo Wellcome | 50% | |||||||
796 | flutikasoon- propionaat |
D07AC17 | CUTIVATE CREAM 0,05% kreem 0,05% 30g N1 | Glaxo Wellcome | 50% | |||||||
797 | flutikasoon- propionaat |
D07AC17 | CUTIVATE OINTMENT 0,005% salv 0,005% 15g N1 | Glaxo Wellcome | 50% | |||||||
798 | flutikasoon- propionaat |
D07AC17 | CUTIVATE OINTMENT 0,005% salv 0,005% 30g N1 | Glaxo Wellcome | 50% | |||||||
799 | flutikasoon- propionaat |
R01AD08 | FLIXONASE AQUEOUS NASAL SPRAY 50 MCG ninasprei 50mcg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
800 | flutikasoon- propionaat |
R01AD08 | FLIXONASE NASAL DROPS ninatilgad 1mg/ml 4TK N7 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
801 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE DISKUS 100 MCG inhalatsioonipulber 100mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil rv alla 18-aastasele lapsele |
||||
802 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE DISKUS 250 MCG inhalatsioonipulber 250mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
803 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE DISKUS 50 MCG inhalatsioonipulber 50mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
804 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE INHALER inhal aeros 250mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
805 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE INHALER inhal aeros 50mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
806 | flutikasoon- propionaat |
R03BA05 | FLIXOTIDE NEBULES nebulisaatori susp. 0,5mg 2ml 2ml N10 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
807 | flutikasoonpropionaat | R03BA05 | FLIXOTIDE NEBULES nebulisaatori susp. 2mg 2ml 2ml N10 | Glaxo Wellcome | 50% | 75% | J45* | *rev pediaatril ja pulmonoloogil, rv alla 18-aastasele lapsele |
||||
808 | fluvastatiin | C10AA04 | LESCOL 20 MG kapsel 20mg N28 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
809 | fluvastatiin | C10AA04 | LESCOL 40 MG kapsel 40mg N28 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
810 | fluvastatiin | C10AA04 | LESCOL XL tablett 80mg N28 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
811 | fluvastatiin | C10AA04 | LESCOL XL tablett 80mg N70 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
812 | fluvastatiin | C10AA04 | LESCOL XL tablett 80mg N98 | Novartis Pharma | 50% | 75% | E78* | *(2) | ||||
813 | fluvoksamiin | N06AB08 | FEVARIN tablett 100mg N30 | Solvay Pharmaceuticals | 50% | |||||||
814 | fluvoksamiin | N06AB08 | FEVARIN tablett 100mg N50 | Solvay Pharmaceuticals | 50% | |||||||
815 | fluvoksamiin | N06AB08 | FEVARIN tablett 50mg N30 | Solvay Pharmaceuticals | 50% | |||||||
816 | fluvoksamiin | N06AB08 | FEVARIN tablett 50mg N50 | Solvay Pharmaceuticals | 50% | |||||||
817 | fluvoksamiin | N06AB08 | FEVARIN tablett 50mg N60 | Solvay Pharmaceuticals | 50% | |||||||
818 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N1 | Ares-Serono | 50% | |||||||
819 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N10 | Ares-Serono | 50% | |||||||
820 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N3 | Ares-Serono | 50% | |||||||
821 | follitropiin alfa | G03GA05 | GONAL-F 37,5 IU injektsioonisubstants 37,5TÜ N5 | Ares-Serono | 50% | |||||||
822 | follitropiin alfa | G03GA05 | GONAL-F injektsioonisubstants 75TÜ N1 | ARES TRADING SA | 50% | |||||||
823 | follitropiin alfa | G03GA05 | GONAL-F injektsioonisubstants 75TÜ N10 | ARES TRADING SA | 50% | |||||||
824 | follitropiin alfa | G03GA05 | GONAL-F injektsioonisubstants 75TÜ N3 | ARES TRADING SA | 50% | |||||||
825 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N1 | N.V. ORGANON | 50% | |||||||
826 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N10 | N.V. ORGANON | 50% | |||||||
827 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N3 | N.V. ORGANON | 50% | |||||||
828 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 100TÜ N5 | N.V. ORGANON | 50% | |||||||
829 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N1 | N.V. ORGANON | 50% | |||||||
830 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N10 | N.V. ORGANON | 50% | |||||||
831 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N3 | N.V. ORGANON | 50% | |||||||
832 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 150TÜ N5 | N.V. ORGANON | 50% | |||||||
833 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N1 | N.V. ORGANON | 50% | |||||||
834 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N10 | N.V. ORGANON | 50% | |||||||
835 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N3 | N.V. ORGANON | 50% | |||||||
836 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 50TÜ N5 | N.V. ORGANON | 50% | |||||||
837 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N1 | N.V. ORGANON | 50% | |||||||
838 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N10 | N.V. ORGANON | 50% | |||||||
839 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N3 | N.V. ORGANON | 50% | |||||||
840 | follitropiin beeta | G03GA06 | PUREGON injektsioonisubstants 75TÜ N5 | N.V. ORGANON | 50% | |||||||
841 | follitropiin beeta | G03GA06 | PUREGON süstelahus 100TÜ 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
842 | follitropiin beeta | G03GA06 | PUREGON süstelahus 100TÜ 0.5ml 0.5ml N10 | N.V. ORGANON | 50% | |||||||
843 | follitropiin beeta | G03GA06 | PUREGON süstelahus 100TÜ 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
844 | follitropiin beeta | G03GA06 | PUREGON süstelahus 150TÜ 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
845 | follitropiin beeta | G03GA06 | PUREGON süstelahus 150TÜ 0.5ml 0.5ml N10 | N.V. ORGANON | 50% | |||||||
846 | follitropiin beeta | G03GA06 | PUREGON süstelahus 150TÜ 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
847 | follitropiin beeta | G03GA06 | PUREGON süstelahus 300IU 0.36ml N1 | N.V. ORGANON | 50% | |||||||
848 | follitropiin beeta | G03GA06 | PUREGON süstelahus 50TÜ 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
849 | follitropiin beeta | G03GA06 | PUREGON süstelahus 50TÜ 0.5ml 0.5ml N10 | N.V. ORGANON | 50% | |||||||
850 | follitropiin beeta | G03GA06 | PUREGON süstelahus 50TÜ 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
851 | follitropiin beeta | G03GA06 | PUREGON süstelahus 600IU 0.72ml N1 | N.V. ORGANON | 50% | |||||||
852 | formoterool | R03AC13 | FORADIL inhalatsioonipulber 12mcg N30 | Novartis Pharma | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
853 | formoterool | R03AC13 | FORADIL inhalatsioonipulber 12mcg N60 | Novartis Pharma | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
854 | formoterool | R03AC13 | OXIS TURBUHALER inhalatsioonipulber 4,5mcg/annuses 60annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
855 | formoterool | R03AC13 | OXIS TURBUHALER inhalatsioonipulber 9mcg/annuses 60annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
856 | fosföstrool | L02AA04 | HONVAN tablett 120mg N100 | Asta Medica | 50% | |||||||
857 | fosföstrool | L02AA04 | HONVAN tablett 120mg N50 | Asta Medica | 50% | |||||||
858 | fosinopriil | C09AA09 | MONOPRIL tablett 10mg N28 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50* | *(1) | ||||
859 | fosinopriil | C09AA09 | MONOPRIL tablett 20mg N28 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50* | *(1) | ||||
860 | furosemiid | C03CA01 | FUROSEMIDE ALPHARMA TABLETS 40MG tablett 40mg N28 | ALPHARMA | 50% | 75% | I50 | |||||
861 | furosemiid | C03CA01 | FUROSEMIDE ALPHARMA TABLETS 40MG tablett 40mg N50 | ALPHARMA | 50% | 75% | I50 | |||||
862 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 20mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
863 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 40mg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
864 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 40mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
865 | furosemiid | C03CA01 | FUROSEMIID NYCOMED tablett 5mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
866 | furosemiid | C03CA01 | LASIX RETARD retardkapsel 60mg N100 | Aventis Pharma Deutschland | 50% | 75% | I50 | |||||
867 | furosemiid | C03CA01 | LASIX RETARD retardkapsel 60mg N30 | Aventis Pharma Deutschland | 50% | 75% | I50 | |||||
868 | furosemiid+triamtereen | C03EB80 | FURESIS COMP tablett 40mg+50mg N100 | Orion | 50% | |||||||
869 | furosemiid+triamtereen | C03EB80 | FURESIS COMP tablett 40mg+50mg N30 | Orion | 50% | |||||||
870 | furosemiid+triamtereen | C03EB80 | FURESIS COMP tablett 40mg+50mg N50 | Orion | 50% | |||||||
871 | fusiidhape | D06AX01 | FUCIDIN kreem 2% 15g N1 | Leo | 50% | |||||||
872 | fusiidhape | D06AX01 | FUCIDIN salv 2% 15g N1 | Leo | 50% | |||||||
873 | fusiidhape | J01XC01 | FUCIDIN suspensioon 50mgml 90ml N1 | Leo | 50% | |||||||
874 | fusiidhape | J01XC01 | FUCIDIN tablett 250mg N12 | Leo | 50% | |||||||
875 | fusiidhape | S01AA13 | FUCITHALMIC viskoossed silmatilgad 1% 5g N1 | Leo | 50% | |||||||
876 | gabapentiin | N03AX12 | NEURONTIN kapsel 100mg N100 | Pfizer H.C.P | 50% | |||||||
877 | gabapentiin | N03AX12 | NEURONTIN kapsel 100mg N20 | Pfizer H.C.P | 50% | |||||||
878 | gabapentiin | N03AX12 | NEURONTIN kapsel 300mg N100 | Pfizer H.C.P | 50% | |||||||
879 | gabapentiin | N03AX12 | NEURONTIN kapsel 300mg N50 | Pfizer H.C.P | 50% | |||||||
880 | gabapentiin | N03AX12 | NEURONTIN kapsel 400mg N100 | Pfizer H.C.P | 50% | |||||||
881 | gabapentiin | N03AX12 | NEURONTIN kapsel 400mg N50 | Pfizer H.C.P | 50% | |||||||
882 | ganireliks | H01CC01 | ORGALUTRAN süstelahus 0,25mg 0.5ml 0.5ml N1 | N.V. ORGANON | 50% | |||||||
883 | ganireliks | H01CC01 | ORGALUTRAN süstelahus 0,25mg 0.5ml 0.5ml N5 | N.V. ORGANON | 50% | |||||||
884 | gantsükloviir | J05AB06 | CYMEVENE kapsel 250mg N84 | Roche | 50% | |||||||
885 | gestodeen+etünüülöstradiool | G03AA10 | FEMODEN tablett 0,075mg+0,03mg N21 | Schering AG | 50% | 75% | Z30 | |||||
886 | gestodeen+etünüülöstradiool | G03AA10 | HARMONET tablett 0,075mg+0,02mg N21 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
887 | gestodeen+etünüülöstradiool | G03AA10 | HARMONET tablett 0,075mg+0,02mg N63 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
888 | gestodeen+etünüülöstradiool | G03AA10 | LOGEST tablett 0,075mg+0,02mg N21 | Schering AG | 50% | 75% | Z30 | |||||
889 | gestodeen+etünüülöstradiool | G03AA10 | MINESSE tablett 0,06mg+0,015mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
890 | gestodeen+etünüülöstradiool | G03AA10 | MINESSE tablett 0,06mg+0,015mg N84 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
891 | gestodeen+etünüülöstradiool | G03AA10 | MINULET tablett 0,075mg+0,03mg N21 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
892 | gestodeen+etünüülöstradiool | G03AA10 | MINULET tablett 0,075mg+0,03mg N63 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
893 | gestodeen+etünüülöstradiool | G03AA10 | MIRELLE tablett 60mcg+15mcg N28 | Schering AG | 50% | 75% | Z30 | |||||
894 | gestodeen+etünüülöstradiool | G03AA10 | MIRELLE tablett 60mcg+15mcg N56 | Schering AG | 50% | 75% | Z30 | |||||
895 | gestodeen+etünüülöstradiool | G03AB06 | TRI-MINULET tablett -1+-1 N21 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
896 | gestodeen+etünüülöstradiool | G03AB06 | TRI-MINULET tablett -1+-1 N63 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
897 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N100 | TFT | 50% | 75% | E11; E14 | |||||
898 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N120 | TFT | 50% | 75% | E11; E14 | |||||
899 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N30 | TFT | 50% | 75% | E11; E14 | |||||
900 | glibenklamiid | A10BB01 | GLIBENCLAMID 5 TFT tablett 5mg N60 | TFT | 50% | 75% | E11; E14 | |||||
901 | glibenklamiid | A10BB01 | GLIBENCLAMID- RATIOPHARM 3,5 tablett 3,5mg N120 | ratiopharm | 50% | 75% | E11; E14 | |||||
902 | glibenklamiid | A10BB01 | GLIBENCLAMID- RATIOPHARM 3,5 tablett 3,5mg N30 | ratiopharm | 50% | 75% | E11; E14 | |||||
903 | glibenklamiid | A10BB01 | MANINIL 1,75 tablett 1,75mg N120 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
904 | glibenklamiid | A10BB01 | MANINIL 1,75 tablett 1,75mg N30 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
905 | glibenklamiid | A10BB01 | MANINIL 1,75 tablett 1,75mg N60 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
906 | glibenklamiid | A10BB01 | MANINIL 3,5 tablett 3,5mg N120 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
907 | glibenklamiid | A10BB01 | MANINIL 3,5 tablett 3,5mg N30 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
908 | glibenklamiid | A10BB01 | MANINIL 3,5 tablett 3,5mg N60 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
909 | glibenklamiid | A10BB01 | MANINIL 5 tablett 5mg N120 | Berlin-Chemie | 50% | 75% | E11; E14 | |||||
910 | gliklasiid | A10BB09 | DIABREZIDE tablett 80mg N40 | Molteni | 50% | 75% | E11; E14 | |||||
911 | gliklasiid | A10BB09 | DIAPREL MR tablett 30mg N60 | Servier | 50% | 75% | E11; E14 | |||||
912 | gliklasiid | A10BB09 | DIAPREL tablett 80mg N60 | Servier | 50% | 75% | E11; E14 | |||||
913 | glimepriid | A10BB12 | AMARYL tablett 1mg N30 | Aventis Pharma Deutschland | 50% | |||||||
914 | glimepriid | A10BB12 | AMARYL tablett 1mg N90 | Aventis Pharma Deutschland | 50% | |||||||
915 | glimepriid | A10BB12 | AMARYL tablett 2mg N30 | Aventis Pharma Deutschland | 50% | |||||||
916 | glimepriid | A10BB12 | AMARYL tablett 2mg N90 | Aventis Pharma Deutschland | 50% | |||||||
917 | glimepriid | A10BB12 | AMARYL tablett 3mg N30 | Aventis Pharma Deutschland | 50% | |||||||
918 | glimepriid | A10BB12 | AMARYL tablett 3mg N90 | Aventis Pharma Deutschland | 50% | |||||||
919 | glipisiid | A10BB07 | GLIBENESE GITS tablett 10mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | E11; E14 | |||||
920 | glipisiid | A10BB07 | GLIBENESE GITS tablett 5mg N30 | Pfizer H.C.P. Corporation | 50% | 75% | E11; E14 | |||||
921 | glipisiid | A10BB07 | MINIDIAB tablett 5mg N30 | Pharmacia Enterprises | 50% | 75% | E11; E14 | |||||
922 | glipisiid | A10BB07 | MINIDIAB tablett 5mg N75 | Pharmacia Enterprises | 50% | 75% | E11; E14 | |||||
923 | glükagoon | H04AA01 | GLUCAGEN 1 MG HYPOKIT injektsioonisubstants 1mg N1 | Novo Nordisk | 50% | |||||||
924 | glükoosamiin | M01AX05 | ARTHRYL pulber lahuseks | Rottapharm | 50% | |||||||
925 | glükoosamiin | M01AX05 | ARTHRYL pulber lahuseks 1500mg N20 | Rottapharm | 50% | |||||||
926 | glükoosamiin | M01AX05 | ARTHRYL pulber lahuseks 1500mg N30 | Rottapharm | 50% | |||||||
927 | glütserüülnitraat | C01DA02 | MINITRAN 10 TTS 10mg 24h N100 | 3M Health Care | 50% | |||||||
928 | glütserüülnitraat | C01DA02 | MINITRAN 10 TTS 10mg 24h N30 | 3M Health Care | 50% | |||||||
929 | glütserüülnitraat | C01DA02 | MINITRAN 5 TTS 5mg 24h N100 | 3M Health Care | 50% | |||||||
930 | glütserüülnitraat | C01DA02 | MINITRAN 5 TTS 5mg 24h N30 | 3M Health Care | 50% | |||||||
931 | glütserüülnitraat | C01DA02 | NITRO MACK RETARD 2,5 MG retardkapsel 2,5mg N50 | H. Mack | 50% | |||||||
932 | glütserüülnitraat | C01DA02 | NITRO MACK RETARD 5 MG retardkapsel 5mg N100 | H. Mack | 50% | |||||||
933 | glütserüülnitraat | C01DA02 | NITRODERM TTS 10 TTS 10mg 24h N10 | Novartis Pharma | 50% | |||||||
934 | glütserüülnitraat | C01DA02 | NITRODERM TTS 5 TTS 5mg 24h N10 | Novartis Pharma | 50% | |||||||
935 | glütserüülnitraat | C01DA02 | NITROLINGUAL SPRAY sprei 0,4mg/annuses 11.2g N200 | Pohl-Boskamp | 50% | |||||||
936 | glütserüülnitraat | C01DA02 | NITROLINGUAL SPRAY sprei 0,4mg/annuses 14.2g N250 | Pohl-Boskamp | 50% | |||||||
937 | glütserüülnitraat | C01DA02 | NITROLINGUAL SPRAY sprei 0,4mg/annuses 4.9g N75 | Pohl-Boskamp | 50% | |||||||
938 | gosereliin | L02AE03 | ZOLADEX depookapsel 3,6mg N1 | AstraZeneca UK Ltd. | 50% | |||||||
939 | gosereliin | L02AE03 | ZOLADEX LA depookapsel 10,8mg N1 | AstraZeneca UK Ltd. | 50% | |||||||
940 | granisetroon | A04AA02 | KYTRIL süstelahus 1mg/ml 1ml N5 | Roche | 50% | |||||||
941 | granisetroon | A04AA02 | KYTRIL süstelahus 1mg/ml 3ml N5 | Roche | 50% | |||||||
942 | granisetroon | A04AA02 | KYTRIL tablett 1mg N10 | Roche | 50% | |||||||
943 | haloperidool | N05AD01 | HALOPERIDOL TABLETS 5 MG tablett 5mg N50 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
944 | haloperidool | N05AD01 | HALOPERIDOL tablett 1,5mg N50 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
945 | haloperidool | N05AD01 | HALOPERIDOL tilgad 2mg/ml 10ml N1 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
946 | haloperidool | N05AD01 | HALOPERIDOL-DECANOATE-RICHTER süstelahus 50mg/ml 1ml N1 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
947 | haloperidool | N05AD01 | HALOPERIDOL-DECANOATE-RICHTER süstelahus 50mg/ml 1ml N5 | Richter | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)* |
*rev psühhiaatril | ||||
948 | haltsinoniid | D07AD02 | BETACORTON rasvane kreem 0,1% 20g N1 | Spirig | 50% | |||||||
949 | haltsinoniid | D07AD02 | BETACORTON rasvane kreem 0,1% 50g N1 | Spirig | 50% | |||||||
950 | haltsinoniid | D07AD02 | BETACORTON SOLUTION nahalahus 0,1% 100ml N1 | Spirig | 50% | |||||||
951 | haltsinoniid | D07AD02 | BETACORTON SOLUTION nahalahus 0,1% 25ml N1 | Spirig | 50% | |||||||
952 | haltsinoniid+karbamiid | D07XD80 | BETACORTON CREAM kreem 0,1%+5% 20g N1 | Spirig | 50% | |||||||
953 | haltsinoniid+karbamiid | D07XD80 | BETACORTON CREAM kreem 0,1%+5% 50g N1 | Spirig | 50% | |||||||
954 | haltsinoniid+salitsüülhape | D07XD81 | BETACORTON S SOLUTION nahalahus 0,1%+2% 100ml N1 | Spirig | 50% | |||||||
955 | haltsinoniid+salitsüülhape | D07XD81 | BETACORTON S SOLUTION nahalahus 0,1%+2% 25ml N1 | Spirig | 50% | |||||||
956 | Human menopausal gonadotrophin | G03GA02 | PERGONAL injektsioonisubstants 75TÜ N1 | ARES TRADING SA | 50% | |||||||
957 | Human menopausal gonadotrophin | G03GA02 | PERGONAL injektsioonisubstants 75TÜ N10 | ARES TRADING SA | 50% | |||||||
958 | hüdroklorotiasiid | C03AA03 | HYPOTHIAZID tablett 100mg N20 | Chinoin | 50% | 75% | I10-I13; I15; I50*; O10-O16 | *rev kardioloogil | ||||
959 | hüdroklorotiasiid | C03AA03 | HYPOTHIAZID tablett 25mg N20 | Chinoin | 50% | 75% | I10-I13; I15; I50*; O10-O16 | *rev kardioloogil | ||||
960 | hüdroklorotiasiid+amiloriid | C03EA81 | MODURETIC tablett 5mg+50mg N30 | MSD | 50% | |||||||
961 | hüdroklorotiasiid+triamtereen | C03EA80 | TRIAMPUR COMPOSITUM tablett 12,5mg+25mg N50 | AWD | 50% | |||||||
962 | hüdrokortisoon | D07AA02 | HYDROCORTISON DAK salv 1% 30ml N1 | Nycomed SEFA | 50% | |||||||
963 | hüdrokortisoon | H02AB09 | SOLU-CORTEF injektsioonisubstants 100mg N1 | Pharmacia Enterprises | 50% | 100% | E23*; E25*;
E27*; E89.3*; E89.6*; T86** |
*rev endokrino- loogil; **rv patsienti jälgival ja ravival arstil |
||||
964 | hüdrokortisoon | H02AB09 | SOLU-CORTEF injektsioonisubstants 100mg N25 | Pharmacia Enterprises | 50% | 100% | E23*; E25*;
E27*; E89.3*; E89.6*; T86** |
*rev endokrino- loogil; **rv patsienti jälgival ja ravival arstil |
||||
965 | hüdrokortisoon+fusiidhape | D07XA82 | FUCIDIN H kreem 10mg+20mgg 15g N1 | Leo | 50% | |||||||
966 | hüdrokortisoon+kloorheksidiin | D07BA80 | SIBICORT kreem 1%+1% 100g N1 | Orion | 50% | |||||||
967 | hüdrokortisoon+kloorheksidiin | D07BA80 | SIBICORT kreem 1%+1% 20g N1 | Orion | 50% | |||||||
968 | hüdrokortisoon+kloorheksidiin | D07BA80 | SIBICORT kreem 1%+1% 50g N1 | Orion | 50% | |||||||
969 | hüdrokortisoon+lidokaiin | H02AB80 | HYDROCORTISON-RICHTER SUSPENSION FOR INJECTION süstesuspensioon 25mg+5mgml 5ml N1 | Richter | 50% | 100% | E23*; E25*;
E27*; E89.3*; E89.6*; T86** |
*rev endokrino- loogil; **rv patsienti jälgival ja ravival arstil |
||||
970 | hüdrokortisoon+tsiprofloksatsiin | S02CA82 | CIPROBAY HC kõrvatilgad 1%+0,2% 10 ml N1 | Alcon Inc. | 50% | |||||||
971 | hüdrokortisoonbutüraat | D07AB02 | LOCOID CRELO Nahaemulsioon 1mg/g 30g N1 | Yamanouchi | 50% | |||||||
972 | hüdrokortisoonbutüraat | D07AB02 | LOCOID kreem 0,1% 30g N1 | Yamanouchi | 50% | |||||||
973 | hüdrokortisoonbutüraat | D07AB02 | LOCOID rasvane kreem 0,1% 30g N1 | Yamanouchi | 50% | |||||||
974 | hüdroksükarbamiid | L01XX05 | HYDREA kapsel 500mg N100 | Bristol-Myers Squibb | 50% | |||||||
975 | hüdroksüklorokiin | P01BA02 | PLAQUENIL tablett 200mg N60 | Sanofi | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46* | *rv reumatoloogil | ||||
976 | hüdroksüsiin | R06AE80 | ATARAX siirup 2mg/ml 200ml N1 | UCB Pharma Oy Finland | 50% | |||||||
977 | hüdroksüsiin | R06AE80 | ATARAX tablett 25mg N100 | UCB Pharma Oy Finland | 50% | |||||||
978 | hüdroksüsiin | R06AE80 | ATARAX tablett 25mg N25 | UCB Pharma Oy Finland | 50% | |||||||
979 | ibuprofeen | M01AE01 | BURANA tablett 400mg N30 | Orion | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
980 | ibuprofeen | M01AE01 | IBUMAX tablett 400mg N100 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
981 | ibuprofeen | M01AE01 | IBUMAX tablett 400mg N30 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
982 | ibuprofeen | M01AE01 | IBUMAX tablett 600mg N10 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
983 | ibuprofeen | M01AE01 | IBUMAX tablett 600mg N100 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
984 | ibuprofeen | M01AE01 | IBUMAX tablett 600mg N30 | Vitabalans | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
985 | ibuprofeen | M01AE01 | IBUMETIN 400 tablett 400mg N100 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
986 | ibuprofeen | M01AE01 | IBUMETIN 400 tablett 400mg N50 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
987 | ibuprofeen | M01AE01 | IBUMETIN 600 tablett 600mg N100 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
988 | ibuprofeen | M01AE01 | IBUMETIN 600 tablett 600mg N20 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
989 | ibuprofeen | M01AE01 | IBUMETIN 600 tablett 600mg N50 | Nycomed SEFA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
990 | ibuprofeen | M01AE01 | IBUPROFEN 400 TFT tablett 400mg N20 | TFT | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
991 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 400MG tablett 400mg N20 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
992 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 400MG tablett 400mg N50 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
993 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 400MG tablett 400mg N84 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
994 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 600MG tablett 600mg N20 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
995 | ibuprofeen | M01AE01 | IBUPROFEN ALPHARMA TABLETS 600MG tablett 600mg N50 | ALPHARMA | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
996 | ibuprofeen | M01AE01 | IBUPROFEN LANNACHER tablett 400mg N30 | Lannacher | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
997 | ibuprofeen | M01AE01 | IBUPROFEN LANNACHER tablett 600mg N30 | Lannacher | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
998 | ibuprofeen | M01AE01 | SOLPAFLEX retardkapsel 300mg N24 | GlaxoSmithKline | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
999 | ibuprofeen | M01AE01 | SOLPAFLEX retardkapsel 300mg N36 | GlaxoSmithKline | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
1000 | ibuprofeen | M01AE01 | SOLPAFLEX retardkapsel 300mg N48 | GlaxoSmithKline | 50% | 75% | M05; M06; M08; M15-M19; M45; M46 | 100% | C00-D48 | |||
1001 | idarubitsiin | L01DB06 | ZAVEDOS kapsel 10mg N1 | Pharmacia Enterprises | 50% | |||||||
1002 | idarubitsiin | L01DB06 | ZAVEDOS kapsel 5mg N1 | Pharmacia Enterprises | 50% | |||||||
1003 | imatinib | L01XX28 | GLIVEC kapsel 100mg N120 | Novartis Pharma | 50% | |||||||
1004 | imatinib | L01XX28 | GLIVEC kapsel 100mg N180 | Novartis Pharma | 50% | |||||||
1005 | imatinib | L01XX28 | GLIVEC kapsel 100mg N24 | Novartis Pharma | 50% | |||||||
1006 | imatinib | L01XX28 | GLIVEC kapsel 100mg N48 | Novartis Pharma | 50% | |||||||
1007 | imatinib | L01XX28 | GLIVEC kapsel 100mg N96 | Novartis Pharma | 50% | |||||||
1008 | imatinib | L01XX28 | GLIVEC kapsel 50mg N30 | Novartis Pharma | 50% | |||||||
1009 | imidapriil | C09AA80 | TANATRIL tablett 10mg N100 | ALGOL OY | 50% | |||||||
1010 | imidapriil | C09AA80 | TANATRIL tablett 10mg N30 | ALGOL OY | 50% | |||||||
1011 | imidapriil | C09AA80 | TANATRIL tablett 5mg N100 | ALGOL OY | 50% | |||||||
1012 | imidapriil | C09AA80 | TANATRIL tablett 5mg N30 | ALGOL OY | 50% | |||||||
1013 | imikute toitesegu | SOIJA TUTTELI 400 g | Valio | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1014 | imikute toitesegu | ISOMIL 400 g (laktoosivaba) | Abbot | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1015 | imikute toitesegu | ALSOY (DS32-A) 450 g | Nestle | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1016 | imikute toitesegu | PEPTIDI TUTTELI 400 g | Valio | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1017 | imikute toitesegu | ALFARE (DS24) 400 g (vadaku) | Nestle | 75% | K52.2; K90.4; L20.8; L27.2 | |||||||
1018 | imikvimood | D06BB10 | ALDARA kreem 5% 250mg N12 | 3M Health Care | 50% | |||||||
1019 | imipramiin | N06AA02 | IMIPRAMINE ALPHARMA TABLETS 25 MG tablett 25mg N48 | ALPHARMA | 50% | |||||||
1020 | imipramiin | N06AA02 | IMIPRAMINE ALPHARMA TABLETS 25 MG tablett 25mg N50 | ALPHARMA | 50% | |||||||
1021 | indapamiid | C03BA11 | PRO-INDAP kapsel 2,5mg N30 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
1022 | indapamiid | C03BA11 | TERTENSIF SR retardtablett 1,5mg N30 | Servier | 50% | |||||||
1023 | indapamiid | C03BA11 | TERTENSIF tablett 2,5mg N30 | Servier | 50% | |||||||
1024 | indinaviir | J05AE02 | CRIXIVAN kapsel 333 mg N135 | MSD | 50% | |||||||
1025 | indinaviir | J05AE02 | CRIXIVAN kapsel 100mg N180 | MSD | 50% | |||||||
1026 | indinaviir | J05AE02 | CRIXIVAN kapsel 200mg N180 | MSD | 50% | |||||||
1027 | indinaviir | J05AE02 | CRIXIVAN kapsel 200mg N270 | MSD | 50% | |||||||
1028 | indinaviir | J05AE02 | CRIXIVAN kapsel 200mg N360 | MSD | 50% | |||||||
1029 | indinaviir | J05AE02 | CRIXIVAN kapsel 400mg N180 | MSD | 50% | |||||||
1030 | indinaviir | J05AE02 | CRIXIVAN kapsel 400mg N90 | MSD | 50% | |||||||
1031 | indometatsiin | M01AB01 | INDOMET- RATIOPHARM 50 kapsel 50mg N100 | ratiopharm | 50% | 100% | C00-D48 | |||||
1032 | indometatsiin | M01AB01 | INDOMET- RATIOPHARM 50 kapsel 50mg N20 | ratiopharm | 50% | 100% | C00-D48 | |||||
1033 | indometatsiin | M01AB01 | INDOMET- RATIOPHARM 50 kapsel 50mg N50 | ratiopharm | 50% | 100% | C00-D48 | |||||
1034 | indometatsiin | M01AB01 | INDOMETATSIIN NYCOMED kapsel 25mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1035 | indometatsiin | M01AB01 | INDOMETATSIIN NYCOMED kapsel 50mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1036 | indometatsiin | M02AA23 | INDOMET-RATIO- PHARM GEL geel 1% 100g N1 |
ratiopharm | 50% | |||||||
1037 | indometatsiin | M02AA23 | INDOMET-RATIO- PHARM GEL geel 1% 50g N1 |
ratiopharm | 50% | |||||||
1038 | indometatsiin | M02AA23 | MOBILAT AKUT INDO SPRAY lahus paikseks kasut. 8mg/ml 50ml N1 | Sankyo | 50% | |||||||
1039 | insuliin aspart | A10AB05 | NOVOMIX 30 FLEXPEN süstesuspensioon 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1040 | insuliin aspart | A10AB05 | NOVOMIX 30 PENFILL süstesuspensioon 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1041 | insuliin aspart | A10AB05 | NOVORAPID FLEXPEN süstelahus 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1042 | insuliin aspart | A10AB05 | NOVORAPID NOVOLET 3 ML süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1043 | insuliin aspart | A10AB05 | NOVORAPID PENFILL 3 ML süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1044 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 10ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1045 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1046 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1047 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1048 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1049 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1050 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1051 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N2 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1052 | insuliinglargiin | A10AE04 | LANTUS süstelahus 100TÜ/ml 5ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1053 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 18000000TÜ/ml 1ml N1 | Roche | 50% | |||||||
1054 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 3000000TÜ 0.5ml 0.5ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1055 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 3000000TÜ/ml 1ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1056 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 9000000TÜ 0.5ml 0.5ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1057 | interferoon alfa | L03AA04 | ROFERON-A süstelahus 9000000TÜ/ml 1ml N1 | Roche | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
1058 | interferoon alfa-2b | L03AB05 | INTRON A injektsioonisubstants 10miljTÜ N1 | Schering-Plough | 50% | |||||||
1059 | interferoon alfa-2b | L03AB05 | INTRON A injektsioonisubstants 3miljTÜ N1 | Schering-Plough | 50% | |||||||
1060 | interferoon alfa-2b | L03AB05 | INTRON A injektsioonisubstants 5miljTÜ N1 | Schering-Plough | 50% | |||||||
1061 | interferoon alfa-2b | L03AB05 | INTRON A süstelahus 15miljTÜ/ml N1 | Schering-Plough | 50% | |||||||
1062 | interferoon alfa-2b | L03AB05 | INTRON A süstelahus 25miljTÜ/ml N1 | Schering-Plough | 50% | |||||||
1063 | interferoon alfa-2b | L03AB05 | INTRON A süstelahus 50miljTÜ/ml N1 | Schering-Plough | 50% | |||||||
1064 | interferoon beeta | L03AA11 | AVONEX injektsioonisubstants 30mcg N4 | Schering-Plough | 50% | |||||||
1065 | interferoon beeta | L03AA11 | BETAFERON injektsioonisubstants 9600000TÜ N15 | Schering AG | 50% | |||||||
1066 | interferoon beeta | L03AA11 | BETAFERON injektsioonisubstants 9600000TÜ N5 | Schering AG | 50% | |||||||
1067 | interferoon beta-1a | L03AB07 | REBIF 44 MCG süstelahus 44mcg 0.5ml 0.5ml N1 | Serono Europe Ltd. | 50% | |||||||
1068 | interferoon beta-1a | L03AB07 | REBIF 44 MCG süstelahus 44mcg 0.5ml 0.5ml N15 | Serono Europe Ltd. | 50% | |||||||
1069 | interferoon beta-1a | L03AB07 | REBIF 44 MCG süstelahus 44mcg 0.5ml 0.5ml N3 | Serono Europe Ltd. | 50% | |||||||
1070 | interferoon beta-1a | L03AB07 | REBIF süstelahus 22mcg 0.5ml 0.5ml N1 | Serono Europe Ltd. | 50% | |||||||
1071 | interferoon beta-1a | L03AB07 | REBIF süstelahus 22mcg 0.5ml 0.5ml N15 | Serono Europe Ltd. | 50% | |||||||
1072 | interferoon beta-1a | L03AB07 | REBIF süstelahus 22mcg 0.5ml 0.5ml N3 | Serono Europe Ltd. | 50% | |||||||
1073 | ipratroopiumbromiid | R03BB01 | ATROVENT inhal aeros 0,02mg/annuses 15ml N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
1074 | ipratroopiumbromiid | R03BB01 | ATROVENT inhalatsioonilahus 0,25mg/ml 20ml N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
1075 | irbesartaan | C09CA04 | APROVEL tablett 150mg N14 | Sanofi Pharma BMS | 50% | |||||||
1076 | irbesartaan | C09CA04 | APROVEL tablett 150mg N28 | Sanofi Pharma BMS | 50% | |||||||
1077 | irbesartaan | C09CA04 | APROVEL tablett 150mg N56 | Sanofi Pharma BMS | 50% | |||||||
1078 | irbesartaan | C09CA04 | APROVEL tablett 150mg N98 | Sanofi Pharma BMS | 50% | |||||||
1079 | irbesartaan | C09CA04 | APROVEL tablett 300mg N14 | Sanofi Pharma BMS | 50% | |||||||
1080 | irbesartaan | C09CA04 | APROVEL tablett 300mg N28 | Sanofi Pharma BMS | 50% | |||||||
1081 | irbesartaan | C09CA04 | APROVEL tablett 300mg N56 | Sanofi Pharma BMS | 50% | |||||||
1082 | irbesartaan | C09CA04 | APROVEL tablett 300mg N98 | Sanofi Pharma BMS | 50% | |||||||
1083 | irbesartaan | C09CA04 | APROVEL tablett 75mg N28 | Sanofi Pharma BMS | 50% | |||||||
1084 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 150mg+12,5mg N28 | Sanofi Pharma BMS | 50% | |||||||
1085 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 150mg+12,5mg N56 | Sanofi Pharma BMS | 50% | |||||||
1086 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 150mg+12,5mg N98 | Sanofi Pharma BMS | 50% | |||||||
1087 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 300mg+12,5mg N28 | Sanofi Pharma BMS | 50% | |||||||
1088 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 300mg+12,5mg N56 | Sanofi Pharma BMS | 50% | |||||||
1089 | irbesartaan+hüdroklorotiasiid | C09DA04 | COAPROVEL tablett 300mg+12,5mg N98 | Sanofi Pharma BMS | 50% | |||||||
1090 | isokonasool | D01AC05 | TRAVOGEN kreem 1%/g 20g N1 | Schering AG | 50% | |||||||
1091 | isokonasool | D01AC05 | TRAVOGEN kreem 1%/g 50g N1 | Schering AG | 50% | |||||||
1092 | isokonasool | G01AF07 | GYNO-TRAVOGEN vaginaaloovul 600mg N1 | Schering AG | 50% | |||||||
1093 | isokonasool+diflukortoloon | D01AC80 | TRAVOCORT kreem 1%+0,1%/g 15g N1 | Schering AG | 50% | |||||||
1094 | isokonasool+diflukortoloon | D01AC80 | TRAVOCORT kreem 1%+0,1%/g 30g N1 | Schering AG | 50% | |||||||
1095 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 20 retardkapsel 20mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1096 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 20 retardkapsel 20mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1097 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 40 RETARDKAPSELN retardkapsel 40mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1098 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 40 RETARDKAPSELN retardkapsel 40mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1099 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 5 tablett 5mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1100 | isosorbiiddinitraat | C01DA08 | ISDN-RATIOPHARM 5 tablett 5mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1101 | isosorbiiddinitraat | C01DA08 | ISO MACK RETARD 20 MG retardkapsel 20mg N50 | H. Mack | 50% | 75% | I20 | |||||
1102 | isosorbiiddinitraat | C01DA08 | ISO MACK RETARD 40 MG retardkapsel 40mg N50 | H. Mack | 50% | 75% | I20 | |||||
1103 | isosorbiiddinitraat | C01DA08 | ISO MACK RETARD 60 MG retardkapsel 60mg N50 | H. Mack | 50% | 75% | I20 | |||||
1104 | isosorbiiddinitraat | C01DA08 | ISO MACK SPRAY sprei 1,25mg/annuses 20ml N1 | H. Mack | 50% | 75% | I20 | |||||
1105 | isosorbiiddinitraat | C01DA08 | ISOKET 20 retardtablett 20mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1106 | isosorbiiddinitraat | C01DA08 | ISOKET 40 retardtablett 40mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1107 | isosorbiidmononitraat | C01DA14 | ELANTAN 20 tablett 20mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1108 | isosorbiidmononitraat | C01DA14 | ELANTAN 40 tablett 40mg N50 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1109 | isosorbiidmononitraat | C01DA14 | ELANTAN LONG retardkapsel 50mg N20 | Schwarz Pharma AG | 50% | 75% | I20 | |||||
1110 | isosorbiidmononitraat | C01DA14 | IMDUR retardtablett 60mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I20 | |||||
1111 | isosorbiidmononitraat | C01DA14 | IMDUR retardtablett 60mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I20 | |||||
1112 | isosorbiidmononitraat | C01DA14 | IS-5-MONO- RATIOPHARM 20 tablett 20mg N100 | ratiopharm | 50% | 75% | I20 | |||||
1113 | isosorbiidmononitraat | C01DA14 | IS-5-MONO- RATIOPHARM 20 tablett 20mg N20 | ratiopharm | 50% | 75% | I20 | |||||
1114 | isosorbiidmononitraat | C01DA14 | IS-5-MONO- RATIOPHARM 20 tablett 20mg N50 | ratiopharm | 50% | 75% | I20 | |||||
1115 | isosorbiidmononitraat | C01DA14 | MONO MACK 20 MG tablett 20mg N50 | H. Mack | 50% | 75% | I20 | |||||
1116 | isosorbiidmononitraat | C01DA14 | MONO MACK 40 MG tablett 40mg N50 | H. Mack | 50% | 75% | I20 | |||||
1117 | isosorbiidmononitraat | C01DA14 | MONO MACK DEPOT retardtablett 100mg N20 | H. Mack | 50% | 75% | I20 | |||||
1118 | isosorbiidmononitraat | C01DA14 | OLICARD 40 RETARD retardkapsel 40mg N50 | Solvay | 50% | 75% | I20 | |||||
1119 | isosorbiidmononitraat | C01DA14 | OLICARD 60 RETARD retardkapsel 60mg N50 | Solvay | 50% | 75% | I20 | |||||
1120 | isotretinoiin | D10BA01 | ROACCUTANE kapsel 10mg N30 | Roche | 50% | 75% | L70.1*; L70.2* | *rv dermatovene- roloogil |
||||
1121 | isradipiin | C08CA03 | LOMIR SRO kapsel 5mg N100 | Novartis Pharma | 50% | |||||||
1122 | isradipiin | C08CA03 | LOMIR SRO kapsel 5mg N30 | Novartis Pharma | 50% | |||||||
1123 | isradipiin | C08CA03 | LOMIR tablett 2,5mg N28 | Novartis Pharma | 50% | |||||||
1124 | itrakonasool | J02AC02 | ORUNGAL kapsel 100mg N15 | Janssen | 50% | |||||||
1125 | itrakonasool | J02AC02 | ORUNGAL kapsel 100mg N28 | Janssen | 50% | |||||||
1126 | itrakonasool | J02AC02 | ORUNGAL kapsel 100mg N4 | Janssen | 50% | |||||||
1127 | itrakonasool | J02AC02 | SPORANOX suukaudne lahus 10mg/ml 150ml N1 | Janssen | 50% | |||||||
1128 | kaltsipotriool | D05AX02 | DAIVONEX kreem 50mcgg 30g N1 | Leo | 50% | 75% | L40*; M07* | *rev dermatovene- roloogil |
||||
1129 | kaltsipotriool | D05AX02 | DAIVONEX lahus peanahale 50mcgml 60ml N1 | Leo | 50% | 75% | L40*; M07* | *rev dermatovene- roloogil |
||||
1130 | kaltsipotriool | D05AX02 | DAIVONEX salv 0,005% 30g N1 | Leo | 50% | 75% | L40*; M07* | *rev dermatovene- roloogil |
||||
1131 | kaltsitoniin | H05BA01 | MIACALCIC ninasprei 200TÜ/annuses 2ml N1 | Novartis Pharma | 50% | |||||||
1132 | kaltsitoniin | H05BA01 | MIACALCIC süstelahus 100TÜml 1ml N5 | Novartis Pharma | 50% | |||||||
1133 | kaltsitriool | A11CC04 | ROCALTROL kapsel 0,25mcg N30 | Roche | 50% | 75% | N18* | *rv nefroloogil | 100% | E20*; E89.2*;
N25 |
*rv endokrino- loogil |
|
1134 | kaltsiumatsetaat | A12AA12 | PHOS-EX 250 MG tablette 250 mg N180 | SUOMEEN SAIRAALAPALVELU OY | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1135 | kaltsiumatsetaat | A12AA12 | CALCIUMACETAT-NEFRO tablett 500 mg N100 | MEDICE Chem.-pharm. Fabrik Pütter GmbH & Co. | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1136 | kaltsiumatsetaat | A12AA12 | CALCIUMACETAT-NEFRO tablett 500 mg N500 | MEDICE Chem.-pharm. Fabrik Pütter GmbH & Co. | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1137 | kaltsiumfolinaat | V03AF03 | ANTREX tablett 15mg N10 | Orion | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1138 | kaltsiumfolinaat | V03AF03 | ANTREX tablett 15mg N100 | Orion | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1139 | kaltsiumfolinaat | V03AF03 | CALCIUMFOLINAT “EBEWE” kapsel 15mg N20 | Ebewe | 50% | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
||
1140 | kaltsiumkarbonaat | A12AA04 | CALCIGRAN SINE närimistablett 1250 mg N30 | Nycomed SEFA | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
|||
1141 | kaltsiumkarbonaat | A12AA04 | CALCIGRAN SINE närimistablett 1250 mg N60 | Nycomed SEFA | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
|||
1142 | kaltsiumkarbonaat | A12AA04 | CALCIGRAN SINE närimistablett 1250 mg N100 | Nycomed SEFA | 75% | N18 | 100% | E20*; E89.2* | *rv endokrino- loogil |
|||
1143 | kapetsitabiin | L01BC06 | XELODA tablett 150mg N60 | Roche | 50% | |||||||
1144 | kapetsitabiin | L01BC06 | XELODA tablett 500mg N120 | Roche | 50% | |||||||
1145 | kaptopriil | C09AA01 | CAPOTEN tablett 25mg N30 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1146 | kaptopriil | C09AA01 | CAPOTEN tablett 25mg N40 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1147 | kaptopriil | C09AA01 | CAPOTEN tablett 50mg N90 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1148 | kaptopriil | C09AA01 | CAPTOHEXAL 25 tablett 25mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1149 | kaptopriil | C09AA01 | CAPTOHEXAL 25 tablett 25mg N20 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1150 | kaptopriil | C09AA01 | CAPTOHEXAL 25 tablett 25mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1151 | kaptopriil | C09AA01 | CAPTOHEXAL 50 tablett 50mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1152 | kaptopriil | C09AA01 | CAPTOHEXAL 50 tablett 50mg N20 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1153 | kaptopriil | C09AA01 | CAPTOHEXAL 50 tablett 50mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1154 | kaptopriil | C09AA01 | CAPTOHEXAL COR tablett 12,5mg N100 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1155 | kaptopriil | C09AA01 | CAPTOHEXAL COR tablett 12,5mg N20 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1156 | kaptopriil | C09AA01 | CAPTOHEXAL COR tablett 12,5mg N50 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1157 | kaptopriil | C09AA01 | CAPTOPRIL ALPHARMA TABLETS BP 12,5 MG tablett 12,5mg N30 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1158 | kaptopriil | C09AA01 | CAPTOPRIL ALPHARMA TABLETS BP 25 MG tablett 25mg N30 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1159 | kaptopriil | C09AA01 | CAPTOPRIL ALPHARMA TABLETS BP 50 MG tablett 50mg N30 | ALPHARMA | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1160 | kaptopriil | C09AA01 | CAPTOPRIL STADA 12,5 tablett 12,5mg N100 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1161 | kaptopriil | C09AA01 | CAPTOPRIL STADA 12,5 tablett 12,5mg N30 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1162 | kaptopriil | C09AA01 | CAPTOPRIL STADA 12,5 tablett 12,5mg N50 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1163 | kaptopriil | C09AA01 | CAPTOPRIL STADA 25 tablett 25mg N100 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1164 | kaptopriil | C09AA01 | CAPTOPRIL STADA 25 tablett 25mg N30 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1165 | kaptopriil | C09AA01 | CAPTOPRIL STADA 25 tablett 25mg N50 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1166 | kaptopriil | C09AA01 | CAPTOPRIL STADA 50 tablett 50mg N100 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1167 | kaptopriil | C09AA01 | CAPTOPRIL STADA 50 tablett 50mg N30 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1168 | kaptopriil | C09AA01 | CAPTOPRIL STADA 50 tablett 50mg N50 | Stada | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1169 | kaptopriil | C09AA01 | KAPTEKS tablett 12,5mg N30 | Grindeks | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1170 | kaptopriil | C09AA01 | KAPTEKS tablett 25mg N30 | Grindeks | 50% | 75% | (I10-I13)*; I15*; I20 | *(1) | ||||
1171 | kaptopriil | C09AA01 | KAPTEKS tablett 50mg N30 | Grindeks | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1172 | kaptopriil | C09AA01 | KAPTOPRIL 12,5 tablett 12,5mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1173 | kaptopriil | C09AA01 | KAPTOPRIL 25 tablett 25mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1174 | kaptopriil | C09AA01 | KAPTOPRIL 50 tablett 50mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1175 | kaptopriil | C09AA01 | NYCAPRIL 25 MG tablett 25mg N40 | Nycomed SEFA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1176 | kaptopriil | C09AA01 | NYCAPRIL 50 MG tablett 50mg N30 | Nycomed SEFA | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1177 | kaptopriil+hüdroklorotiasiid | C09BA01 | CAPOZIDE tablett 50mg+25mg N30 | Bristol-Myers Squibb | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
1178 | karbamasepiin | N03AF01 | CARBALEX 200 MG TABLET tablett 200 mg N50 | Gerot | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1179 | karbamasepiin | N03AF01 | CARBALEX 400 MG TABLET tablett 400 mg N50 | Gerot | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1180 | karbamasepiin | N03AF01 | CARBAMAZEPIN NYCOMED 200 MG tablett 200mg N50 | Nycomed SEFA | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1181 | karbamasepiin | N03AF01 | CARBASAN RETARD retardtablett 400mg N50 | Sanofi | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1182 | karbamasepiin | N03AF01 | CARBASAN tablett 200mg N50 | Sanofi | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1183 | karbamasepiin | N03AF01 | FINLEPSIN 200 RETARD retardtablett 200mg N100 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1184 | karbamasepiin | N03AF01 | FINLEPSIN 200 RETARD retardtablett 200mg N200 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1185 | karbamasepiin | N03AF01 | FINLEPSIN 200 RETARD retardtablett 200mg N50 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1186 | karbamasepiin | N03AF01 | FINLEPSIN 400 RETARD retardtablett 400mg N100 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1187 | karbamasepiin | N03AF01 | FINLEPSIN 400 RETARD retardtablett 400mg N200 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1188 | karbamasepiin | N03AF01 | FINLEPSIN 400 RETARD retardtablett 400mg N50 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1189 | karbamasepiin | N03AF01 | FINLEPSIN tablett 200mg N50 | AWD | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1190 | karbamasepiin | N03AF01 | TEGRETOL CR retardtablett 200mg N50 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1191 | karbamasepiin | N03AF01 | TEGRETOL CR retardtablett 400mg N30 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1192 | karbamasepiin | N03AF01 | TEGRETOL tablett 200mg N50 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1193 | karbamasepiin | N03AF01 | TEGRETOL tablett 400mg N30 | Novartis Pharma | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1194 | karbamasepiin | N03AF01 | TIMONIL 150 RETARD retardtablett 150mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1195 | karbamasepiin | N03AF01 | TIMONIL 150 RETARD retardtablett 150mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1196 | karbamasepiin | N03AF01 | TIMONIL 200 tablett 200mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1197 | karbamasepiin | N03AF01 | TIMONIL 200 tablett 200mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1198 | karbamasepiin | N03AF01 | TIMONIL 300 RETARD retardtablett 300mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1199 | karbamasepiin | N03AF01 | TIMONIL 300 RETARD retardtablett 300mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1200 | karbamasepiin | N03AF01 | TIMONIL 600 RETARD retardtablett 600mg N100 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1201 | karbamasepiin | N03AF01 | TIMONIL 600 RETARD retardtablett 600mg N50 | Desitin | 50% | 75% | G50 | 100% | (F00-F09)*; E89.2*;
N25; (F10-F19.4-7)*; (F20-F29)*; (F30-F31)*; (F32/33.2-3)*; F60.3*; (F70-F79)*; G40** |
*rev psühhiaatril; **rev neuroloogil | ||
1202 | karbotsüsteiin | R05CB03 | FLUDITEC siirup 20mg/ml 125 ml N1 | Laboratoire Innotech int | 50% | |||||||
1203 | karbotsüsteiin | R05CB03 | FLUDITEC siirup 50mg/ml 125ml N1 | Laboratoire Innotech int | 50% | |||||||
1204 | karbotsüsteiin | R05CB03 | MUCOPRONT kapsel 375mg N20 | H. Mack | 50% | |||||||
1205 | karbotsüsteiin | R05CB03 | MUCOPRONT siirup 50mg/g 200ml N1 | H. Mack | 50% | |||||||
1206 | karbotsüsteiin | R05CB03 | MUCOPRONT siirup 50mg/g 90ml N1 | H. Mack | 50% | |||||||
1207 | karbotsüsteiin | R05CB03 | PULMOCLASE kapsel 375mg N50 | UCB Pharma Oy Finland | 50% | |||||||
1208 | karbotsüsteiin | R05CB03 | PULMOCLASE siirup 50mg/ml 200ml N1 | UCB Pharma Oy Finland | 50% | |||||||
1209 | karbotsüsteiin | R05CB03 | PULMOCLASE siirup 50mg/ml 500ml N1 | UCB Pharma Oy Finland | 50% | |||||||
1210 | karvedilool | C07AG02 | CORYOL tablett 12,5mg N30 | KRKA, d.d. | 50% | |||||||
1211 | karvedilool | C07AG02 | CORYOL tablett 25mg N30 | KRKA, d.d. | 50% | |||||||
1212 | karvedilool | C07AG02 | DILATREND tablett 12,5mg N30 | Roche | 50% | |||||||
1213 | karvedilool | C07AG02 | DILATREND tablett 25mg N30 | Roche | 50% | |||||||
1214 | karvedilool | C07AG02 | DILATREND tablett 6,25mg N30 | Roche | 50% | |||||||
1215 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | HUMAJECT NPH süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1216 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1217 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1218 | Keskmise toimeajaga humaaninsuliin | A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1219 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1220 | Keskmise toimeajaga humaanin- suliin |
A10AC01 | INSUMAN BASAL süstesuspensioon 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1221 | Keskmise toimeajaga humaanin- suliin |
A10AC01 | MONOTARD HM süstesuspensioon 100TÜ/ml 10ml N1 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1222 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE HM PENFILL süstesuspensioon 100TÜ/ml 1.5ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1223 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE HM PENFILL süstesuspensioon 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1224 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE HM süstesuspensioon 100TÜ/ml 10ml N1 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1225 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE INNOLET süstesuspensioon 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1226 | Keskmise toimeajaga humaan- insuliin |
A10AC01 | PROTAPHANE NOVOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1227 | ketobemidoon | N02AB01 | KETOGAN NOVUM tablett 5mg N100 | Pharmacia Enterprises | 50% | |||||||
1228 | ketobemidoon | N02AB01 | KETOGAN NOVUM tablett 5mg N20 | Pharmacia Enterprises | 50% | |||||||
1229 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 10mg N100 | Pharmacia Enterprises | 50% | |||||||
1230 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 10mg N20 | Pharmacia Enterprises | 50% | |||||||
1231 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 25mg N100 | Pharmacia Enterprises | 50% | |||||||
1232 | ketobemidoon | N02AB01 | KETOGAN RETARD retardkapsel 25mg N20 | Pharmacia Enterprises | 50% | |||||||
1233 | ketokonasool | D01AC08 | NIZORAL kreem 2%/g 15g N1 | Janssen | 50% | |||||||
1234 | ketokonasool | D01AC08 | NIZORAL kreem 2%/g 30g N1 | Janssen | 50% | |||||||
1235 | ketokonasool | J02AB02 | NIZORAL tablett 200mg N10 | Janssen | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
1236 | ketokonasool | J02AB02 | NIZORAL tablett 200mg N30 | Janssen | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
1237 | ketokonasool | J02AB02 | ORONAZOL tablett 200mg N20 | KRKA, d.d. | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
1238 | ketoprofeen | M01AE03 | BI-PROFENID retardtablett 150mg N20 | LABORATOIRE AVENTIS | 50% | |||||||
1239 | ketoprofeen | M01AE03 | KETO tablett 100mg N100 | Vitabalans | 50% | |||||||
1240 | ketoprofeen | M01AE03 | KETO tablett 100mg N20 | Vitabalans | 50% | |||||||
1241 | ketoprofeen | M01AE03 | KETO tablett 100mg N30 | Vitabalans | 50% | |||||||
1242 | ketoprofeen | M01AE03 | KETO tablett 50mg N100 | Vitabalans | 50% | |||||||
1243 | ketoprofeen | M01AE03 | KETO tablett 50mg N20 | Vitabalans | 50% | |||||||
1244 | ketoprofeen | M01AE03 | KETO tablett 50mg N30 | Vitabalans | 50% | |||||||
1245 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 ZÄPFCHEN suposiit 100mg N10 | ratiopharm | 50% | |||||||
1246 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 ZÄPFCHEN suposiit 100mg N50 | ratiopharm | 50% | |||||||
1247 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 tablett 100mg N100 | ratiopharm | 50% | |||||||
1248 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 tablett 100mg N20 | ratiopharm | 50% | |||||||
1249 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 100 tablett 100mg N50 | ratiopharm | 50% | |||||||
1250 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | |||||||
1251 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 50 tablett 50mg N20 | ratiopharm | 50% | |||||||
1252 | ketoprofeen | M01AE03 | KETOPROFEN- RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | |||||||
1253 | ketoprofeen | M01AE03 | PROFENID kapsel 50mg N24 | LABORATOIRE AVENTIS | 50% | |||||||
1254 | ketoprofeen | M01AE03 | PROFENID suposiit 100mg N12 | LABORATOIRE AVENTIS | 50% | |||||||
1255 | ketoprofeen | M01AE03 | PROFENID tablett 100mg N30 | LABORATOIRE AVENTIS | 50% | |||||||
1256 | ketorolak | S01BC05 | ACULAR silmatilgad 0,5% 5 ml N1 | Allergan | 50% | |||||||
1257 | ketotifeen | R06AX17 | ZADITEN siirup 0,2mg/ml 100ml N1 | Novartis Pharma | 50% | |||||||
1258 | ketotifeen | R06AX17 | ZADITEN tablett 1mg N30 | Novartis Pharma | 50% | |||||||
1259 | kinidiin | C01BA01 | KINIDIN DURULES retardtablett 200mg N100 | AstraZeneca UK Ltd. | 50% | |||||||
1260 | klaritromütsiin | J01FA09 | FROMILID 250 tablett 250mg N14 | KRKA, d.d. | 50% | |||||||
1261 | klaritromütsiin | J01FA09 | FROMILID 500 tablett 500mg N14 | KRKA, d.d. | 50% | |||||||
1262 | klaritromütsiin | J01FA09 | FROMILID suspensioonigraanulid 125mg 5ml 25g N1 | KRKA, d.d. | 50% | |||||||
1263 | klaritromütsiin | J01FA09 | KLACID 250 MG TABS tablett 250mg N10 | Sanofi | 50% | |||||||
1264 | klaritromütsiin | J01FA09 | KLACID 250 MG TABS tablett 250mg N14 | Sanofi | 50% | |||||||
1265 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 25mgml 100ml N1 | Sanofi | 50% | |||||||
1266 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 25mgml 60ml N1 | Sanofi | 50% | |||||||
1267 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 50mgml 100ml N1 | Sanofi | 50% | |||||||
1268 | klaritromütsiin | J01FA09 | KLACID PEDIATRIC SUSPENSION suspensioonigraanulid 50mgml 60ml N1 | Sanofi | 50% | |||||||
1269 | klaritromütsiin | J01FA09 | KLACID SR retardtablett 500mg N5 | Sanofi | 50% | |||||||
1270 | klaritromütsiin | J01FA09 | KLACID SR retardtablett 500mg N7 | Sanofi | 50% | |||||||
1271 | klemastiin | R06AA04 | TAVEGYL tablett 1mg N20 | Novartis Consumer Health | 50% | |||||||
1272 | klindamütsiin | D10AF01 | DALACIN T lahus paikseks kasut. 10mgml 30ml N1 | Pharmacia Enterprises | 50% | |||||||
1273 | klindamütsiin | G01AA10 | DALACIN vaginaalkreem 20mgg 40g N1 | Pharmacia Enterprises | 50% | |||||||
1274 | klindamütsiin | G01AA10 | DALACIN VAGINAL OVULE oovul 100mg N3 | Pharmacia Enterprises | 50% | |||||||
1275 | klindamütsiin | J01FF01 | DALACIN C kapsel 150mg N100 | Pharmacia Enterprises | 50% | |||||||
1276 | klindamütsiin | J01FF01 | DALACIN C kapsel 150mg N16 | Pharmacia Enterprises | 50% | |||||||
1277 | klindamütsiin | J01FF01 | DALACIN C kapsel 300mg N16 | Pharmacia Enterprises | 50% | |||||||
1278 | klobetasool | D07AD01 | DERMOVATE kreem 0,05% 25g N1 | Glaxo Wellcome | 50% | |||||||
1279 | klobetasool | D07AD01 | DERMOVATE lahus 0,05% 25ml N1 | Glaxo Wellcome | 50% | |||||||
1280 | klobetasool | D07AD01 | DERMOVATE salv 0,05% 25g N1 | Glaxo Wellcome | 50% | |||||||
1281 | klodroonhape | M05BA02 | BONEFOS kapsel 400mg N100 | Leiras | 50% | |||||||
1282 | klodroonhape | M05BA02 | BONEFOS kapsel 400mg N30 | Leiras | 50% | |||||||
1283 | klodroonhape | M05BA02 | BONEFOS tablett 800mg N60 | Leiras | 50% | |||||||
1284 | klodroonhape | M05BA02 | LODRONAT 520 tablett 520mg N60 | Roche | 50% | |||||||
1285 | klomifeen | G03GB02 | SEROPHENE tablett 50mg N10 | ARES TRADING SA | 50% | |||||||
1286 | klomifeen | G03GB02 | SEROPHENE tablett 50mg N30 | ARES TRADING SA | 50% | |||||||
1287 | klomipramiin | N06AA04 | ANAFRANIL 10 tablett 10mg N30 | Novartis Pharma | 50% | |||||||
1288 | klomipramiin | N06AA04 | ANAFRANIL SR retardtablett 75mg N20 | Novartis Pharma | 50% | |||||||
1289 | klomipramiin | N06AA04 | ANAFRANIL tablett 25mg N30 | Novartis Pharma | 50% | |||||||
1290 | klonasepaam | N03AE01 | RIVOTRIL tablett 0,5mg N50 | Roche | 50% | 100% | G40* | *rev neuroloogil | ||||
1291 | klonasepaam | N03AE01 | RIVOTRIL tablett 2mg N30 | Roche | 50% | 100% | G40* | *rev neuroloogil | ||||
1292 | kloorambutsiil | L01AA02 | LEUKERAN TABLETS 2 MG tablett 2mg N25 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1293 | klooram- fenikool |
S01AA01 | OFTAN AKVAKOL silmatilgad 0,5% 10 ml N1 | Santen | 50% | |||||||
1294 | kloor- protikseen |
N05AF03 | TRUXAL tablett 100mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1295 | kloor- protikseen |
N05AF03 | TRUXAL tablett 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1296 | kloor- protikseen |
N05AF03 | TRUXAL tablett 50mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1297 | klopidogreel | B01AC04 | PLAVIX tablett 75mg N28 | Sanofi Pharma BMS | 50% | |||||||
1298 | klopidogreel | B01AC04 | PLAVIX tablett 75mg N50 | Sanofi Pharma BMS | 50% | |||||||
1299 | klopidogreel | B01AC04 | PLAVIX tablett 75mg N84 | Sanofi Pharma BMS | 50% | |||||||
1300 | klosapiin | N05AH02 | LEPONEX tablett 100mg N50 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1301 | klosapiin | N05AH02 | LEPONEX tablett 25mg N50 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1302 | klostrido- peptidaas |
D03BA02 | IRUXOL MONO salv 1,2TÜ 10g N1 | Knoll GmbH | 50% | |||||||
1303 | klostrido- peptidaas |
D03BA02 | IRUXOL MONO salv 1,2TÜ 30g N1 | Knoll GmbH | 50% | |||||||
1304 | klotrimasool | D01AC01 | KLOTRIMASOOL kreem 1%/g 20g N1 | GlaxoSmithKline Pharmaceu | 50% | |||||||
1305 | klotrimasool | G01AF02 | ANTIFUNGOL 3 vagin. tablett 200mg N3 | Hexal AG | 50% | |||||||
1306 | klotrimasool | G01AF02 | ANTIFUNGOL 3 VAGINAALKREEM vaginaalkreem 20mg/g 20g N1 | Hexal AG | 50% | |||||||
1307 | klotrimasool | G01AF02 | ANTIFUNGOL COMBI vagin tab+kreem N23 | Hexal AG | 50% | |||||||
1308 | klotrimasool | G01AF02 | CANIFUG CREMOLUM 100 KOMBI vagin supp/kreem 100mg N6 | Wolff | 50% | |||||||
1309 | klotrimasool | G01AF02 | CANIFUG CREMOLUM 100 vaginaalsuposiit 100mg N6 | Wolff | 50% | |||||||
1310 | klotrimasool | G01AF02 | CANIFUG CREMOLUM 200 vaginaalsuposiit 200mg N3 | Wolff | 50% | |||||||
1311 | klotrimasool | G01AF02 | CANIFUG VAGINALCREME 2% vaginaalkreem 2% 20g N1 | Wolff | 50% | |||||||
1312 | klotrimasool | G01AF02 | KLOTRIMASOOL vagin. tablett 100mg N6 | GlaxoSmithKline Pharmaceu | 50% | |||||||
1313 | kodeiin+ fenüült- oloksamiin |
R05DA80 | CODIPRONT retardkapsel 30mg+10mg N10 | H. Mack | 50% | |||||||
1314 | kodeiin+ fenüül- toloksamiin |
R05DA80 | CODIPRONT SIIRUP retardsuspensioon 2mg+0,66mg/g 100g N1 | H. Mack | 50% | |||||||
1315 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN närimistablett 200 TÜ + 500 mg N30 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1316 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN närimistablett 200 TÜ + 500 mg N60 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1317 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN närimistablett 200 TÜ + 500 mg N100 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1318 | kolekaltsi- ferool+ kaltsium |
A11JB80 | CALCIGRAN FORTE närimistablett 400 TÜ + 500 mg N60 | Nycomed SEFA | 75% | N18* | *rv nefroloogil | |||||
1319 | Konjugeeritud östrogeenid | G03CA57 | OESTROFEMINAL 0,3 MG kapsel 0,3mg N21 | H. Mack | 50% | |||||||
1320 | Konjugeeritud östrogeenid | G03CA57 | OESTROFEMINAL 0,6 MG kapsel 0,6mg N21 | H. Mack | 50% | |||||||
1321 | Konjugeeritud östrogeenid | G03CA57 | OESTROFEMINAL 1,25 MG kapsel 1,25mg N21 | H. Mack | 50% | |||||||
1322 | Konjugeeritud östrogeenid | G03CA57 | PREMARIN tablett 0,625mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1323 | Konjugeeritud östrogeenid | G03CA57 | PREMARIN tablett 0,625mg N84 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1324 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMELLE tablett 0,625mg+5mg N84 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1325 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,3 tablett 0,3 mg+1,5 mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1326 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,3 tablett 0,3 mg+1,5 mg N28x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1327 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,45 tablett 0,45 mg+1,5 mg N28 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1328 | Konjugeeritud östrogeenid+medroksü- progesteroon |
G03FA12 | PREMIA 0,45 tablett 0,45 mg+1,5 mg N28x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1329 | kooriongonadotropiin | G03GA01 | PREGNYL injektsiooni- substants 5000TÜ N3 |
N.V. ORGANON | 50% | |||||||
1330 | kooriongonadotropiin | G03GA01 | PROFASI injektsiooni- substants 2000TÜ N3 |
ARES TRADING SA | 50% | |||||||
1331 | kooriongonadotropiin | G03GA01 | PROFASI injektsioonisubstants 5000TÜ N1 | ARES TRADING SA | 50% | |||||||
1332 | kooriongonadotropiin | G03GA01 | PROFASI injektsiooni- substants 5000TÜ N10 |
ARES TRADING SA | 50% | |||||||
1333 | kromoglütsiinhape | R01AC01 | CROMO-RATIOPHARM NASENSPRAY ninasprei 2%/ml 15ml N1 | ratiopharm | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1334 | kromoglütsiinhape | R01AC01 | LOMUSOL ninasprei 2%/ml 26ml N1 | LABORATOIRE AVENTIS | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1335 | kromoglütsiin- hape |
R01AC01 | STADAGLICIN NINASPREI ninasprei 2%/ml 15ml N1 | Stada | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1336 | kromoglütsiin- hape |
R03BC01 | INTAL NEBSOL nebulisaatori lahus 1%/g 2ml N48 | Aventis Pharma Int | 50% | 75% | J30*; J45** | *rv alla 18-aastasele lapsele; **rv alla 18-aastasele lapsele ning rev pediaatril ja pulmonoloogil | ||||
1337 | kromoglütsiinhape | S01GX01 | LECROLYN silmatilgad 4% 5ml N1 | Santen | 50% | |||||||
1338 | kromoglütsiin- hape |
S01GX01 | LECROLYN silmatilgad üksikannustena 4% 0.25ml N30 | Santen | 50% | |||||||
1339 | kvetiapiin | N05AH04 | SEROQUEL tablett 100mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
1340 | kvetiapiin | N05AH04 | SEROQUEL tablett 200mg N60 | AstraZeneca UK Ltd. | 50% | |||||||
1341 | kvetiapiin | N05AH04 | SEROQUEL tablett 200mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
1342 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N1 | AstraZeneca UK Ltd. | 50% | |||||||
1343 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N30 | AstraZeneca UK Ltd. | 50% | |||||||
1344 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N4 | AstraZeneca UK Ltd. | 50% | |||||||
1345 | kvetiapiin | N05AH04 | SEROQUEL tablett 25mg N6 | AstraZeneca UK Ltd. | 50% | |||||||
1346 | kvinapriil | C09AA06 | ACCUPRO 10 tablett 10mg N30 | Pfizer H.C.P | 50% | |||||||
1347 | kvinapriil | C09AA06 | ACCUPRO 20 tablett 20mg N30 | Pfizer H.C.P | 50% | |||||||
1348 | kvinapriil | C09AA06 | ACCUPRO 5 tablett 5mg N30 | Pfizer H.C.P | 50% | |||||||
1349 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE 20 tablett 20mg+12,5mg N100 | Pfizer H.C.P | 50% | |||||||
1350 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE 20 tablett 20mg+12,5mg N30 | Pfizer H.C.P | 50% | |||||||
1351 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE 20 tablett 20mg+12,5mg N50 | Pfizer H.C.P | 50% | |||||||
1352 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE tablett 10mg+12,5mg N100 | Pfizer H.C.P | 50% | |||||||
1353 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE tablett 10mg+12,5mg N30 | Pfizer H.C.P | 50% | |||||||
1354 | kvinapriil+ hüdro- klorotiasiid |
C09BA06 | ACCUZIDE tablett 10mg+12,5mg N50 | Pfizer H.C.P | 50% | |||||||
1355 | labetalool | C07AG01 | TRANDATE TABLETS 100 MG tablett 100mg N50 | Glaxo Wellcome | 50% | 75% | O10-O16 | |||||
1356 | lamivudiin | J05AB10 | EPIVIR tablett 150mg N60 | Glaxo Wellcome | 50% | |||||||
1357 | lamivudiin | J05AF05 | ZEFFIX tablett 100mg N28 | Glaxo Wellcome | 50% | |||||||
1358 | lamivudiin+ zidovudiin |
J05AB81 | COMBIVIR tablett 150mg+300mg N60 | Glaxo Wellcome | 50% | |||||||
1359 | lamotrigiin | N03AX09 | LAMICTAL lahustuv/närimis- tablett 2mg N30 |
Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1360 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 100 MG tablett 100mg N30 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1361 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 100 MG tablett 100mg N56 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1362 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 25 MG tablett 25mg N30 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1363 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 25 MG tablett 25mg N56 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1364 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 50 MG tablett 50mg N30 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1365 | lamotrigiin | N03AX09 | LAMICTAL TABLETS 50 MG tablett 50mg N56 | Glaxo Wellcome | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil antiepileptilistele ravimitele resistentse epilepsia näidustusel |
||||
1366 | lansoprasool | A02BC03 | LANZUL kapsel 30mg N14 | KRKA, d.d. | 50% | |||||||
1367 | latanoprost | S01EX03 | XALATAN silmatilgad 0,005% 2.5ml N1 | Pharmacia Enterprises | 50% | 100% | (H40-H42)* | *rv oftalmoloogil, kui monoteraapia beeta-adreno- blokaatori ja karboanhüdraasi inhibiitoriga ei ole langetanud piisavalt silma siserõhku või mõlema rühma ravimid on vastunäidustatud |
||||
1368 | latanoprost | S01EX03 | XALATAN silmatilgad 0,005% 2.5ml N3 | Pharmacia Enterprises | 50% | 100% | (H40-H42)* | *rv oftalmoloogil, kui monoteraapia beeta-adreno- blokaatori ja karboanhüdraasi inhibiitoriga ei ole langetanud piisavalt silma siserõhku või mõlema rühma ravimid on vastunäidustatud |
||||
1369 | latsidipiin | C08CA09 | LACIPIL tablett 4mg N14 | Glaxo Wellcome | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1370 | latsidipiin | C08CA09 | LACIPIL tablett 4mg N28 | Glaxo Wellcome | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1371 | latsidipiin | C08CA09 | LACIPIL tablett 4mg N56 | Glaxo Wellcome | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1372 | lercanidipiin | C08CA13 | LERCAPIN tablett 10mg N14 | Berlin-Chemie | 50% | |||||||
1373 | lercanidipiin | C08CA13 | LERCAPIN tablett 10mg N28 | Berlin-Chemie | 50% | |||||||
1374 | lercanidipiin | C08CA13 | LERCAPIN tablett 10mg N7 | Berlin-Chemie | 50% | |||||||
1375 | letrosool | L02BG04 | FEMARA tablett 2,5mg N30 | Novartis Pharma | 50% | |||||||
1376 | levamisool | P02CE01 | DECARIS 150 MG TABLET tablett 150mg N1 | Richter | 50% | |||||||
1377 | levamisool | P02CE01 | DECARIS 50 MG TABLET tablett 50mg N2 | Richter | 50% | |||||||
1378 | levlunomiid | L04AA13 | ARAVA 10 MG tablett 10mg N100 | Aventis Pharma Deutschland | 50% | |||||||
1379 | levlunomiid | L04AA13 | ARAVA 10 MG tablett 10mg N30 | Aventis Pharma Deutschland | 50% | |||||||
1380 | levlunomiid | L04AA13 | ARAVA 100 MG tablett 100mg N3 | Aventis Pharma Deutschland | 50% | |||||||
1381 | levlunomiid | L04AA13 | ARAVA 20 MG tablett 20mg N100 | Aventis Pharma Deutschland | 50% | |||||||
1382 | levlunomiid | L04AA13 | ARAVA 20 MG tablett 20mg N30 | Aventis Pharma Deutschland | 50% | |||||||
1383 | levocarnitiin | A16AA01 | NEFROCARNIT, SYRUP siirup 1g 3.3ml 50ml N1 | Medice | 50% | |||||||
1384 | levocarnitiin | A16AA01 | NEFROCARNIT, SYRUP siirup 1g 3.3ml 50ml N3 | Medice | 50% | |||||||
1385 | levodopa+ benserasiid |
N04BA80 | DOPA-MERZ 100/25 tablett 100mg+25mg N30 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
1386 | levodopa+ benserasiid |
N04BA80 | DOPA-MERZ 100/25 tablett 100mg+25mg N90 | Merz+Co | 50% | 100% | G20* | *rev neuroloogil | ||||
1387 | levodopa+ benserasiid |
N04BA80 | MADOPAR 250 tablett 200mg+50mg N100 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1388 | levodopa+ benserasiid |
N04BA80 | MADOPAR DISPERSIBLE lahustuv tablett 100mg+25mg N100 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1389 | levodopa+ benserasiid |
N04BA80 | MADOPAR DISPERSIBLE lahustuv tablett 100mg+25mg N30 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1390 | levodopa+ benserasiid |
N04BA80 | MADOPAR HBS tablett 100mg+25mg N100 | Roche | 50% | 100% | G20* | *rev neuroloogil | ||||
1391 | levodopa+karbidopa | N04BA81 | SINEMET 25/100 tablett 100mg+25mg N30 | MSD | 50% | 100% | G20* | *rev neuroloogil | ||||
1392 | levodopa+ karbidopa |
N04BA81 | SINEMET CR 250 tablett 200mg+50mg N100 | MSD | 50% | 100% | G20* | *rev neuroloogil | ||||
1393 | levodopa+ karbidopa |
N04BA81 | SINEMET tablett 250mg+25mg N100 | MSD | 50% | 100% | G20* | *rev neuroloogil | ||||
1394 | Levodro- propisiin |
R05DB80 | LEVOPRONT siirup 6mg/ml 120ml N1 | H. Mack | 50% | |||||||
1395 | Levodro- propisiin |
R05DB80 | LEVOPRONT siirup 6mg/ml 60ml N1 | H. Mack | 50% | |||||||
1396 | levokabastiin | R01AC02 | LIVOSTIN ninasprei 0,05%/ml 10ml N1 | KRKA, d.d. | 50% | |||||||
1397 | levokabastiin | R01AC02 | LIVOSTIN ninasprei 0,05%/ml 15ml N1 | KRKA, d.d. | 50% | |||||||
1398 | levokabastiin | S01GX02 | LIVOSTIN silmasuspensioon 0,05% 4ml N1 | KRKA, d.d. | 50% | |||||||
1399 | levonorgestreel | G03AC03 | MIKRO-30 WYETH tablett 30mcg N105 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
1400 | levonorgestreel | G03AC03 | MIKRO-30 WYETH tablett 30mcg N35 | WYETH LEDERLE PHARMA GmbH | 50% | 75% | Z30 | |||||
1401 | levonorgestreel | G03AC03 | POSTINOR tablett 0,75mg N4 | Richter | 50% | |||||||
1402 | levonorgestreel+etünüülöstr- adiool |
G03AA07 | FERTILAN tablett 0,25mg+0,05mg N4 | Richter | 50% | |||||||
1403 | levonorgestreel+etünüülöst- radiool |
G03AA07 | MICROGYNON tablett 0,15mg+0,03mg N21 | Schering AG | 50% | 75% | Z30 | |||||
1404 | levonorgestreel+etünüülöst- radiool |
G03AA07 | MINISISTON tablett 0,125mg+0,03mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
1405 | levonorgestreel+östrogeen | G03AB03 | TRIQUILAR drazhee N21 | Schering AG | 50% | 75% | Z30 | |||||
1406 | levonorgestreel+östrogeen | G03AB03 | TRI-REGOL tablett N63 | Richter | 50% | 75% | Z30 | |||||
1407 | levonorgestreel+östrogeen | G03AB03 | TRISISTON tablett -1+-1 N21 | Jenapharm | 50% | 75% | Z30 | |||||
1408 | levonorgestreel+östrogeen | G03AB03 | TRISISTON tablett -1+-1 N63 | Jenapharm | 50% | 75% | Z30 | |||||
1409 | levonorgestreel+östrogeen | G03FA11 | CLIMARA DUO TTS N8 | Schering AG | 50% | |||||||
1410 | levonorgestreel+östrogeen | G03FA11 | KLIMONORM tablett N21 | Jenapharm | 50% | |||||||
1411 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 100 BERLIN-CHEMIE tablett 100mcg N100 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1412 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 100 BERLIN-CHEMIE tablett 100mcg N50 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1413 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 150 BERLIN-CHEMIE tablett 150mcg N100 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1414 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 150 BERLIN-CHEMIE tablett 150mcg N50 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1415 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N100 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1416 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N30 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1417 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N50 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1418 | levotüroksiin- naatrium |
H03AA01 | L-THYROXIN 50 BERLIN-CHEMIE tablett 50mcg N84 | Berlin-Chemie | 50% | 100% | E03; E89.0;
E89.3 |
|||||
1419 | linesoliid | J01XX08 | ZYVOXID tablett 400 mg N10 | Pharmacia Enterprises | 50% | |||||||
1420 | linesoliid | J01XX08 | ZYVOXID tablett 400 mg N20 | Pharmacia Enterprises | 50% | |||||||
1421 | linesoliid | J01XX08 | ZYVOXID tablett 400 mg N30 | Pharmacia Enterprises | 50% | |||||||
1422 | linesoliid | J01XX08 | ZYVOXID tablett 600 mg N10 | Pharmacia Enterprises | 50% | |||||||
1423 | linesoliid | J01XX08 | ZYVOXID tablett 600 mg N20 | Pharmacia Enterprises | 50% | |||||||
1424 | linesoliid | J01XX08 | ZYVOXID tablett 600 mg N30 | Pharmacia Enterprises | 50% | |||||||
1425 | lisinopriil | C09AA03 | DIROTON tablett 10mg N28 | Richter | 50% | |||||||
1426 | lisinopriil | C09AA03 | DIROTON tablett 20mg N28 | Richter | 50% | |||||||
1427 | lisinopriil | C09AA03 | DIROTON tablett 5mg N28 | Richter | 50% | |||||||
1428 | lisinopriil | C09AA03 | PRINIVIL tablett 10mg N28 | MSD | 50% | |||||||
1429 | lisinopriil | C09AA03 | PRINIVIL tablett 20mg N28 | MSD | 50% | |||||||
1430 | lisinopriil | C09AA03 | PRINIVIL tablett 5mg N28 | MSD | 50% | |||||||
1431 | lodoksamiid | S01GX05 | ALOMIDE silmatilgad 0,1% 10ml N1 | Alcon | 50% | |||||||
1432 | lomefloksatsiin | S01AX17 | OKACIN silmatilgad 0,3%/ml 5ml N1 | NOVARTIS Ophthalmics | 50% | |||||||
1433 | loperamiid | A07DA03 | IMODIUM kapsel 2mg N20 | Janssen | 50% | |||||||
1434 | loperamiid | A07DA03 | LOPEDIUM ISO kihisev tablett 2mg N20 | Hexal AG | 50% | |||||||
1435 | loperamiid | A07DA03 | LOPEDIUM kapsel 2mg N30 | Hexal AG | 50% | |||||||
1436 | loperamiid | A07DA03 | LOPEDIUM kapsel 2mg N50 | Hexal AG | 50% | |||||||
1437 | loperamiid | A07DA03 | LOPERAMID-RATIOPHARM FILMTABLETTEN tablett 2mg N20 | ratiopharm | 50% | |||||||
1438 | loperamiid | A07DA03 | LOPERAMID-RATIOPHARM FILMTABLETTEN tablett 2mg N50 | ratiopharm | 50% | |||||||
1439 | lopinaviir+ ritonaviir |
J05AE80 | KALETRA kapsel 133,3mg+33,3mg N180 | ABBOTT LABORATORIES Ltd. | 50% | |||||||
1440 | lopinaviir+ ritonaviir |
J05AE80 | KALETRA suukaudne lahus 80mg+20mg/ml 60ml N5 | ABBOTT LABORATORIES Ltd. | 50% | |||||||
1441 | loratadiin | R06AX13 | CLARITINE FAST suukaudne lüofilisaat 10mg 1annus N100 | Schering-Plough | 50% | |||||||
1442 | loratadiin | R06AX13 | CLARITINE FAST suukaudne lüofilisaat 10mg 1annus N30 | Schering-Plough | 50% | |||||||
1443 | loratadiin | R06AX13 | CLARITINE siirup 1mg/ml 120ml N1 | Schering-Plough | 50% | |||||||
1444 | loratadiin | R06AX13 | CLARITINE tablett 10mg N100 | Schering-Plough | 50% | |||||||
1445 | loratadiin | R06AX13 | CLARITINE tablett 10mg N30 | Schering-Plough | 50% | |||||||
1446 | lornoksikaam | M01AC05 | XEFO tablett 4 mg N20 | Nycomed SEFA | 50% | |||||||
1447 | lornoksikaam | M01AC05 | XEFO tablett 8 mg N20 | Nycomed SEFA | 50% | |||||||
1448 | losartaan | C09CA01 | COZAAR tablett 100mg N14 | MSD | 50% | |||||||
1449 | losartaan | C09CA01 | COZAAR tablett 100mg N28 | MSD | 50% | |||||||
1450 | losartaan | C09CA01 | COZAAR tablett 12,5mg N21 | MSD | 50% | |||||||
1451 | losartaan | C09CA01 | COZAAR tablett 12,5mg N28 | MSD | 50% | |||||||
1452 | losartaan | C09CA01 | COZAAR tablett 50mg N14 | MSD | 50% | |||||||
1453 | losartaan | C09CA01 | COZAAR tablett 50mg N28 | MSD | 50% | |||||||
1454 | losartaan+ hüdro- klorotiasiid |
C09DA01 | FORTZAAR tablett 100mg+25mg N28 | MSD | 50% | |||||||
1455 | losartaan+ hüdro- klorotiasiid |
C09DA01 | HYZAAR tablett 50mg+12,5mg N28 | MSD | 50% | |||||||
1456 | lovastatiin | C10AA02 | HOLETAR tablett 20mg N20 | KRKA, d.d. | 50% | |||||||
1457 | lovastatiin | C10AA02 | HOLETAR tablett 40mg N30 | KRKA, d.d. | 50% | |||||||
1458 | Lutropiin alfa | G03GA07 | LUVERIS 75 IU injektsioonisub- stants 75TÜ N1 |
Serono Europe Ltd. | 50% | |||||||
1459 | Lutropiin alfa | G03GA07 | LUVERIS 75 IU injektsioonisub- stants 75TÜ N10 |
Serono Europe Ltd. | 50% | |||||||
1460 | Lutropiin alfa | G03GA07 | LUVERIS 75 IU injektsioonisub- stants 75TÜ N3 |
Serono Europe Ltd. | 50% | |||||||
1461 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID HM PENFILL süstelahus 100TÜ/ml 1.5ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1462 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID HM PENFILL süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1463 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID HM süstelahus 100TÜ/ml 10ml N1 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1464 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID INNOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1465 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | ACTRAPID NOVOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1466 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMAJECT REGULAR süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1467 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG HUMAJECT süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1468 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG MIX50 PEN süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1469 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG MIX50 süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1470 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG PEN süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1471 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMALOG süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1472 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMULIN REGULAR süstelahus 100TÜ/ml 1.5ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1473 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMULIN REGULAR süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1474 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | HUMULIN REGULAR süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1475 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1476 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1477 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1478 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1479 | Lühikese toimeajaga humaan- insuliin |
A10AB01 | INSUMAN RAPID süstelahus 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1480 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMAJECT 70/30 süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1481 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMALOG MIX25 PEN süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1482 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMALOG MIX25 süstesuspensioon 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1483 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMULIN (30/70) süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1484 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMULIN (MIX 70/30) süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1485 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | HUMULIN M (MIX 70/30) süstelahus 100TÜ/ml 1.5ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1486 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N10 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1487 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N3 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1488 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N4 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1489 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 3ml N5 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1490 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | INSUMAN COMB 25 süstesuspensioon 100TÜ/ml 5ml N1 | Aventis Pharma Deutschland | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1491 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 20 HM PENFILL süstesuspensioon 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1492 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 30 HM PENFILL süstesuspensioon 100TÜ/ml 1.5ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1493 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 30 HM PENFILL süstesuspensioon 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1494 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD 30 INNOLET süstesuspensioon 100IU/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1495 | Lühikese toimeajaga ja keskmise toimeajaga humaan- insuliin |
A10AD01 | MIXTARD NOVOLET süstelahus 100TÜ/ml 3ml N5 | Novo Nordisk | 50% | 100% | E10-E11; E13-14;
E89.1; O24; P70.2 |
|||||
1496 | lünöstrenool | G03DC03 | ORGAMETRIL tablett 5mg N30 | N.V. ORGANON | 50% | |||||||
1497 | lünöstrenool | G03DC03 | ORGAMETRIL tablett 5mg N90 | N.V. ORGANON | 50% | |||||||
1498 | mebendasool | P02CA01 | MEBENDAZOLS 100 MG TABLETES tablett 100mg N6 | Grindeks | 50% | |||||||
1499 | mebendasool | P02CA01 | VERMOX 100 MG TABLETS tablett 100mg N6 | Richter | 50% | |||||||
1500 | medroksü- progesteroon |
G03DA02 | CYKRINA tablett 10mg N42 | WYETH LEDERLE PHARMA GmbH | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1501 | medroksü- progesteroon |
G03DA02 | CYKRINA tablett 5mg N42 | WYETH LEDERLE PHARMA GmbH | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1502 | medroksü- progesteroon |
G03DA02 | DEPO-PROVERA süstesuspensioon 150mgml 1ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1503 | medroksü- progesteroon |
G03DA02 | DEPO-PROVERA süstesuspensioon 150mgml 3.3ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1504 | medroksü- progesteroon |
G03DA02 | PROVERA tablett 10mg N100 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1505 | medroksü- progesteroon |
G03DA02 | PROVERA tablett 10mg N40 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1506 | medroksü- progesteroon |
G03DA02 | PROVERA tablett 5mg N24 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1507 | medroksü- progesteroon |
L02AB02 | DEPO-PROVERA süstesuspensioon 150mg/ml 1ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1508 | medroksü- progesteroon |
L02AB02 | DEPO-PROVERA süstesuspensioon 150mg/ml 3.3ml N1 | Pharmacia Enterprises | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1509 | medroksü- progesteroon+Konjugeeritud östrogeenid |
G03FB80 | PREMELLE SEKVENS tablett N28x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1510 | medroksü- progesteroon+Konjugeeritud östrogeenid |
G03FB80 | PREMPAC SEKVENS tablett N42x3 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
1511 | medroksü- progesteroon+östrageen |
G03FB06 | DIVINA tablett N21 | Orion | 50% | |||||||
1512 | megestrool | L02AB01 | MEGACE 160 tablett 160mg N30 | Bristol-Myers Squibb | 50% | |||||||
1513 | megestrool | L02AB01 | MEGACE suspensioon 40mg/ml 120ml N1 | Bristol-Myers Squibb | 50% | |||||||
1514 | megestrool | L02AB01 | MEGACE suspensioon 40mg/ml 240ml N1 | Bristol-Myers Squibb | 50% | |||||||
1515 | megestrool | L02AB01 | MEGACE suspensioon 40mg/ml 480ml N1 | Bristol-Myers Squibb | 50% | |||||||
1516 | melfalaan | L01AA03 | ALKERAN INJECTION injektsiooni- substants 50mg N1 |
Glaxo Wellcome | 50% | |||||||
1517 | melfalaan | L01AA03 | ALKERAN TABLETS tablett 2mg N25 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1518 | meloksikaam | M01AC06 | MOVALIS tablett 15mg N20 | Boehringer Ingelheim | 50% | |||||||
1519 | meloksikaam | M01AC06 | MOVALIS tablett 15mg N50 | Boehringer Ingelheim | 50% | |||||||
1520 | meloksikaam | M01AC06 | MOVALIS tablett 7,5mg N20 | Boehringer Ingelheim | 50% | |||||||
1521 | meloksikaam | M01AC06 | MOVALIS tablett 7,5mg N50 | Boehringer Ingelheim | 50% | |||||||
1522 | melperoon | N05AD03 | BURONIL drazhee 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1523 | melperoon | N05AD03 | BURONIL drazhee 50mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1524 | merkaptopuriin | L01BB02 | PURI-NETHOL TABLETS tablett 50mg N25 | Glaxo Wellcome | 50% | 100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | ||||
1525 | mesalasiin | A07EC02 | PENTASA retardtablett 500mg N100 | Ferring A/S | 50% | 75% | K50*; K51* | *rv gastroenteroloogil | ||||
1526 | mesalasiin | A07EC02 | SALOFALK 250 TABLETS Gastroresistentne tablett 250mg N100 | Falk | 50% | 75% | K50*; K51* | *rv gastroenteroloogil | ||||
1527 | mesalasiin | A07EC02 | SALOFALK 250 TABLETS Gastroresistentne tablett 250mg N50 | Falk | 50% | 75% | K50*; K51* | *rv gastroenteroloogil | ||||
1528 | mesalasiin | A07EC02 | SALOFALK 500 TABLETS Gastroresistentne tablett 500mg N100 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1529 | mesalasiin | A07EC02 | SALOFALK 500 TABLETS Gastroresistentne tablett 500mg N50 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1530 | mesalasiin | A07EC02 | PENTASA rektaalsuspensioon 1g N7 | Ferring A/S | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1531 | mesalasiin | A07EC02 | PENTASA suposiit 1g N28 | Ferring A/S | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1532 | mesalasiin | A07EC02 | SALOFALK 250 SUPPOSITORIES suposiit 250mg N10 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1533 | mesalasiin | A07EC02 | SALOFALK 250 SUPPOSITORIES suposiit 250mg N30 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1534 | mesalasiin | A07EC02 | SALOFALK 500 SUPPOSITORIES suposiit 500mg N10 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1535 | mesalasiin | A07EC02 | SALOFALK 500 SUPPOSITORIES suposiit 500mg N30 | Falk | 50% | 75% | K50*; K51* | *rv gastroentero- loogil |
||||
1536 | mesna | V03AF01 | UROMITEXAN tablett 400mg N10 | Asta Medica | 50% | |||||||
1537 | mesna | V03AF01 | UROMITEXAN tablett 400mg N20 | Asta Medica | 50% | |||||||
1538 | mesna | V03AF01 | UROMITEXAN tablett 400mg N30 | Asta Medica | 50% | |||||||
1539 | mesna | V03AF01 | UROMITEXAN tablett 400mg N50 | Asta Medica | 50% | |||||||
1540 | mesna | V03AF01 | UROMITEXAN tablett 600mg N10 | Asta Medica | 50% | |||||||
1541 | mesna | V03AF01 | UROMITEXAN tablett 600mg N20 | Asta Medica | 50% | |||||||
1542 | mesna | V03AF01 | UROMITEXAN tablett 600mg N200 | Asta Medica | 50% | |||||||
1543 | mesna | V03AF01 | UROMITEXAN tablett 600mg N30 | Asta Medica | 50% | |||||||
1544 | mesna | V03AF01 | UROMITEXAN tablett 600mg N50 | Asta Medica | 50% | |||||||
1545 | metadoon | N02AC02 | METADON DAK 1 MG/ML suukaudne lahus 1mg/ml 1000ml N1 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1546 | metadoon | N02AC02 | METADON DAK tablett 20mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1547 | metadoon | N02AC02 | METADON DAK tablett 5mg N10 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1548 | metadoon | N02AC02 | METHADON 10 MG/ML süstelahus 10mg/ml 1ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1549 | metformiin | A10BA02 | GLUFORMIN tablett 850 N30 | Pliva | 50% | |||||||
1550 | metformiin | A10BA02 | GLUFORMIN tablett 850 N60 | Pliva | 50% | |||||||
1551 | metformiin | A10BA02 | METFORAL 500 tablett 500mg N120 | Berlin-Chemie | 50% | |||||||
1552 | metformiin | A10BA02 | METFORAL 500 tablett 500mg N30 | Berlin-Chemie | 50% | |||||||
1553 | metformiin | A10BA02 | METFORAL 500 tablett 500mg N60 | Berlin-Chemie | 50% | |||||||
1554 | metformiin | A10BA02 | METFORAL 850 tablett 850mg N120 | Berlin-Chemie | 50% | |||||||
1555 | metformiin | A10BA02 | METFORAL 850 tablett 850mg N30 | Berlin-Chemie | 50% | |||||||
1556 | metformiin | A10BA02 | METFORAL 850 tablett 850mg N60 | Berlin-Chemie | 50% | |||||||
1557 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 500 MG tablett 500mg N100 | ALPHARMA | 50% | |||||||
1558 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 500 MG tablett 500mg N28 | ALPHARMA | 50% | |||||||
1559 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 500 MG tablett 500mg N30 | ALPHARMA | 50% | |||||||
1560 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 850 MG tablett 850mg N50 | ALPHARMA | 50% | |||||||
1561 | metformiin | A10BA02 | METFORMIN ALPHARMA TABLETS 850 MG tablett 850mg N56 | ALPHARMA | 50% | |||||||
1562 | metformiin | A10BA02 | METFORMIN-HEXAL tablett 500mg N100 | Hexal AG | 50% | |||||||
1563 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 500 MG tablett 500mg N120 | ratiopharm | 50% | |||||||
1564 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 500 MG tablett 500mg N30 | ratiopharm | 50% | |||||||
1565 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 850 MG tablett 850mg N120 | ratiopharm | 50% | |||||||
1566 | metformiin | A10BA02 | METFORMIN-RATIOPHARM 850 MG tablett 850mg N30 | ratiopharm | 50% | |||||||
1567 | metoklo- pramiid |
A03FA01 | CERUCAL tablett 10mg N50 | AWD | 50% | 100% | C00-D48 | |||||
1568 | metoklo- pramiid |
A03FA01 | METOCLOPRAMIDE ALPHARMA TABLETS 10 MG tablett 10mg N20 | ALPHARMA | 50% | 100% | C00-D48 | |||||
1569 | metoklo- pramiid |
A03FA01 | MCP-RATIOPHARM 10 suposiit 10mg N5 | ratiopharm | 50% | 100% | C00-D48 | |||||
1570 | metoklo- pramiid |
A03FA01 | METOCLOPRAMIDE INJECTION BP süstelahus 5mg/ml 2ml N100 | Biologici | 50% | 100% | C00-D48 | |||||
1571 | metoklo- pramiid |
A03FA01 | SOL. METOCLOPRAMIDI 10MG süstelahus 5mg/ml 2ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1572 | metoklo- pramiid |
A03FA01 | SOL. METOCLOPRAMIDI 10MG süstelahus 5mg/ml 2ml N100 | Ilsanta | 50% | 100% | C00-D48 | |||||
1573 | metoklo- pramiid |
A03FA01 | CERUCAL süstelahus 5mg/ml 2ml N10 | AWD | 50% | 100% | C00-D48 | |||||
1574 | metoklo- pramiid |
A03FA01 | MCP-RATIOPHARM SF süstelahus 5mg/ml 2ml N5 | ratiopharm | 50% | 100% | C00-D48 | |||||
1575 | metoprolool | C07AB02 | BETALOC ZOK 25 MG retardtablett 25mg N14 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1576 | metoprolool | C07AB02 | BETALOC ZOK 25 MG retardtablett 25mg N28 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1577 | metoprolool | C07AB02 | BETALOC ZOK 25 MG retardtablett 25mg N98 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1578 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 100mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1579 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 100mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1580 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 200mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1581 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 200mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1582 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 50mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1583 | metoprolool | C07AB02 | BETALOC ZOK retardtablett 50mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1584 | metoprolool | C07AB02 | EMZOK tablett 100mg N100 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1585 | metoprolool | C07AB02 | EMZOK tablett 100mg N30 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1586 | metoprolool | C07AB02 | EMZOK tablett 200mg N100 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1587 | metoprolool | C07AB02 | EMZOK tablett 200mg N30 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1588 | metoprolool | C07AB02 | EMZOK tablett 50mg N100 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1589 | metoprolool | C07AB02 | EMZOK tablett 50mg N30 | IVAX - CR a.s. | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1590 | metoprolool | C07AB02 | METOPROLOL 100 STADA tablett 100mg N100 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1591 | metoprolool | C07AB02 | METOPROLOL 100 STADA tablett 100mg N20 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1592 | metoprolool | C07AB02 | METOPROLOL 100 STADA tablett 100mg N50 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1593 | metoprolool | C07AB02 | METOPROLOL 200 STADA RETARD retardtablett 200mg N100 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1594 | metoprolool | C07AB02 | METOPROLOL 200 STADA RETARD retardtablett 200mg N50 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1595 | metoprolool | C07AB02 | METOPROLOL 50 STADA tablett 50mg N100 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1596 | metoprolool | C07AB02 | METOPROLOL 50 STADA tablett 50mg N20 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1597 | metoprolool | C07AB02 | METOPROLOL 50 STADA tablett 50mg N50 | Stada | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1598 | metoprolool | C07AB02 | METOPROLOL-RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1599 | metoprolool | C07AB02 | METOPROLOL-RATIOPHARM 50 tablett 50mg N30 | ratiopharm | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1600 | metoprolool | C07AB02 | METOPROLOL-RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1601 | metoprolool | C07AB02 | VASOCARDIN 100 tablett 100mg N20 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1602 | metoprolool | C07AB02 | VASOCARDIN 100 tablett 100mg N50 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1603 | metoprolool | C07AB02 | VASOCARDIN 50 tablett 50mg N20 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1604 | metoprolool | C07AB02 | VASOCARDIN 50 tablett 50mg N50 | Slovakofarma | 50% | 75% | I10-I13; I15; I50*; I20 | *rv kardioloogil | ||||
1605 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 100mg+10mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1606 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 100mg+10mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1607 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 50mg+5mg N100 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1608 | Metoprolool+ felodipiin |
C07FB80 | LOGIMAX retardtablett 50mg+5mg N30 | AstraZeneca UK Ltd. | 50% | 75% | I10-I13; I15 | |||||
1609 | metotreksaat | L01BA01 | TREXAN tablett 2,5mg N100 | Orion | 50% | 75% | L40*; M07**; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46** | *rv dermatovene- roloogil ja reuma- toloogil; **rv reumatoloogil |
100% | (C00-D48)* | *rv onkoloogil ja hematoloogil | |
1610 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 15g N1 | Galderma | 50% | |||||||
1611 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 30g N1 | Galderma | 50% | |||||||
1612 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 50g N1 | Galderma | 50% | |||||||
1613 | metronidasool | D06BX01 | ROZEX geel 0,75%/ 5g N1 | Galderma | 50% | |||||||
1614 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 15g N1 | Galderma | 50% | |||||||
1615 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 30g N1 | Galderma | 50% | |||||||
1616 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 50g N1 | Galderma | 50% | |||||||
1617 | metronidasool | D06BX01 | ROZEX kreem 0,75%/ 5g N1 | Galderma | 50% | |||||||
1618 | metronidasool | G01AF01 | FLAGYL vaginaalsuposiit 500mg N10 | LABORATOIRE AVENTIS | 50% | |||||||
1619 | metronidasool | J01XD01 | APO-METRONIDAZOLE tablett 250mg N20 | Apotex | 50% | |||||||
1620 | metronidasool | J01XD01 | APO-METRONIDAZOLE tablett 250mg N40 | Apotex | 50% | |||||||
1621 | metronidasool | J01XD01 | ARILIN 500 tablett 500mg N10 | Wolff | 50% | |||||||
1622 | metronidasool | J01XD01 | ARILIN 500 tablett 500mg N20 | Wolff | 50% | |||||||
1623 | metronidasool | J01XD01 | ARILIN KOMBIPACKUNG tabl/vagin supp N24 | Wolff | 50% | |||||||
1624 | metronidasool | J01XD01 | EFLORAN tablett 400mg N10 | KRKA, d.d. | 50% | |||||||
1625 | metronidasool | J01XD01 | METRONIDAZOL NYCOMED tablett 250mg N20 | Nycomed SEFA | 50% | |||||||
1626 | metronidasool | J01XD01 | METRONIDAZOL NYCOMED tablett 500mg N10 | Nycomed SEFA | 50% | |||||||
1627 | metronidasool | J01XD01 | METRONIDAZOL NYCOMED tablett 500mg N100 | Nycomed SEFA | 50% | |||||||
1628 | metronidasool | P01AB01 | METRONIDAZOL NYCOMED tablett 500mg N10 | Nycomed SEFA | 50% | |||||||
1629 | metronidasool | P01AB01 | METRONIDAZOL NYCOMED tablett 500mg N100 | Nycomed SEFA | 50% | |||||||
1630 | metüül- prednisoloon |
H02AB04 | DEPO-MEDROL süstesuspensioon 40mg/ml 1ml N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1631 | metüül- prednisoloon |
H02AB04 | DEPO-MEDROL süstesuspensioon 40mg/ml 2ml N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1632 | metüül- prednisoloon |
H02AB04 | DEPO-MEDROL süstesuspensioon 40mg/ml 5ml N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1633 | metüül- prednisoloon |
H02AB04 | MEDROL tablett 16mg N50 | Pharmacia Enterprises | 50% | 75% | K50*; K51*; K73*;K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroentero- loogil; **rev reumato- loogil; ***rv nefroloogil ja pediaatril |
100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1634 | metüül- prednisoloon |
H02AB04 | MEDROL tablett 4mg N100 | Pharmacia Enterprises | 50% | 75% | K50*; K51*; K73*;K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroentero- loogil; **rev reumato- loogil; ***rv nefroloogil ja pediaatril |
100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1635 | metüül- prednisoloon |
H02AB04 | MEDROL tablett 4mg N30 | Pharmacia Enterprises | 50% | 75% | K50*; K51*; K73*;K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroentero- loogil; **rev reumato- loogil; ***rv nefroloogil ja pediaatril |
100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1636 | metüül- prednisoloon |
H02AB04 | SOLOMET depooinj 40mgml 1ml N1 | Orion | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1637 | metüül- prednisoloon |
H02AB04 | SOLOMET depooinj 40mgml 5ml N1 | Orion | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1638 | metüül- prednisoloon |
H02AB04 | SOLOMET tablett 4mg N100 | Orion | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1639 | metüül- prednisoloon |
H02AB04 | SOLOMET tablett 4mg N30 | Orion | 50% | 75% | K50*; K51*; K73*; K74*; M05**; M06**; M08**; (M30-M33)**; M35**; M45**; M46**; (N00-N08)*** | *rv gastroenteroloogil; **rev reumatoloogil; ***rv nefroloogil ja pediaatril | 100% | G35*; T86** | *rev neuroloogil; **rv patsienti jälgival ja ravival arstil | |
1640 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 1000mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1641 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 125mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1642 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 250mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1643 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 40mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1644 | metüül- prednisoloon |
H02AB04 | SOLU-MEDROL injektsioonisubstants 500mg N1 | Pharmacia Enterprises | 50% | 75% | M05*; M06*; M08*; (M30-M33)*; M35*; M45*; M46*; (N00-N08)** | *rev reumatoloogil; **rv nefroloogil ja pediaatril | 100% | T86* | *rv patsienti jälgival ja ravival arstil | |
1645 | metüül- predniso- loonatseponaat |
D07AC14 | ADVANTAN kreem 0,1%/ 15g N1 | Schering AG | 50% | |||||||
1646 | metüül- predniso- loonatseponaat |
D07AC14 | ADVANTAN salv 0,1% 15g N1 | Schering AG | 50% | |||||||
1647 | mikonasool | A01AB09 | DAKTARIN suugeel 20mg/ml 40g N1 | Janssen | 50% | |||||||
1648 | mikonasool | D01AC02 | DAKTARIN kreem 2%/g 15g N1 | Janssen | 50% | |||||||
1649 | mikonasool | D01AC02 | DAKTARIN kreem 2%/g 30g N1 | Janssen | 50% | |||||||
1650 | mikonasool | G01AF04 | GYNO-DAKTARIN vaginaalne kapsel 1200mg N1 | Janssen | 50% | |||||||
1651 | mikonasool | G01AF04 | GYNO-DAKTARIN vaginaalne kapsel 200mg N7 | Janssen | 50% | |||||||
1652 | mikonasool | G01AF04 | GYNO-DAKTARIN vaginaalne kapsel 400mg N3 | Janssen | 50% | |||||||
1653 | mikonasool+ masipredoon |
D01AX01 | MYCOSOLON OINTMENT salv 2%+0,25% 15g N1 | Richter | 50% | |||||||
1654 | milnatsipraan | N06AX17 | IXEL kapsel 50mg N56 | Pierre Fabre Medicament | 50% | |||||||
1655 | miltefosiin | L01XX09 | MILTEX lahus paikseks kasutamiseks 60mg/ml 10ml N1 | Asta Medica | 50% | |||||||
1656 | miltefosiin | L01XX09 | MILTEX lahus paikseks kasutamiseks 60mg/ml 10ml N5 | Asta Medica | 50% | |||||||
1657 | mirtasapiin | N06AX11 | REMERON tablett 15mg N100 | N.V. ORGANON | 50% | |||||||
1658 | mirtasapiin | N06AX11 | REMERON tablett 15mg N30 | N.V. ORGANON | 50% | |||||||
1659 | mirtasapiin | N06AX11 | REMERON tablett 15mg N60 | N.V. ORGANON | 50% | |||||||
1660 | mirtasapiin | N06AX11 | REMERON tablett 15mg N90 | N.V. ORGANON | 50% | |||||||
1661 | mirtasapiin | N06AX11 | REMERON tablett 30mg N100 | N.V. ORGANON | 50% | |||||||
1662 | mirtasapiin | N06AX11 | REMERON tablett 30mg N30 | N.V. ORGANON | 50% | |||||||
1663 | mirtasapiin | N06AX11 | REMERON tablett 30mg N60 | N.V. ORGANON | 50% | |||||||
1664 | mirtasapiin | N06AX11 | REMERON tablett 30mg N90 | N.V. ORGANON | 50% | |||||||
1665 | mirtasapiin | N06AX11 | REMERON tablett 45mg N100 | N.V. ORGANON | 50% | |||||||
1666 | mirtasapiin | N06AX11 | REMERON tablett 45mg N30 | N.V. ORGANON | 50% | |||||||
1667 | mirtasapiin | N06AX11 | REMERON tablett 45mg N60 | N.V. ORGANON | 50% | |||||||
1668 | mirtasapiin | N06AX11 | REMERON tablett 45mg N90 | N.V. ORGANON | 50% | |||||||
1669 | misolastiin | R06AX25 | MIZOLLEN tablett 10mg N10 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
1670 | misolastiin | R06AX25 | MIZOLLEN tablett 10mg N15 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
1671 | misolastiin | R06AX25 | MIZOLLEN tablett 10mg N30 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
1672 | modafiniil | N06BA07 | MODIODAL tablett 100mg N30 | Merckle | 50% | |||||||
1673 | moklobemiid | N06AG02 | AURORIX tablett 150mg N30 | Roche | 50% | |||||||
1674 | moksonidiin | C02AC05 | PHYSIOTENS 0,2 tablett 0,2 mg N28 | Solvay | 50% | |||||||
1675 | moksonidiin | C02AC05 | PHYSIOTENS 0,3 mg N28 | Solvay | 50% | |||||||
1676 | moksonidiin | C02AC05 | PHYSIOTENS 0,4 mg N28 | Solvay | 50% | |||||||
1677 | mometasoon | D07AC13 | ELOCON kreem 0,1% 20g N1 | Schering-Plough | 50% | |||||||
1678 | mometasoon | D07AC13 | ELOCON kreem 0,1% 50g N1 | Schering-Plough | 50% | |||||||
1679 | mometasoon | D07AC13 | ELOCON nahalahus 0,1% 20ml N1 | Schering-Plough | 50% | |||||||
1680 | mometasoon | D07AC13 | ELOCON nahalahus 0,1% 50ml N1 | Schering-Plough | 50% | |||||||
1681 | mometasoon | D07AC13 | ELOCON salv 0,1% 20g N1 | Schering-Plough | 50% | |||||||
1682 | mometasoon | D07AC13 | ELOCON salv 0,1% 50g N1 | Schering-Plough | 50% | |||||||
1683 | mometasoon | R01AD09 | NASONEX ninasprei 0,5mg/ml 18g N140 | Schering-Plough | 50% | |||||||
1684 | montelukast | R03DC03 | SINGULAIR 4 MG närimistablett 4mg 1TABL N14 | MSD | 50% | |||||||
1685 | montelukast | R03DC03 | SINGULAIR 4 MG närimistablett 4mg 1TABL N28 | MSD | 50% | |||||||
1686 | montelukast | R03DC03 | SINGULAIR närimistablett 5mg N14 | MSD | 50% | |||||||
1687 | montelukast | R03DC03 | SINGULAIR närimistablett 5mg N28 | MSD | 50% | |||||||
1688 | montelukast | R03DC03 | SINGULAIR tablett 10mg N14 | MSD | 50% | |||||||
1689 | montelukast | R03DC03 | SINGULAIR tablett 10mg N28 | MSD | 50% | |||||||
1690 | morfiin | N02AA01 | DOLTARD retardtablett 30mg N20 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1691 | morfiin | N02AA01 | DOLTARD retardtablett 60mg N20 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1692 | morfiin | N02AA01 | MORFIN DAK 20 MG/ML süstelahus 20mg/ml 1ml N10 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1693 | morfiin | N02AA01 | MORFIN DAK süstelahus 0,4mg/ml 10ml N5 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1694 | morfiin | N02AA01 | MORFIN NYCOMED 30 MG tablett 30mg N25 | Nycomed SEFA | 50% | 100% | C00-D48 | |||||
1695 | morfiin | N02AA01 | MORPHINE 10 MG/ML süstelahus 10mg/ml 1ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1696 | morfiin | N02AA01 | MORPHINE 10 MG/ML süstelahus 10mg/ml 2ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
1697 | morfiin | N02AA01 | MS CONTIN 100 MG suposiit 100mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1698 | morfiin | N02AA01 | MS CONTIN 200 MG suposiit 200mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1699 | morfiin | N02AA01 | MS CONTIN 30 MG suposiit 30mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1700 | morfiin | N02AA01 | MS CONTIN 60 MG suposiit 60mg N24 | Mundipharma | 50% | 100% | C00-D48 | |||||
1701 | morfiin | N02AA01 | MSI 10 MUNDIPHARMA süstelahus 10mg/ml 1ml N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1702 | morfiin | N02AA01 | MSI 100 MUNDIPHARMA süstelahus 100mg 5ml 5 ml N5 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1703 | morfiin | N02AA01 | MSI 20 MUNDIPHARMA süstelahus 20mg/ml 1ml N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1704 | morfiin | N02AA01 | MSI 200 MUNDIPHARMA süstelahus 200mg 10ml 10ml N5 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1705 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1706 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1707 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1708 | morfiin | N02AA01 | MST CONTINUS 100 MG suspensiooni- graanulid 100mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1709 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1710 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1711 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1712 | morfiin | N02AA01 | MST CONTINUS 200 MG suspensiooni- graanulid 200mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1713 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1714 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1715 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1716 | morfiin | N02AA01 | MST CONTINUS 30 MG suspensiooni- graanulid 30mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1717 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1718 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1719 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1720 | morfiin | N02AA01 | MST CONTINUS 60 MG suspensiooni- graanulid 60mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1721 | morfiin | N02AA01 | MST CONTINUS retardtablett 100mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1722 | morfiin | N02AA01 | MST CONTINUS retardtablett 10mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1723 | morfiin | N02AA01 | MST CONTINUS retardtablett 200mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1724 | morfiin | N02AA01 | MST CONTINUS retardtablett 30mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1725 | morfiin | N02AA01 | MST CONTINUS retardtablett 60mg N60 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1726 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N10 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1727 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N20 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1728 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N30 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1729 | morfiin | N02AA01 | MST CONTINUS suspensiooni- graanulid 20mg N60 |
Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1730 | morfiin | N02AA01 | MXL 120 MG kapsel 120mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1731 | morfiin | N02AA01 | MXL 120 MG kapsel 120mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1732 | morfiin | N02AA01 | MXL 120 MG kapsel 120mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1733 | morfiin | N02AA01 | MXL 150 MG kapsel 150mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1734 | morfiin | N02AA01 | MXL 150 MG kapsel 150mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1735 | morfiin | N02AA01 | MXL 150 MG kapsel 150mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1736 | morfiin | N02AA01 | MXL 200 MG kapsel 200mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1737 | morfiin | N02AA01 | MXL 200 MG kapsel 200mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1738 | morfiin | N02AA01 | MXL 200 MG kapsel 200mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1739 | morfiin | N02AA01 | MXL 30 MG kapsel 30mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1740 | morfiin | N02AA01 | MXL 30 MG kapsel 30mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1741 | morfiin | N02AA01 | MXL 30 MG kapsel 30mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1742 | morfiin | N02AA01 | MXL 60 MG kapsel 60mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1743 | morfiin | N02AA01 | MXL 60 MG kapsel 60mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1744 | morfiin | N02AA01 | MXL 60 MG kapsel 60mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1745 | morfiin | N02AA01 | MXL 90 MG kapsel 90mg N10 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1746 | morfiin | N02AA01 | MXL 90 MG kapsel 90mg N14 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1747 | morfiin | N02AA01 | MXL 90 MG kapsel 90mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1748 | morfiin | N02AA01 | SEVREDOL tablett 10mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1749 | morfiin | N02AA01 | SEVREDOL tablett 10mg N56 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1750 | morfiin | N02AA01 | SEVREDOL tablett 20mg N28 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1751 | morfiin | N02AA01 | SEVREDOL tablett 20mg N56 | Mundipharma Austria | 50% | 100% | C00-D48 | |||||
1752 | morfiin | N02AA01 | SLOVALGIN 30 RETARD retardtablett 30mg N10 | Slovakofarma | 50% | 100% | C00-D48 | |||||
1753 | morfiin | N02AA01 | SLOVALGIN 30 RETARD retardtablett 30mg N20 | Slovakofarma | 50% | 100% | C00-D48 | |||||
1754 | morfiin | N02AA01 | SLOVALGIN 30 RETARD retardtablett 30mg N60 | Slovakofarma | 50% | 100% | C00-D48 | |||||
1755 | morfiin | N02AA01 | VENDAL RETARD 10 MG retardtablett 10mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1756 | morfiin | N02AA01 | VENDAL RETARD 100 MG retardtablett 100mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1757 | morfiin | N02AA01 | VENDAL RETARD 200 MG retardtablett 200mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1758 | morfiin | N02AA01 | VENDAL RETARD 30 MG retardtablett 30mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1759 | morfiin | N02AA01 | VENDAL RETARD 60 MG retardtablett 60mg N30 | Lannacher | 50% | 100% | C00-D48 | |||||
1760 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 10 000 kapsel N100 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1761 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 10 000 kapsel N20 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1762 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 10 000 kapsel N50 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1763 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 25 000 kapsel -1 N100 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1764 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 25 000 kapsel -1 N20 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1765 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON 25 000 kapsel -1 N50 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1766 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON kapsel N20 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1767 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | KREON kapsel N50 | Solvay | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1768 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | MEZYM FORTE 20 000 enterotablett -1 N100 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1769 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | MEZYM FORTE 20 000 enterotablett -1 N200 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1770 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | MEZYM FORTE 20 000 enterotablett -1 N50 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1771 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N100 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1772 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N20 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1773 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N200 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1774 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 10000 kapsel -1 N50 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1775 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N100 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1776 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N20 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1777 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N200 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1778 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANGROL 25000 kapsel N50 | Berlin-Chemie | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1779 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANZYNORM FORTE enterotablett N30 | KRKA, d.d. | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1780 | Multiensüümid (lipaas, proteaas jt) | A09AA02 | PANZYTRAT 10000 kapsel 10000TÜ N20 | Abbott GmbH & Co. KG | 50% | 100% | E84* | *rev pulmono- loogil |
||||
1781 | müko- fenoolhape |
L04AA06 | CELLCEPT kapsel 250mg N100 | Roche | 50% | |||||||
1782 | müko- fenoolhape |
L04AA06 | CELLCEPT kapsel 250mg N300 | Roche | 50% | |||||||
1783 | müko- fenoolhape |
L04AA06 | CELLCEPT pulber suspensiooniks 200mg/ml 110g N1 | Roche | 50% | |||||||
1784 | müko- fenoolhape |
L04AA06 | CELLCEPT tablett 500mg N150 | Roche | 50% | |||||||
1785 | müko- fenoolhape |
L04AA06 | CELLCEPT tablett 500mg N50 | Roche | 50% | |||||||
1786 | nabumetoon | M01AX01 | RELIFEX kihisev tablett 1g N100 | GlaxoSmithKline | 50% | |||||||
1787 | nabumetoon | M01AX01 | RELIFEX kihisev tablett 1g N20 | GlaxoSmithKline | 50% | |||||||
1788 | nabumetoon | M01AX01 | RELIFEX tablett 500mg N100 | GlaxoSmithKline | 50% | |||||||
1789 | nabumetoon | M01AX01 | RELIFEX tablett 500mg N20 | GlaxoSmithKline | 50% | |||||||
1790 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 11400TÜ anti Xa 0.6ml 0.6ml N10 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1791 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 11400TÜ anti Xa 0.6ml 0.6ml N2 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1792 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 15200TÜ anti Xa 0.8ml 0.8ml N10 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1793 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 15200TÜ anti Xa 0.8ml 0.8ml N2 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1794 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 19000TÜ anti Xa/ml 1ml N10 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1795 | nadropariin | B01AB06 | FRAXIPARINE FORTE süstelahus 19000TÜ anti Xa/ml 1ml N2 | Sanofi-Synthelabo France | 50% | 75% | O99.8 | |||||
1796 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 3800TÜ anti Xa 0.4ml 0.4ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1797 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 3800TÜ anti Xa 0.4ml 0.4ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1798 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 5700TÜ anti Xa 0.6ml 0.6ml N1 | Sanofi | 50% | 75% | O99.8 | |||||
1799 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 5700TÜ anti Xa 0.6ml 0.6ml N6 | Sanofi | 50% | 75% | O99.8 | |||||
1800 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 7600TÜ anti Xa 0.8ml 0.8ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1801 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 7600TÜ anti Xa 0.8ml 0.8ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1802 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 0.3ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1803 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 0.3ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1804 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 1ml N10 | Sanofi | 50% | 75% | O99.8 | |||||
1805 | nadropariin | B01AB06 | FRAXIPARINE süstelahus 9500TÜ anti Xa/ml 1ml N2 | Sanofi | 50% | 75% | O99.8 | |||||
1806 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 15g N1 | Biochemie GmbH | 50% | |||||||
1807 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 200g N1 | Biochemie GmbH | 50% | |||||||
1808 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 30g N1 | Biochemie GmbH | 50% | |||||||
1809 | naftifiin | D01AE22 | EXODERIL CREAM kreem 1% 5g N1 | Biochemie GmbH | 50% | |||||||
1810 | naftifiin | D01AE22 | EXODERIL SOLUTION lahus 1% 10ml N1 | Biochemie GmbH | 50% | |||||||
1811 | naftifiin | D01AE22 | EXODERIL SOLUTION lahus 1% 20ml N1 | Biochemie GmbH | 50% | |||||||
1812 | nandroloon | A14AB01 | RETABOLIL süstelahus 50mg/ml 1ml N1 | Richter | 50% | |||||||
1813 | nandroloon | A14AB01 | RETABOLIL süstelahus 50mg/ml 1ml N25 | Richter | 50% | |||||||
1814 | naprokseen | M01AE02 | ALEVE tablett 220mg N10 | Roche | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1815 | naprokseen | M01AE02 | NALGESIN FORTE tablett 550mg N10 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1816 | naprokseen | M01AE02 | NALGESIN tablett 275mg N10 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1817 | naprokseen | M01AE02 | NAPROKSENS 250 MG tablett 250mg N30 | Grindeks | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1818 | naprokseen | M01AE02 | NAPROKSENS 500 MG tablett 500mg N30 | Grindeks | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1819 | naprokseen | M01AE02 | NAPROSYN 250 tablett 250mg N30 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1820 | naprokseen | M01AE02 | NAPROSYN 250 tablett 250mg N50 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1821 | naprokseen | M01AE02 | NAPROSYN 500 suposiit 500mg N10 | KRKA, d.d. | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1822 | naprokseen | M01AE02 | NAPROXEN ALPHARMA TABLETS 250 MG tablett 250mg N20 | ALPHARMA | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1823 | naprokseen | M01AE02 | NAPROXEN ALPHARMA TABLETS 250 MG tablett 250mg N56 | ALPHARMA | 50% | 75% | M05; M06; M08; M45; M46 | |||||
1824 | naratriptaan | N02CC02 | NARAMIG tablett 2,5mg N2 | Glaxo Wellcome | 50% | |||||||
1825 | naratriptaan | N02CC02 | NARAMIG tablett 2,5mg N4 | Glaxo Wellcome | 50% | |||||||
1826 | naratriptaan | N02CC02 | NARAMIG tablett 2,5mg N6 | Glaxo Wellcome | 50% | |||||||
1827 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N12 | Novartis Pharma | 50% | |||||||
1828 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N120 | Novartis Pharma | 50% | |||||||
1829 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N24 | Novartis Pharma | 50% | |||||||
1830 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N30 | Novartis Pharma | 50% | |||||||
1831 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N360 | Novartis Pharma | 50% | |||||||
1832 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N60 | Novartis Pharma | 50% | |||||||
1833 | nategliniid | A10BX03 | STARLIX 120 tablett 120mg N84 | Novartis Pharma | 50% | |||||||
1834 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N12 | Novartis Pharma | 50% | |||||||
1835 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N120 | Novartis Pharma | 50% | |||||||
1836 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N24 | Novartis Pharma | 50% | |||||||
1837 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N30 | Novartis Pharma | 50% | |||||||
1838 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N360 | Novartis Pharma | 50% | |||||||
1839 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N60 | Novartis Pharma | 50% | |||||||
1840 | nategliniid | A10BX03 | STARLIX 180 tablett 180mg N84 | Novartis Pharma | 50% | |||||||
1841 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N12 | Novartis Pharma | 50% | |||||||
1842 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N120 | Novartis Pharma | 50% | |||||||
1843 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N24 | Novartis Pharma | 50% | |||||||
1844 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N30 | Novartis Pharma | 50% | |||||||
1845 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N360 | Novartis Pharma | 50% | |||||||
1846 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N60 | Novartis Pharma | 50% | |||||||
1847 | nategliniid | A10BX03 | STARLIX 60 tablett 60mg N84 | Novartis Pharma | 50% | |||||||
1848 | nebivolool | C07AB12 | NEBILET tablett 5mg N14 | Berlin-Chemie | 50% | |||||||
1849 | nebivolool | C07AB12 | NEBILET tablett 5mg N28 | Berlin-Chemie | 50% | |||||||
1850 | nebivolool | C07AB12 | NEBILET tablett 5mg N7 | Berlin-Chemie | 50% | |||||||
1851 | nelfinaviir | J05AE04 | VIRACEPT kaetud tablett 250mg N270 | Roche | 50% | |||||||
1852 | nelfinaviir | J05AE04 | VIRACEPT tablett 250mg N270 | Roche | 50% | |||||||
1853 | nevirapiin | J05AX03 | VIRAMUNE suspensioon 50mg 5ml 240ml N1 | Boehringer Ingelheim | 50% | |||||||
1854 | nevirapiin | J05AX03 | VIRAMUNE tablett 200mg N100 | Boehringer Ingelheim | 50% | |||||||
1855 | nevirapiin | J05AX03 | VIRAMUNE tablett 200mg N60 | Boehringer Ingelheim | 50% | |||||||
1856 | nifedipiin | C08CA05 | ADALAT 10 RETARD retardtablett 10mg N100 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1857 | nifedipiin | C08CA05 | ADALAT 10 RETARD retardtablett 10mg N50 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1858 | nifedipiin | C08CA05 | ADALAT OROS 30 MG DEPOT TABLETS retardtablett 30mg N28 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1859 | nifedipiin | C08CA05 | ADALAT OROS 30 MG DEPOT TABLETS retardtablett 30mg N98 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1860 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 20mg N28 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1861 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 20mg N98 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1862 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 60mg N28 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1863 | nifedipiin | C08CA05 | ADALAT OROS retardtablett 60mg N98 | Bayer AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1864 | nifedipiin | C08CA05 | CORDIPIN RETARD retardtablett 20mg N30 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1865 | nifedipiin | C08CA05 | CORDIPIN tablett 10mg N50 | KRKA, d.d. | 50% | |||||||
1866 | nifedipiin | C08CA05 | CORDIPIN XL tablett 40mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1867 | nifedipiin | C08CA05 | CORINFAR RETARD retardtablett 20mg N100 | AWD | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1868 | nifedipiin | C08CA05 | CORINFAR RETARD retardtablett 20mg N30 | AWD | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1869 | nifedipiin | C08CA05 | CORINFAR RETARD retardtablett 20mg N50 | AWD | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1870 | nifedipiin | C08CA05 | CORINFAR tablett 10mg N100 | AWD | 50% | |||||||
1871 | nifedipiin | C08CA05 | CORINFAR tablett 10mg N30 | AWD | 50% | |||||||
1872 | nifedipiin | C08CA05 | CORINFAR tablett 10mg N50 | AWD | 50% | |||||||
1873 | nifedipiin | C08CA05 | NIFECARD retardtablett 20mg N50 | LEK d.d | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1874 | nifedipiin | C08CA05 | NIFEDEKS tablett 10mg N30 | Grindeks | 50% | |||||||
1875 | nifedipiin | C08CA05 | NIFEDEKS tablett 10mg N50 | Grindeks | 50% | |||||||
1876 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 10 KAPSLID kapsel 10mg N100 | ratiopharm | 50% | |||||||
1877 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 10 KAPSLID kapsel 10mg N30 | ratiopharm | 50% | |||||||
1878 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 10 KAPSLID kapsel 10mg N50 | ratiopharm | 50% | |||||||
1879 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 20 retardtablett 20mg N100 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1880 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 20 retardtablett 20mg N30 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1881 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 20 retardtablett 20mg N50 | ratiopharm | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1882 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 5 KAPSLID kapsel 5mg N100 | ratiopharm | 50% | |||||||
1883 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 5 KAPSLID kapsel 5mg N30 | ratiopharm | 50% | |||||||
1884 | nifedipiin | C08CA05 | NIFEDIPIN-RATIOPHARM 5 KAPSLID kapsel 5mg N50 | ratiopharm | 50% | |||||||
1885 | nifedipiin | C08CA05 | NIFEHEXAL RETARD retardtablett 20mg N30 | Hexal AG | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1886 | nifedipiin | C08CA05 | NIFETARD-TFT retardtablett 20mg N20 | TFT | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1887 | nifedipiin | C08CA05 | NYCOPIN retardtablett 40mg N30 | Nycomed SEFA | 50% | 75% | (I10-I13)*; I15*; I20; M34**; O10-O16 | *(1); **rev reumatoloogil | ||||
1888 | nifluumhape | M02AA17 | NIFLURIL kreem 3% 60g N1 | Laboratoires Upsa | 50% | |||||||
1889 | nimodipiin | C08CA06 | DILCEREN tablett 30mg N50 | Slovakofarma | 50% | |||||||
1890 | nimodipiin | C08CA06 | NIMOTOP 30 MG TABLETS tablett 30mg N100 | Bayer AG | 50% | |||||||
1891 | nitrendipiin | C08CA08 | LUSOPRESS tablett 20mg N28 | Lusofarmaco | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1892 | nitrendipiin | C08CA08 | UNIPRES 10 tablett 10mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1893 | nitrendipiin | C08CA08 | UNIPRES 20 tablett 20mg N20 | KRKA, d.d. | 50% | 75% | (I10-I13)*; I15* | *(1) | ||||
1894 | nitrofurantoiin | G04AC01 | NITROFURANTOIN NYCOMED tablett 50mg N20 | Nycomed SEFA | 50% | |||||||
1895 | noretisteroon | G03AC01 | MICRONOR tablett 0,35mg N84 | Cilag | 50% | 75% | Z30 | |||||
1896 | noretisteroon | G03DC02 | NORCOLUT tablett 5mg N20 | Richter | 50% | |||||||
1897 | noretisteroon+etünüül- östradiool |
G03AA05 | NON-OVLON drazhee 1mg+0,05mg N21 | Jenapharm | 50% | 75% | Z30 | |||||
1898 | noretisteroon+östradiool | G03FA01 | ACTIVELLE tablett 0,5mg+1mg N28 | Novo Nordisk | 50% | |||||||
1899 | noretisteroon+östradiool | G03FA01 | ESTRACOMB TTS TTS N8 | Novartis Pharma | 50% | |||||||
1900 | noretisteroon+östradiool | G03FA01 | KLIANE tablett 1mg+2mg N28 | Schering AG | 50% | |||||||
1901 | noretisteroon+östradiool | G03FA01 | KLIANE tablett 1mg+2mg N84 | Schering AG | 50% | |||||||
1902 | noretisteroon+östradiool | G03FA01 | KLIOGEST tablett 1mg+2mg N28 | Novo Nordisk | 50% | |||||||
1903 | noretisteroon+östradiool | G03FA01 | SYSTEN CONTI TTS 11,2mg+3,2mg N8 | Cilag | 50% | |||||||
1904 | noretisteroon+östradiool | G03FA01 | SYSTEN SEQUI TTS N8 | Cilag | 50% | |||||||
1905 | norfloksatsiin | J01MA06 | NOLICIN tablett 400mg N20 | KRKA, d.d. | 50% | |||||||
1906 | norfloksatsiin | J01MA06 | NORFLOXACIN-RATIOPHARM 400 MG tablett 400mg N10 | ratiopharm | 50% | |||||||
1907 | norfloksatsiin | J01MA06 | NORFLOXACIN-RATIOPHARM 400 MG tablett 400mg N20 | ratiopharm | 50% | |||||||
1908 | norfloksatsiin | J01MA06 | NORFLOXACIN-RATIOPHARM 400 MG tablett 400mg N50 | ratiopharm | 50% | |||||||
1909 | norfloksatsiin | S01AX12 | CHIBROXIN silmatilgad 0,3% 5 ml N1 | MSD | 50% | |||||||
1910 | norgestimaat+etünüül- östradiool |
G03AA11 | CILEST tablett 0,25mg+0,03mg N21 | Cilag | 50% | 75% | Z30 | |||||
1911 | norgestimaat+etünüül- östradiool |
G03AA11 | CILEST tablett 0,25mg+0,03mg N63 | Cilag | 50% | 75% | Z30 | |||||
1912 | norgestreel+ östrageen |
G03FA10 | CYCLO-PROGYNOVA drazhee N21 | Schering AG | 50% | |||||||
1913 | nortriptüliin | N06AA10 | NORITREN tablett 25mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
1914 | ofloksatsiin | J01MA01 | TARIVID tablett 200mg N10 | Aventis Pharma Deutschland | 50% | |||||||
1915 | ofloksatsiin | J01MA01 | TARIVID tablett 200mg N100 | Aventis Pharma Deutschland | 50% | |||||||
1916 | ofloksatsiin | J01MA01 | TARIVID tablett 200mg N3 | Aventis Pharma Deutschland | 50% | |||||||
1917 | okskarbasepiin | N03AF02 | APYDAN 300 MG tablett 300mg N100 | Desitin | 50% | |||||||
1918 | okskarbasepiin | N03AF02 | APYDAN 300 MG tablett 300mg N200 | Desitin | 50% | |||||||
1919 | okskarbasepiin | N03AF02 | APYDAN 300 MG tablett 300mg N50 | Desitin | 50% | |||||||
1920 | okskarbasepiin | N03AF02 | APYDAN 600 MG tablett 600mg N100 | Desitin | 50% | |||||||
1921 | okskarbasepiin | N03AF02 | APYDAN 600 MG tablett 600mg N200 | Desitin | 50% | |||||||
1922 | okskarbasepiin | N03AF02 | APYDAN 600 MG tablett 600mg N50 | Desitin | 50% | |||||||
1923 | okskarbasepiin | N03AF02 | TRILEPTAL 150 kaetud tablett 150mg N100 | Novartis Pharma | 50% | |||||||
1924 | okskarbasepiin | N03AF02 | TRILEPTAL 150 kaetud tablett 150mg N50 | Novartis Pharma | 50% | |||||||
1925 | okskarbasepiin | N03AF02 | TRILEPTAL 300 kaetud tablett 300mg N100 | Novartis Pharma | 50% | |||||||
1926 | okskarbasepiin | N03AF02 | TRILEPTAL 300 kaetud tablett 300mg N50 | Novartis Pharma | 50% | |||||||
1927 | okskarbasepiin | N03AF02 | TRILEPTAL 300 tablett 300mg N50 | Novartis Pharma | 50% | |||||||
1928 | okskarbasepiin | N03AF02 | TRILEPTAL 600 kaetud tablett 600mg N100 | Novartis Pharma | 50% | |||||||
1929 | okskarbasepiin | N03AF02 | TRILEPTAL 600 kaetud tablett 600mg N50 | Novartis Pharma | 50% | |||||||
1930 | okskarbasepiin | N03AF02 | TRILEPTAL 600 tablett 600mg N50 | Novartis Pharma | 50% | |||||||
1931 | oksübutüniin | G04BD04 | DRIPTANE tablett 5mg N60 | LABORATOIRES FOURNIER S.A | 50% | 75% | N31* | *rv neuroloogil ja urolooogil | ||||
1932 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N25 | Mundipharma Austria | 50% | |||||||
1933 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N100 | Mundipharma Austria | 50% | |||||||
1934 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N28 | Mundipharma Austria | 50% | |||||||
1935 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 10 MG tablett 10mg N56 | Mundipharma Austria | 50% | |||||||
1936 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N25 | Mundipharma Austria | 50% | |||||||
1937 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N100 | Mundipharma Austria | 50% | |||||||
1938 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N28 | Mundipharma Austria | 50% | |||||||
1939 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 20 MG tablett 20mg N56 | Mundipharma Austria | 50% | |||||||
1940 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N25 | Mundipharma Austria | 50% | |||||||
1941 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N100 | Mundipharma Austria | 50% | |||||||
1942 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N28 | Mundipharma Austria | 50% | |||||||
1943 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 40 MG tablett 40mg N56 | Mundipharma Austria | 50% | |||||||
1944 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N100 | Mundipharma Austria | 50% | |||||||
1945 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N25 | Mundipharma Austria | 50% | |||||||
1946 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N28 | Mundipharma Austria | 50% | |||||||
1947 | oksükodoon | N02AA05 | OXYCONTIN TABLETS 80 MG tablett 80mg N56 | Mundipharma Austria | 50% | |||||||
1948 | oktreotiid | H01CB02 | SANDOSTATIN LAR injektsioonisubstants 10mg N1 | Novartis Pharma | 50% | |||||||
1949 | oktreotiid | H01CB02 | SANDOSTATIN LAR injektsioonisubstants 20mg N1 | Novartis Pharma | 50% | |||||||
1950 | oktreotiid | H01CB02 | SANDOSTATIN LAR injektsioonisubstants 30mg N1 | Novartis Pharma | 50% | |||||||
1951 | oktreotiid | H01CB02 | SANDOSTATIN süstelahus 0,05mgml 1ml N5 | Novartis Pharma | 50% | |||||||
1952 | oktreotiid | H01CB02 | SANDOSTATIN süstelahus 0,1mgml 1ml N5 | Novartis Pharma | 50% | |||||||
1953 | olansapiin | N05AH03 | ZYPREXA tablett 10mg N28 | Eli Lilly Export S.A. | 50% | |||||||
1954 | olansapiin | N05AH03 | ZYPREXA tablett 5mg N28 | Eli Lilly Export S.A. | 50% | |||||||
1955 | omeprasool | A02BC01 | GASEC-20 enterokapsel 20mg N14 | MEPHA Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1956 | omeprasool | A02BC01 | GASEC-20 enterokapsel 20mg N28 | MEPHA Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1957 | omeprasool | A02BC01 | GASEC-20 enterokapsel 20mg N7 | MEPHA Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1958 | omeprasool | A02BC01 | LOMAC-20 kapsel 20mg N10 | Cipla | 50% | 75% | (K25-K27)* | *(3) | ||||
1959 | omeprasool | A02BC01 | LOSEC 20 MG CAPSULES enterokapsel 20mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1960 | omeprasool | A02BC01 | LOSEC 20 MG CAPSULES enterokapsel 20mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1961 | omeprasool | A02BC01 | LOSEC 20 MG CAPSULES enterokapsel 20mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1962 | omeprasool | A02BC01 | LOSEC kapsel 10mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1963 | omeprasool | A02BC01 | LOSEC kapsel 10mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1964 | omeprasool | A02BC01 | LOSEC kapsel 10mg N56 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1965 | omeprasool | A02BC01 | LOSEC kapsel 40mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1966 | omeprasool | A02BC01 | LOSEC kapsel 40mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1967 | omeprasool | A02BC01 | LOSEC kapsel 40mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1968 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 10mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1969 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 10mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1970 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 10mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1971 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N100 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1972 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N14 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1973 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1974 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 20mg N7 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1975 | omeprasool | A02BC01 | LOSEC MUPS enterotablett 40mg N28 | AstraZeneca UK Ltd. | 50% | 75% | (K25-K27)* | *(3) | ||||
1976 | omeprasool | A02BC01 | OMEP 20 kapsel 20mg N14 | Hexal AG | 50% | 75% | (K25-K27)* | *(3) | ||||
1977 | omeprasool | A02BC01 | OMEP 20 kapsel 20mg N15 | Hexal AG | 50% | 75% | (K25-K27)* | *(3) | ||||
1978 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N100 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1979 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N15 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1980 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N30 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1981 | omeprasool | A02BC01 | OMEPRAZOL-RATIOPHARM NT kapsel 20mg N60 | ratiopharm | 50% | 75% | (K25-K27)* | *(3) | ||||
1982 | omeprasool | A02BC01 | ULCEX enterokapsel 20mg N14 | Grindeks | 50% | 75% | (K25-K27)* | *(3) | ||||
1983 | omeprasool | A02BC01 | ULCEX enterokapsel 20mg N7 | Grindeks | 50% | 75% | (K25-K27)* | *(3) | ||||
1984 | omoconasool | G01AF16 | MIKOGAL vaginaalsuposiit 150mg N6 | Biogal | 50% | |||||||
1985 | omoconasool | G01AF16 | MIKOGAL vaginaalsuposiit 300mg N3 | Biogal | 50% | |||||||
1986 | omoconasool | G01AF16 | MIKOGAL vaginaalsuposiit 900mg N1 | Biogal | 50% | |||||||
1987 | ondansetroon | A04AA01 | EMETRON tablett 4mg N10 | Richter | 50% | |||||||
1988 | ondansetroon | A04AA01 | EMETRON tablett 8mg N10 | Richter | 50% | |||||||
1989 | ondansetroon | A04AA01 | ZOFRAN tablett 8mg N10 | Glaxo Wellcome | 50% | |||||||
1990 | ondansetroon | A04AA01 | ZOFRAN süstelahus 2mg/ml 2ml N5 | Glaxo Wellcome | 50% | |||||||
1991 | ondansetroon | A04AA01 | ZOFRAN süstelahus 2mg/ml 4ml N5 | Glaxo Wellcome | 50% | |||||||
1992 | ondansetroon | A04AA01 | EMETRON süstelahus 2mg/ml 2ml N5 | Richter | 50% | |||||||
1993 | ondansetroon | A04AA01 | EMETRON süstelahus 2mg/ml 4ml N5 | Richter | 50% | |||||||
1994 | orfenadriin | M03BC01 | NORFLEX tablett 100mg N60 | 3M Health Care | 50% | |||||||
1995 | orfenadriin+ paratsetamool |
M03BC80 | NORGESIC tablett 35mg+450mg N100 | 3M Health Care | 50% | |||||||
1996 | orfenadriin+ paratsetamool |
M03BC80 | NORGESIC tablett 35mg+450mg N30 | 3M Health Care | 50% | |||||||
1997 | orfenadriin+ paratsetamool |
M03BC80 | NORGESIC tablett 35mg+450mg N60 | 3M Health Care | 50% | |||||||
1998 | ornidasool | P01AB03 | TIBERAL tablett 500mg N10 | Roche | 50% | |||||||
1999 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N100 | Byk Gulden | 50% | |||||||
2000 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N14 | Byk Gulden | 50% | |||||||
2001 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N28 | Byk Gulden | 50% | |||||||
2002 | pantoprasool | A02BC02 | CONTROLOC 20 MG enterotablett 20mg N56 | Byk Gulden | 50% | |||||||
2003 | pantoprasool | A02BC02 | CONTROLOC 40 MG enterotablett 40mg N14 | Byk Gulden | 50% | |||||||
2004 | pantoprasool | A02BC02 | CONTROLOC 40 MG enterotablett 40mg N28 | Byk Gulden | 50% | |||||||
2005 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE lahustuv tablett 500mg+30mg N16 | Laboratoires Upsa | 50% | |||||||
2006 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE lahustuv tablett 500mg+30mg N8 | Laboratoires Upsa | 50% | |||||||
2007 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE tablett 500mg+30mg N16 | Laboratoires Upsa | 50% | |||||||
2008 | paratsetamool+kodeiin | N02BE92 | EFFERALGAN CODEINE tablett 500mg+30mg N8 | Laboratoires Upsa | 50% | |||||||
2009 | paratsetamool+kodeiin | N02BE92 | PRODEINE 30 tablett 500mg+30mg N100 | Sanofi | 50% | |||||||
2010 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N100 | GlaxoSmithKline | 50% | |||||||
2011 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N14 | GlaxoSmithKline | 50% | |||||||
2012 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N20 | GlaxoSmithKline | 50% | |||||||
2013 | paroksetiin | N06AB05 | SEROXAT tablett 20mg N30 | GlaxoSmithKline | 50% | |||||||
2014 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 100mcg N1 |
Schering-Plough | 50% | |||||||
2015 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 120mcg N1 |
Schering-Plough | 50% | |||||||
2016 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 50mcg N1 |
Schering-Plough | 50% | |||||||
2017 | peginterferoon alfa-2b | L03AB10 | PEGINTRON injektsiooni- substants 80mcg N1 |
Schering-Plough | 50% | |||||||
2018 | pentoksüveriin | R05DB05 | TOCLASE siirup 1,5mg/ml 200ml N1 | UCB Pharma Oy Finland | 50% | |||||||
2019 | pentoksüveriin | R05DB05 | TOCLASE tablett 50mg 1Tabl N25 | UCB Pharma Oy Finland | 50% | |||||||
2020 | pergoliid | N04BC02 | PERMAX tablett 0,05mg N100 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2021 | pergoliid | N04BC02 | PERMAX tablett 0,05mg N30 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2022 | pergoliid | N04BC02 | PERMAX tablett 0,25mg N30 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2023 | pergoliid | N04BC02 | PERMAX tablett 1mg N30 | Eli Lilly Export S.A. | 50% | 100% | G20* | *rev neuroloogil | ||||
2024 | perindopriil | C09AA04 | COVEREX tablett 4mg N30 | Egis | 50% | |||||||
2025 | perindopriil | C09AA04 | PRESTARIUM tablett 4mg N30 | Servier | 50% | |||||||
2026 | perindopriil+ indapamiid |
C09BA80 | NOLIPREL FORTE tablett 4mg+1,25mg N30 | Servier | 50% | |||||||
2027 | perindopriil+ indapamiid |
C09BA80 | NOLIPREL tablett 2mg+0,625mg N30 | Servier | 50% | |||||||
2028 | petidiin | N02AB02 | PETHIDINE 50 MG/ML süstelahus 50mg/ml 1ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
2029 | petidiin | N02AB02 | PETHIDINE 50 MG/ML süstelahus 50mg/ml 2ml N10 | Ilsanta | 50% | 100% | C00-D48 | |||||
2030 | piimhape+ naatrium- laktaat |
G01AD80 | VAGISAN vaginaalsuposiit 167mg+100mg N7 | Wolff | 50% | |||||||
2031 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN LENTE süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2032 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN N PEN süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2033 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN NPH süstelahus 100TÜ/ml 1.5ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2034 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN NPH süstelahus 100TÜ/ml 10ml N1 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2035 | Pika toimeajaga humaan- insuliin |
A10AE01 | HUMULIN NPH süstelahus 100TÜ/ml 3ml N5 | Eli Lilly Export S.A. | 50% | 100% | E10-E11; E13-E14; E89.1; O24; P70.2 | |||||
2036 | pilokarpiin | S01EB01 | ISOPTO CARPINE silmatilgad 2% 15 ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2037 | pilokarpiin | S01EB01 | ISOPTO CARPINE silmatilgad 4% 15 ml N1 | Alcon | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2038 | pilokarpiin | S01EB01 | OFTAN PILOCARPIN silmatilgad 1% 10 ml N1 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2039 | pilokarpiin+ timolool |
S01EB80 | FOTIL FORTE silmatilgad 4%+0,5% 5 ml N1 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2040 | pilokarpiin+ timolool |
S01EB80 | FOTIL silmatilgad 2%+0,5% 5 ml N1 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2041 | pilokarpiin+ timolool |
S01EB80 | FOTIL silmatilgad üksikannustena 2%+0,5% 0.25 ml N60 | Santen | 50% | 100% | (H40-H42)* | *rv oftalmoloogil | ||||
2042 | pindolool | C07AA03 | VISKEN tablett 5mg N30 | Novartis Pharma | 50% | |||||||
2043 | pioglitasoon | A10BG03 | ACTOS tablett 15mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2044 | pioglitasoon | A10BG03 | ACTOS tablett 30mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2045 | pioglitasoon | A10BG03 | ACTOS tablett 45mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2046 | piratsetaam | N06BX03 | CEREBRYL 1200 MG tablett 1200mg N60 | Kwizda | 50% | |||||||
2047 | piratsetaam | N06BX03 | CEREBRYL tablett 800mg N60 | Kwizda | 50% | |||||||
2048 | piratsetaam | N06BX03 | NOOTROPIL suukaudne lahus 330mg/ml 125ml N1 | UCB Pharma Oy Finland | 50% | |||||||
2049 | piratsetaam | N06BX03 | NOOTROPIL tablett 1200mg N100 | UCB Pharma Oy Finland | 50% | |||||||
2050 | piratsetaam | N06BX03 | NOOTROPIL tablett 1200mg N20 | UCB Pharma Oy Finland | 50% | |||||||
2051 | piratsetaam | N06BX03 | NOOTROPIL tablett 1200mg N60 | UCB Pharma Oy Finland | 50% | |||||||
2052 | piratsetaam | N06BX03 | NOOTROPIL tablett 800mg N30 | UCB Pharma Oy Finland | 50% | |||||||
2053 | piratsetaam | N06BX03 | NOOTROPIL tablett 800mg N60 | UCB Pharma Oy Finland | 50% | |||||||
2054 | piratsetaam | N06BX03 | NOOTROPIL tablett 800mg N90 | UCB Pharma Oy Finland | 50% | |||||||
2055 | piratsetaam | N06BX03 | PIRACETAM TFT kapsel 400mg N30 | TFT | 50% | |||||||
2056 | piratsetaam | N06BX03 | PIRACETAM TFT kapsel 400mg N60 | TFT | 50% | |||||||
2057 | piroksikaam | M01AC01 | BREXIN pulber lahuseks 20mg N20 | Chiesi | 50% | |||||||
2058 | piroksikaam | M01AC01 | BREXIN tablett 20mg N20 | Chiesi | 50% | |||||||
2059 | piroksikaam | M01AC01 | PIROXICAM 10 STADA TABS tablett 10mg N20 | Stada | 50% | |||||||
2060 | piroksikaam | M01AC01 | PIROXICAM 10 STADA TABS tablett 10mg N50 | Stada | 50% | |||||||
2061 | piroksikaam | M01AC01 | PIROXICAM 20 STADA TABS tablett 20mg N20 | Stada | 50% | |||||||
2062 | piroksikaam | M01AC01 | PIROXICAM 20 STADA TABS tablett 20mg N50 | Stada | 50% | |||||||
2063 | piroksikaam | M01AC01 | PIROXICAM ALPHARMA CAPSULES 20MG kapsel 20mg N20 | ALPHARMA | 50% | |||||||
2064 | piroksikaam | M01AC01 | PIROXICAM TFT tablett 20mg N20 | TFT | 50% | |||||||
2065 | piroksikaam | M01AC01 | PIROXICAM TFT tablett 20mg N25 | TFT | 50% | |||||||
2066 | Plastic IUD+progesto-geenid | G02BA03 | MIRENA emakasisene süsteem 20mcg 24h N1 | Schering AG | 50% | |||||||
2067 | podofül- lotoksiin |
D06BB04 | WARTEC kreem 0,15% 5 g | Stiefel | 50% | |||||||
2068 | podofül- lotoksiin |
D06BB04 | WARTEC lahus 5mgml 3ml N1 | Stiefel | 50% | |||||||
2069 | polüstüreen- sulfonaat |
V03AE01 | ANTI-POTASSIUM graanulid lahuseks 880mg/g 15g N20 | Medice | 50% | 75% | N18 | |||||
2070 | polüstüreen- sulfonaat |
V03AE01 | ANTI-POTASSIUM graanulid lahuseks 880mg/g 15g N50 | Medice | 50% | 75% | N18 | |||||
2071 | polüvidoon- jodiid+ allantoiin |
R02AA89 | JOX lahus 8,5%+0,1%/ 50ml N1 | IVAX - CR a.s. | 50% | |||||||
2072 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,125mg N100 | Pharmacia Enterprises | 50% | |||||||
2073 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,125mg N30 | Pharmacia Enterprises | 50% | |||||||
2074 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,25mg N100 | Pharmacia Enterprises | 50% | |||||||
2075 | pramipeksool | N04BC05 | MIRAPEXIN tablett 0,25mg N30 | Pharmacia Enterprises | 50% | |||||||
2076 | pramipeksool | N04BC05 | MIRAPEXIN tablett 1mg N100 | Pharmacia Enterprises | 50% | |||||||
2077 | pramipeksool | N04BC05 | MIRAPEXIN tablett 1mg N30 | Pharmacia Enterprises | 50% | |||||||
2078 | prasosiin | C02CA01 | PRASOSIN tablett 1mg N25 | TFT | 50% | |||||||
2079 | pravastatiin | C10AA03 | LIPOSTAT 40 MG tablett 40mg N28 | Bristol-Myers Squibb | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(4) | ||||
2080 | pravastatiin | C10AA03 | LIPOSTAT tablett 20mg N28 | Bristol-Myers Squibb | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(4) | ||||
2081 | prednisoloon | C05AA81 | AUROBIN salv 0,2%/ 20g N1 | Richter | 50% | |||||||
2082 | prednisoloon | D07AA03 | LINOLA-H N kreem 0,4% 250g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2083 | prednisoloon | D07AA03 | LINOLA-H N kreem 0,4% 25g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2084 | prednisoloon | D07AA03 | LINOLA-H-FETT N kreem 0,4% 100g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2085 | prednisoloon | D07AA03 | LINOLA-H-FETT N kreem 0,4% 250g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2086 | prednisoloon | D07AA03 | LINOLA-H-FETT N kreem 0,4% 25g N1 | Wolff | 50% | 75% | L10*; L12*; L13.0*; L20*; L23*; L40** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2087 | prednisoloon | H02AB06 | PREDNISOLON tablett 5mg N100 | Richter | 50% | 75% | K50*; K51*; K73*; K74*; L10*; L12*; L13.0*; L20*; L23*; L40**; M07**; M05***; M06***; M08***; (M30-M33)***; M35***; M45***; M46***; (N00-N08)**** | *rv gastroentero- loogil; **rv dermatovene- roloogil ja reumatoloogil; ***rev reumato- loogil; ****rv nefroloogil ja pediaatril |
100% | (C00-D48)*; D59**; (D60-D64)**; D69**; E23***; E25***; E27***; E89.3***; E89.6***; G70**** | *rv hematoloogil, onkoloogil ja uroloogil; **rv hematoloogil; ***rev endokrinoloogil; ****rev neuroloogil | |
2088 | prednisoloon | H02AB06 | PREDNISOLON tablett 5mg N20 | Richter | 50% | 75% | K50*; K51*; K73*; K74*; L10*; L12*; L13.0*; L20*; L23*; L40**; M07**; M05***; M06***; M08***; (M30-M33)***; M35***; M45***; M46***; (N00-N08)**** | *rv gastroentero- loogil; **rv dermatovene- roloogil ja reumatoloogil; ***rev reumato- loogil; ****rv nefroloogil ja pediaatril |
100% | (C00-D48)*; D59**; (D60-D64)**; D69**; E23***; E25***; E27***; E89.3***; E89.6***; G70**** | *rv hematoloogil, onkoloogil ja uroloogil; **rv hematoloogil; ***rev endokrinoloogil; ****rev neuroloogil | |
2089 | prednisoloon+salitsüülhape | D07XA81 | ALPICORT lahus paikseks kasut. 0,2%+0,4% 100ml N1 | Wolff | 50% | |||||||
2090 | primidoon | N03AA03 | LISKANTIN tablett 250mg N100 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
2091 | primidoon | N03AA03 | LISKANTIN tablett 250mg N200 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
2092 | primidoon | N03AA03 | LISKANTIN tablett 250mg N50 | Desitin | 50% | 100% | G40* | *rev neuroloogil | ||||
2093 | proksü- metakaiin |
S01HA04 | ALCAINE silmatilgad 0,5% 15ml N1 | Alcon | 50% | |||||||
2094 | propafenoon | C01BC03 | PROPANORM 150 MG tablett 150mg N50 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2095 | propafenoon | C01BC03 | RYTMONORM tablett 150mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2096 | propafenoon | C01BC03 | RYTMONORM tablett 300mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2097 | propranolool | C07AA05 | PROPRANOLOL ALPHARMA TABLETS 40 MG tablett 40mg N50 | ALPHARMA | 50% | |||||||
2098 | propranolool | C07AA05 | PROPRANOLOL ALPHARMA TABLETS 40 MG tablett 40mg N28 | ALPHARMA | ||||||||
2099 | propranolool | C07AA05 | PROPRA-RATIOPHARM tablett 40mg N100 | ratiopharm | 50% | |||||||
2100 | propranolool | C07AA05 | PROPRA-RATIOPHARM tablett 40mg N50 | ratiopharm | 50% | |||||||
2101 | propüül- tiouratsiil |
H03BA02 | TIOTIL tablett 50mg N100 | ABIGO MEDICAL AB | 50% | |||||||
2102 | pseudoefedriin+loratadiin | R01BA89 | CLARINASE retardtablett 240mg+10mg N7 | Schering-Plough | 50% | |||||||
2103 | püridostigmiin | N07AA02 | KALYMIN 60 N tablett 60mg N100 | AWD | 50% | 100% | G70* | *rev neuroloogil | ||||
2104 | püridostigmiin | N07AA02 | KALYMIN 60 N tablett 60mg N50 | AWD | 50% | 100% | G70* | *rev neuroloogil | ||||
2105 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N14 | Janssen | 50% | |||||||
2106 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N15 | Janssen | 50% | |||||||
2107 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N28 | Janssen | 50% | |||||||
2108 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N30 | Janssen | 50% | |||||||
2109 | rabeprasool | A02BC04 | PARIET 10 MG enterotablett 10mg N7 | Janssen | 50% | |||||||
2110 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N14 | Janssen | 50% | |||||||
2111 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N15 | Janssen | 50% | |||||||
2112 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N28 | Janssen | 50% | |||||||
2113 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N30 | Janssen | 50% | |||||||
2114 | rabeprasool | A02BC04 | PARIET 20 MG enterotablett 20mg N7 | Janssen | 50% | |||||||
2115 | raloxifeen | G03XC01 | EVISTA tablett 60mg N14 | Eli Lilly Export S.A. | 50% | |||||||
2116 | raloxifeen | G03XC01 | EVISTA tablett 60mg N28 | Eli Lilly Export S.A. | 50% | |||||||
2117 | ramipriil | C09AA05 | CARDACE 1,25 MG tablett 1,25mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2118 | ramipriil | C09AA05 | CARDACE 1,25 MG tablett 1,25mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2119 | ramipriil | C09AA05 | CARDACE 2,5 MG tablett 2,5mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2120 | ramipriil | C09AA05 | CARDACE 2,5 MG tablett 2,5mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2121 | ramipriil | C09AA05 | CARDACE 5 MG tablett 5mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2122 | ramipriil | C09AA05 | CARDACE 5 MG tablett 5mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2123 | ramipriil | C09AA05 | CARDACE tablett 10mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2124 | ramipriil | C09AA05 | CARDACE tablett 10mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2125 | ramipriil+ hüdro- klorotiasiid |
C09BA05 | CARDACE COMP tablett 2,5mg+12,5mg N28 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2126 | ramipriil+ hüdro- klorotiasiid |
C09BA05 | CARDACE COMP tablett 2,5mg+12,5mg N98 | Aventis Pharma Deutschland | 50% | 75% | (I10-I13)*; I15*; I50 | *(1) | ||||
2127 | ranitidiin | A02BA02 | RANIBERL 150 tablett 150mg N100 | Berlin-Chemie | 50% | |||||||
2128 | ranitidiin | A02BA02 | RANIBERL 150 tablett 150mg N20 | Berlin-Chemie | 50% | |||||||
2129 | ranitidiin | A02BA02 | RANIBERL 150 tablett 150mg N50 | Berlin-Chemie | 50% | |||||||
2130 | ranitidiin | A02BA02 | RANIBERL 300 tablett 300mg N20 | Berlin-Chemie | 50% | |||||||
2131 | ranitidiin | A02BA02 | RANIBERL 300 tablett 300mg N50 | Berlin-Chemie | 50% | |||||||
2132 | ranitidiin | A02BA02 | RANISAN 150 MG tablett 150mg N20 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2133 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 150 tablett 150mg N100 | ratiopharm | 50% | |||||||
2134 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 150 tablett 150mg N20 | ratiopharm | 50% | |||||||
2135 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 150 tablett 150mg N50 | ratiopharm | 50% | |||||||
2136 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 300 tablett 300mg N100 | ratiopharm | 50% | |||||||
2137 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 300 tablett 300mg N20 | ratiopharm | 50% | |||||||
2138 | ranitidiin | A02BA02 | RANITIDIN- RATIOPHARM 300 tablett 300mg N50 | ratiopharm | 50% | |||||||
2139 | ranitidiin | A02BA02 | RANITIDINE ALPHARMA TABLETS 150 MG tablett 150mg N30 | ALPHARMA | 50% | |||||||
2140 | ranitidiin | A02BA02 | ZANTAC EFFERVESCENT TABLETS 150 MG lahustuv tablett 150mg N10 | Glaxo Wellcome | 50% | |||||||
2141 | ranitidiin | A02BA02 | ZANTAC tablett 150mg N20 | Glaxo Wellcome | 50% | |||||||
2142 | ranitidiin | A02BA02 | ZANTAC tablett 150mg N60 | Glaxo Wellcome | 50% | |||||||
2143 | ranitidiin | A02BA02 | ZANTAC tablett 300mg N10 | Glaxo Wellcome | 50% | |||||||
2144 | ranitidiin | A02BA02 | ZANTAC tablett 300mg N30 | Glaxo Wellcome | 50% | |||||||
2145 | ranitidiin vismuttsitraat | A02BA07 | PYLORID tablett 400mg N14 | Glaxo Wellcome | 50% | |||||||
2146 | raud jt. | RS | TOT’HEMA suukaudne lahus 10 ml N20 | INNOTECH INTERNATIONAL | 75% | D50 | ||||||
2147 | raudaspartaat | B03AA09 | SPARTOCINE tablett 250 mg N40 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2148 | raudaspartaat | B03AA09 | SPARTOCINE tablett 250 mg N100 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2149 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 350 mg N14 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2150 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 350 mg N30 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2151 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 105 mg N14 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2152 | raudaspartaat | B03AA09 | SPARTOCINE graanulid 105 mg N30 | UCB Pharma Oy Finland | 75% | D50 | ||||||
2153 | raudpolü- maltoos |
B03AC04 | FERRUM LEK närimistablett 100mg N30 | LEK d.d | 50% | 75% | D50 | |||||
2154 | raudpolü- maltoos |
B03AC04 | FERRUM LEK siirup 10mg/ml 100ml N1 | LEK d.d | 50% | 75% | D50 | |||||
2155 | raudsulfaat | B03AA07 | RETAFER retardtablett 100 mg N30 | ORION CORPORATION ORION PHARMA | 75% | D50 | ||||||
2156 | raudsulfaat | B03AA07 | RETAFER retardtablett 100 mg N100 | ORION CORPORATION ORION PHARMA | 75% | D50 | ||||||
2157 | reboksetiin | N06AX18 | EDRONAX tablett 4mg N20 | Pharmacia Enterprises | 50% | |||||||
2158 | reboksetiin | N06AX18 | EDRONAX tablett 4mg N60 | Pharmacia Enterprises | 50% | |||||||
2159 | repagliniid | A10BX02 | NOVONORM tablett 0,5mg N30 | Novo Nordisk | 50% | |||||||
2160 | repagliniid | A10BX02 | NOVONORM tablett 0,5mg N90 | Novo Nordisk | 50% | |||||||
2161 | repagliniid | A10BX02 | NOVONORM tablett 1mg N30 | Novo Nordisk | 50% | |||||||
2162 | repagliniid | A10BX02 | NOVONORM tablett 1mg N90 | Novo Nordisk | 50% | |||||||
2163 | repagliniid | A10BX02 | NOVONORM tablett 2mg N30 | Novo Nordisk | 50% | |||||||
2164 | repagliniid | A10BX02 | NOVONORM tablett 2mg N90 | Novo Nordisk | 50% | |||||||
2165 | retinool+ dekspantenool |
S01XA80 | OFTAN A-PANT silmasalv 20TÜ+20mg/g 3.5g N1 | Santen | 50% | |||||||
2166 | ribaviriin | J05AB04 | REBETOL kapsel 200mg N140 | Schering-Plough | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2167 | ribaviriin | J05AB04 | REBETOL kapsel 200mg N168 | Schering-Plough | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2168 | ribaviriin | J05AB04 | REBETOL kapsel 200mg N84 | Schering-Plough | 50% | 75% | B18.2* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2169 | rilusool | N07XX02 | RILUTEK tablett 50mg N56 | Aventis Pharma SA | 50% | |||||||
2170 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 10mg N2 | MSD | 50% | |||||||
2171 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 10mg N6 | MSD | 50% | |||||||
2172 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 5mg N2 | MSD | 50% | |||||||
2173 | risatriptaan | N02CX80 | MAXALT RPD vahveltablett 5mg N6 | MSD | 50% | |||||||
2174 | risedroonhape | M05BA07 | ACTONEL 30 MG kaetud tablett 30mg N28 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2175 | risedroonhape | M05BA07 | ACTONEL 5 MG tablett 5mg N14 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2176 | risedroonhape | M05BA07 | ACTONEL 5 MG tablett 5mg N28 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2177 | risedroonhape | M05BA07 | ACTONEL 5 MG tablett 5mg N84 | Aventis Pharma AB | 50% | 75% | M80* | *rv endokrinoloogil | ||||
2178 | risperidoon | N05AX08 | RISPOLEPT suukaudne lahus 1mg/ml 100ml N1 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)* (F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2179 | risperidoon | N05AX08 | RISPOLEPT tablett 1mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2180 | risperidoon | N05AX08 | RISPOLEPT tablett 1mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2181 | risperidoon | N05AX08 | RISPOLEPT tablett 2mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2182 | risperidoon | N05AX08 | RISPOLEPT tablett 2mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2183 | risperidoon | N05AX08 | RISPOLEPT tablett 3mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2184 | risperidoon | N05AX08 | RISPOLEPT tablett 3mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2185 | risperidoon | N05AX08 | RISPOLEPT tablett 4mg N20 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2186 | risperidoon | N05AX08 | RISPOLEPT tablett 4mg N60 | Janssen | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rv psühhiaatril esmaselt diagnoositud skisofreenia spektri psühhoosi integratiivravi korral kestvusega kuni 2 aastat | ||||
2187 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N112 | Novartis Pharma | 50% | |||||||
2188 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N14 | Novartis Pharma | 50% | |||||||
2189 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N28 | Novartis Pharma | 50% | |||||||
2190 | rivastigmiin | N07AA80 | EXELON kapsel 0,5mg N56 | Novartis Pharma | 50% | |||||||
2191 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N112 | Novartis Pharma | 50% | |||||||
2192 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N14 | Novartis Pharma | 50% | |||||||
2193 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N28 | Novartis Pharma | 50% | |||||||
2194 | rivastigmiin | N07AA80 | EXELON kapsel 1,5mg N56 | Novartis Pharma | 50% | |||||||
2195 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N112 | Novartis Pharma | 50% | |||||||
2196 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N14 | Novartis Pharma | 50% | |||||||
2197 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N28 | Novartis Pharma | 50% | |||||||
2198 | rivastigmiin | N07AA80 | EXELON kapsel 1mg N56 | Novartis Pharma | 50% | |||||||
2199 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N112 | Novartis Pharma | 50% | |||||||
2200 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N14 | Novartis Pharma | 50% | |||||||
2201 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N28 | Novartis Pharma | 50% | |||||||
2202 | rivastigmiin | N07AA80 | EXELON kapsel 3mg N56 | Novartis Pharma | 50% | |||||||
2203 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N112 | Novartis Pharma | 50% | |||||||
2204 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N14 | Novartis Pharma | 50% | |||||||
2205 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N28 | Novartis Pharma | 50% | |||||||
2206 | rivastigmiin | N07AA80 | EXELON kapsel 4,5mg N56 | Novartis Pharma | 50% | |||||||
2207 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N112 | Novartis Pharma | 50% | |||||||
2208 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N14 | Novartis Pharma | 50% | |||||||
2209 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N28 | Novartis Pharma | 50% | |||||||
2210 | rivastigmiin | N07AA80 | EXELON kapsel 6mg N56 | Novartis Pharma | 50% | |||||||
2211 | rivastigmiin | N07AA80 | EXELON suukaudne lahus 2mg/ml 120ml N1 | Novartis Pharma | 50% | |||||||
2212 | rofekoksiib | M01AH02 | VIOXX FORTE tablett 50mg N10 | MSD | 50% | |||||||
2213 | rofekoksiib | M01AH02 | VIOXX FORTE tablett 50mg N2 | MSD | 50% | |||||||
2214 | rofekoksiib | M01AH02 | VIOXX FORTE tablett 50mg N5 | MSD | 50% | |||||||
2215 | rofekoksiib | M01AH02 | VIOXX suspensioon 2,5mg/ml 150ml N1 | MSD | 50% | |||||||
2216 | rofekoksiib | M01AH02 | VIOXX suspensioon 5mg/ml 150ml N1 | MSD | 50% | |||||||
2217 | rofekoksiib | M01AH02 | VIOXX tablett 12,5mg N14 | MSD | 50% | |||||||
2218 | rofekoksiib | M01AH02 | VIOXX tablett 12,5mg N28 | MSD | 50% | |||||||
2219 | rofekoksiib | M01AH02 | VIOXX tablett 12,5mg N7 | MSD | 50% | |||||||
2220 | rofekoksiib | M01AH02 | VIOXX tablett 25mg N14 | MSD | 50% | |||||||
2221 | rofekoksiib | M01AH02 | VIOXX tablett 25mg N28 | MSD | 50% | |||||||
2222 | rofekoksiib | M01AH02 | VIOXX tablett 25mg N7 | MSD | 50% | |||||||
2223 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N112 | GlaxoSmithKline | 50% | |||||||
2224 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N28 | GlaxoSmithKline | 50% | |||||||
2225 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N56 | GlaxoSmithKline | 50% | |||||||
2226 | rosiglitasoon | A10BG02 | AVANDIA tablett 4mg N7 | GlaxoSmithKline | 50% | |||||||
2227 | sakvinaviir | J05AE01 | FORTOVASE kapsel 200mg N180 | Roche | 50% | |||||||
2228 | salbutamool | R03AC02 | AIROMIR inhal aeros 100mcg/annuses 200annust N1 | 3M Health Care | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2229 | salbutamool | R03AC02 | BUVENTOL EASYHALER inhalatsioonipulber 100mcg/annuses 200annust N1 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2230 | salbutamool | R03AC02 | BUVENTOL EASYHALER inhalatsioonipulber 200mcg/annuses 200annust N1 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2231 | salbutamool | R03AC02 | ECOSAL EASI-BREATHE aerosool 0,1mg/annuses 200annust N1 | IVAX - CR a.s. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2232 | salbutamool | R03AC02 | ECOSAL EASI-BREATHE aerosool 0,1mg/annuses 200annust N3 | IVAX - CR a.s. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2233 | salbutamool | R03AC02 | ECOSAL inhal aeros 0,1mg/annuses 200annust N1 | IVAX - CR a.s. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2234 | salbutamool | R03AC02 | SALBUTAMOL NYCOMED inhal aeros 0,1mg/annuses 300annust N1 | Nycomed SEFA | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2235 | salbutamool | R03AC02 | VENTOLIN DISKUS inhalatsioonipulber 200mcg/annuses N60 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2236 | salbutamool | R03AC02 | VENTOLIN inhal aeros 0,1mg/annuses 200annust N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2237 | salbutamool | R03AC02 | VENTOLIN NEBULES inhalatsioonilahus 1mg/ml 2.5ml N20 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2238 | salbutamool | R03AC02 | VENTOLIN RESPIRATOR SOLUTION inhalatsioonilahus 5mg/ml 20ml N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2239 | salbutamool | R03CC02 | VENTOLIN SYRUP siirup 0,4mg/ml 150ml N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *ravimi esmaneväljakirjutamise õigus pediaatril ja pulmonoloogil; **rev
pulmono- loogil |
||||
2240 | salbutamool | R03CC02 | VOLMAX retardtablett 4mg 1TABL N14 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *ravimi esmaneväljakirjutamise õigus pediaatril ja pulmonoloogil; **rev
pulmono- loogil |
||||
2241 | salbutamool | R03CC02 | VOLMAX retardtablett 8mg 1TABL N14 | Byk Gulden | 50% | 75% | J45*; J43**; J44** | *ravimi esmaneväljakirjutamise õigus pediaatril ja pulmonoloogil; **rev
pulmono- loogil |
||||
2242 | salbutamool+ ipratroopium- bromiid |
R03AK81 | COMBIVENT inhal aeros 0,12mg+0,02mg/annuses 200annust N1 | Boehringer Ingelheim | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2243 | salitsüülhape | D01AE12 | PSORIMED lahus paikseks kasut. 10% 100ml N1 | Wolff | 50% | |||||||
2244 | salmeterool | R03AC12 | SEREVENT DISKUS 50 MCG inhalatsioonipulber 50mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2245 | salmeterool | R03AC12 | SEREVENT inhal aeros 0,025mg/annuses 120annust N1 | Glaxo Wellcome | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmono- loogil |
||||
2246 | salmeterool+flutikasoonpropionaat | R03AK82 | SERETIDE DISKUS 100 inhalatsioonipulber 50mcg+100mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rv alla 18.a lapsele, rev pediaatril ja pulmonoloogil | ||||
2247 | salmeterool+flutikasoonpropionaat | R03AK82 | SERETIDE DISKUS 250 inhalatsioonipulber 50mcg+250mcg/annuses 60annust N1 | Glaxo Wellcome | 50% | 75% | J45* | *rv alla 18.a lapsele, rev pediaatril ja pulmonoloogil | ||||
2248 | sanamiviir | J05AH01 | RELENZA inhalatsioonipulber 5mg N5 | Glaxo Wellcome | 50% | |||||||
2249 | selegiliin | N04BD01 | ELDEPRYL tablett 5mg N100 | Orion | 50% | |||||||
2250 | sertindool | N05AE03 | SERDOLECT tablett 12mg N100 | Lundbeck | 50% | |||||||
2251 | sertindool | N05AE03 | SERDOLECT tablett 12mg N28 | Lundbeck | 50% | |||||||
2252 | sertindool | N05AE03 | SERDOLECT tablett 16mg N100 | Lundbeck | 50% | |||||||
2253 | sertindool | N05AE03 | SERDOLECT tablett 16mg N28 | Lundbeck | 50% | |||||||
2254 | sertindool | N05AE03 | SERDOLECT tablett 20mg N100 | Lundbeck | 50% | |||||||
2255 | sertindool | N05AE03 | SERDOLECT tablett 20mg N28 | Lundbeck | 50% | |||||||
2256 | sertindool | N05AE03 | SERDOLECT tablett 4mg N100 | Lundbeck | 50% | |||||||
2257 | sertindool | N05AE03 | SERDOLECT tablett 4mg N30 | Lundbeck | 50% | |||||||
2258 | sertraliin | N06AB06 | ZOLOFT tablett 50mg N28 | Pfizer H.C.P. Corporation | 50% | |||||||
2259 | simvastatiin | C10AA01 | SIMGAL tablett 10mg N28 | IVAX - CR a.s. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2260 | simvastatiin | C10AA01 | SIMGAL tablett 20mg N28 | IVAX - CR a.s. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2261 | simvastatiin | C10AA01 | SIMGAL tablett 40mg N28 | IVAX - CR a.s. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2262 | simvastatiin | C10AA01 | SIMVOR tablett 10mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2263 | simvastatiin | C10AA01 | SIMVOR tablett 10mg N30 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2264 | simvastatiin | C10AA01 | SIMVOR tablett 10mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2265 | simvastatiin | C10AA01 | SIMVOR tablett 20mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2266 | simvastatiin | C10AA01 | SIMVOR tablett 20mg N30 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2267 | simvastatiin | C10AA01 | SIMVOR tablett 20mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2268 | simvastatiin | C10AA01 | SIMVOR tablett 40mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2269 | simvastatiin | C10AA01 | SIMVOR tablett 40mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2270 | simvastatiin | C10AA01 | SIMVOR tablett 5mg N10 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2271 | simvastatiin | C10AA01 | SIMVOR tablett 5mg N50 | Ranbaxy | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2272 | simvastatiin | C10AA01 | ZOCOR 10 MG tablett N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2273 | simvastatiin | C10AA01 | ZOCOR 10 MG tablett N14 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2274 | simvastatiin | C10AA01 | ZOCOR 20 MG tablett 20mg N14 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2275 | simvastatiin | C10AA01 | ZOCOR 20 MG tablett 20mg N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2276 | simvastatiin | C10AA01 | ZOCOR FORTE 40 tablett 40mg N14 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2277 | simvastatiin | C10AA01 | ZOCOR FORTE 40 tablett 40mg N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2278 | simvastatiin | C10AA01 | ZOCOR FORTE XL 80 MG tablett N28 | MSD | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2279 | simvastatiin | C10AA01 | VASILIP tablett 10mg N28 | KRKA, d.d. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2280 | simvastatiin | C10AA01 | VASILIP tablett 20mg N28 | KRKA, d.d. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2281 | simvastatiin | C10AA01 | VASILIP tablett 40mg N28 | KRKA, d.d. | 50% | 75% | E78*; I21*; I22*; I25.2*; Z45*; Z95* | *(5) | ||||
2282 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 150ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2283 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 1ml N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2284 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 2ml N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2285 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 5ml N30 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2286 | siroliimus | L04AA10 | RAPAMUNE ORAL SOLUTION suukaudne lahus 1mg/ml 60ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2287 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 16TÜ N1 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2288 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 16TÜ N5 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2289 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 36TÜ N1 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2290 | somatropiin | H01AC01 | GENOTROPIN injektsioonisubstants 36TÜ N5 | Pharmacia Enterprises | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2291 | somatropiin | H01AC01 | HUMATROPE injektsioonisubstants 16TÜ N1 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2292 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 18IU N1 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2293 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 18TÜ N10 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2294 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 18TÜ N5 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2295 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 36TÜ N1 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2296 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 36TÜ N10 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2297 | somatropiin | H01AC01 | HUMATROPE Pulber ja lahusti süstelahuse valmistamiseks 36TÜ N5 | Eli Lilly Export S.A. | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2298 | somatropiin | H01AC01 | NORDITROPIN 12IU injektsiooni- substants 12TÜ N1 |
Novo Nordisk | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2299 | somatropiin | H01AC01 | NORDITROPIN 4IU injektsiooni- substants 4TÜ N1 |
Novo Nordisk | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2300 | somatropiin | H01AC01 | NORDITROPIN PENSET 12 injektsiooni- substants 12TÜ N1 |
Novo Nordisk | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2301 | somatropiin | H01AC01 | SAIZEN 24 IU (8 MG) EASYJECT injektsiooni- substants 24TÜ N1 |
ARES TRADING SA | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2302 | somatropiin | H01AC01 | SAIZEN 24 IU (8 MG) EASYJECT injektsiooni- substants 24TÜ N5 |
ARES TRADING SA | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2303 | somatropiin | H01AC01 | ZOMACTON injektsiooni- substants 12 TÜ N1 |
Ferring GmbH | 50% | 100% | E23*; E89.3*; N18*; Q96* | *rv endokrino- loogil |
||||
2304 | sotalool | C07AA07 | LORITMIK 160 tablett 160mg N20 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2305 | sotalool | C07AA07 | LORITMIK 160 tablett 160mg N50 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2306 | sotalool | C07AA07 | LORITMIK 80 tablett 80mg N20 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2307 | sotalool | C07AA07 | LORITMIK 80 tablett 80mg N50 | KRKA, d.d. | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2308 | sotalool | C07AA07 | SOTAHEXAL 160 tablett 160mg N20 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2309 | sotalool | C07AA07 | SOTAHEXAL 160 tablett 160mg N50 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2310 | sotalool | C07AA07 | SOTAHEXAL 80 tablett 80mg N20 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2311 | sotalool | C07AA07 | SOTAHEXAL 80 tablett 80mg N50 | Hexal AG | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2312 | sotalool | C07AA07 | SOTALEX 160 tablett 160mg N30 | Bristol-Myers Squibb | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2313 | sotalool | C07AA07 | SOTALEX MITE tablett 80mg N30 | Bristol-Myers Squibb | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2314 | sotalool | C07AA07 | SOTALOL 160-SL tablett 160mg N100 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2315 | sotalool | C07AA07 | SOTALOL 160-SL tablett 160mg N20 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2316 | sotalool | C07AA07 | SOTALOL 80-SL tablett 80mg N100 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2317 | sotalool | C07AA07 | SOTALOL 80-SL tablett 80mg N20 | Slovakofarma | 50% | 75% | (I47-I49)* | *rv kardioloogil | ||||
2318 | spiramütsiin | J01FA02 | ROVAMYCINE tablett 1500000TÜ N16 | LABORATOIRE AVENTIS | 50% | |||||||
2319 | spiramütsiin | J01FA02 | ROVAMYCINE tablett 3000000TÜ N10 | LABORATOIRE AVENTIS | 50% | |||||||
2320 | spirapriil | C09AA11 | QUADROPRIL tablett 6mg N30 | AWD | 50% | |||||||
2321 | spironolaktoon | C03DA01 | SPIRIX 100 MG tablett 100mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
2322 | spironolaktoon | C03DA01 | SPIRIX 25 MG tablett 25mg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
2323 | spironolaktoon | C03DA01 | SPIRIX 25 MG tablett 25mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
2324 | spironolaktoon | C03DA01 | SPIRIX 25 MG tablett 25mg N60 | Nycomed SEFA | 50% | 75% | I50 | |||||
2325 | spironolaktoon | C03DA01 | SPIRIX 50 MG tablett 50mg N100 | Nycomed SEFA | 50% | 75% | I50 | |||||
2326 | spironolaktoon | C03DA01 | SPIRIX 50 MG tablett 50mg N20 | Nycomed SEFA | 50% | 75% | I50 | |||||
2327 | spironolaktoon | C03DA01 | SPIRONOLACTON- RATIOPHARM 50 tablett 50mg N100 | ratiopharm | 50% | 75% | I50 | |||||
2328 | spironolaktoon | C03DA01 | SPIRONOLACTON- RATIOPHARM 50 tablett 50mg N20 | ratiopharm | 50% | 75% | I50 | |||||
2329 | spironolaktoon | C03DA01 | SPIRONOLACTON- RATIOPHARM 50 tablett 50mg N50 | ratiopharm | 50% | 75% | I50 | |||||
2330 | spironolaktoon | C03DA01 | VEROSPIRON CAPSULES 100 MG kapsel 100mg N30 | Richter | 50% | 75% | I50 | |||||
2331 | spironolaktoon | C03DA01 | VEROSPIRON CAPSULES 50 MG kapsel 50mg N30 | Richter | 50% | 75% | I50 | |||||
2332 | spironolaktoon | C03DA01 | VEROSPIRON tablett 25mg N20 | Richter | 50% | 75% | I50 | |||||
2333 | stavudiin | J05AX04 | ZERIT kapsel 15mg N56 | Bristol-Myers Squibb | 50% | |||||||
2334 | stavudiin | J05AX04 | ZERIT kapsel 15mg N60 | Bristol-Myers Squibb | 50% | |||||||
2335 | stavudiin | J05AX04 | ZERIT kapsel 20mg N56 | Bristol-Myers Squibb | 50% | |||||||
2336 | stavudiin | J05AX04 | ZERIT kapsel 20mg N60 | Bristol-Myers Squibb | 50% | |||||||
2337 | stavudiin | J05AX04 | ZERIT kapsel 30mg N56 | Bristol-Myers Squibb | 50% | |||||||
2338 | stavudiin | J05AX04 | ZERIT kapsel 30mg N60 | Bristol-Myers Squibb | 50% | |||||||
2339 | stavudiin | J05AX04 | ZERIT kapsel 40mg N56 | Bristol-Myers Squibb | 50% | |||||||
2340 | stavudiin | J05AX04 | ZERIT kapsel 40mg N60 | Bristol-Myers Squibb | 50% | |||||||
2341 | stavudiin | J05AX04 | ZERIT pulber lahuseks 1mgml 200ml N1 | Bristol-Myers Squibb | 50% | |||||||
2342 | suklopentiksool | N05AF05 | CISORDINOL DEPOT süstelahus 200mg/ml 1ml N1 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2343 | suklopentiksool | N05AF05 | CISORDINOL DEPOT süstelahus 200mg/ml 1ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2344 | suklopentiksool | N05AF05 | CISORDINOL DEPOT süstelahus 500mg/ml 1ml N5 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2345 | suklopentiksool | N05AF05 | CISORDINOL tablett 10mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2346 | suklopentiksool | N05AF05 | CISORDINOL tablett 25mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2347 | suklopentiksool | N05AF05 | CISORDINOL tablett 2mg N100 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2348 | suklopentiksool | N05AF05 | CISORDINOL tablett 2mg N50 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2349 | suklopentiksool | N05AF05 | CISORDINOL-ACUTARD süstelahus 50mg/ml 1ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2350 | suklopentiksool | N05AF05 | CISORDINOL-ACUTARD süstelahus 50mg/ml 2ml N10 | Lundbeck | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2351 | sulfadiasiinhõbe | D06BA01 | DERMAZIN 1% CREAM kreem 1% 50g N1 | LEK d.d | 50% | |||||||
2352 | sulfadiasiinhõbe | D06BA01 | SULFARGIN salv 1%/g 50g N1 | TFT | 50% | |||||||
2353 | sulfadimetoksiin | J01ED01 | SULFADIMETOXIN tablett 500mg N10 | TFT | 50% | |||||||
2354 | sulfametoksasool+trimetoprim | J01EE01 | APO-SULFATRIM tablett 400mg+80mg N20 | Apotex | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2355 | sulfametoksasool+trimetoprim | J01EE01 | APO-SULFATRIM tablett 400mg+80mg N40 | Apotex | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2356 | sulfametoksasool+trimetoprim | J01EE01 | BACTRIM FORTE tablett 800mg+160mg N10 | Roche | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2357 | sulfametoksasool+trimetoprim | J01EE01 | BACTRIM SYRUP siirup 40mg+8mgml 100ml N1 | Roche | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2358 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 240 suspensioon 40mg+8mgml 100ml N1 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2359 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 480 suspensioon 80mg+16mgml 100ml N1 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2360 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 480 tablett 400mg+80mg N20 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2361 | sulfametoksasool+trimetoprim | J01EE01 | BERLOCID 960 tablett 800mg+160mg N20 | Berlin-Chemie | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2362 | sulfametoksasool+trimetoprim | J01EE01 | CO-TRIMOXAZOLE 480 MG tablett 400mg+80mg N20 | Ilsanta | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2363 | sulfametoksasool+trimetoprim | J01EE01 | CO-TRIMOXAZOLS tablett 400mg+80mg N20 | Grindeks | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2364 | sulfametoksasool+trimetoprim | J01EE01 | CO-TRIMOXAZOLS tablett 400mg+80mg N40 | Grindeks | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2365 | sulfametoksasool+trimetoprim | J01EE01 | SULFOTRIM tablett 400mg+80mg N100 | Bristol-Myers Squibb | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2366 | sulfametoksasool+trimetoprim | J01EE01 | SULFOTRIM tablett 400mg+80mg N20 | Bristol-Myers Squibb | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2367 | sulfametrool+trimetoprim | J01EE03 | LIDAPRIM FORTE tablett 800mg+160mg N10 | Nycomed SEFA | 50% | |||||||
2368 | sulfametrool+trimetoprim | J01EE03 | LIDAPRIM SUSPENSIOON suspensioon 40mg+8mgml 100ml N1 | Nycomed SEFA | 50% | |||||||
2369 | sulfametrool+trimetoprim | J01EE03 | LIDAPRIM tablett 400mg+80mg N20 | Nycomed SEFA | 50% | |||||||
2370 | sulfasalasiin | A07EC01 | SALAZOPYRIN enterotablett 500mg N100 | Pharmacia Enterprises | 50% | 75% | K50*; K51*;M05**; M06**; M08**; M45**; M46** | *rv gastroenteroloogil; **rv reumatoloogil | ||||
2371 | sulpiriid | N05AL01 | BETAMAKS tablett 100mg N30 | Grindeks | 50% | |||||||
2372 | sulpiriid | N05AL01 | BETAMAKS tablett 200mg N30 | Grindeks | 50% | |||||||
2373 | sulpiriid | N05AL01 | BETAMAKS tablett 50mg N30 | Grindeks | 50% | |||||||
2374 | sulpiriid | N05AL01 | EGLONYL kapsel 50mg N30 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
2375 | sulpiriid | N05AL01 | EGLONYL tablett 200mg N12 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
2376 | sulpiriid | N05AL01 | EGLONYL tablett 200mg N60 | LABORATOIRES SYNTHELABO/ | 50% | |||||||
2377 | sultamitsilliin | J01CR04 | UNASYN suspensioonigraanulid 50mgml 30ml N1 | Pfizer H.C.P. Corporation | 50% | |||||||
2378 | sultamitsilliin | J01CR04 | UNASYN tablett 375mg N12 | Pfizer H.C.P. Corporation | 50% | |||||||
2379 | sumatriptaan | N02CC01 | IMIGRAN ninasprei 20mg/annuses N1 | Glaxo Wellcome | 50% | |||||||
2380 | sumatriptaan | N02CC01 | IMIGRAN tablett 100mg N2 | Glaxo Wellcome | 50% | |||||||
2381 | sumatriptaan | N02CC01 | IMIGRAN tablett 50mg N2 | Glaxo Wellcome | 50% | |||||||
2382 | zafirlukast | R03DC01 | ACCOLATE tablett 20mg 1TABL N28 | AstraZeneca UK Ltd. | 50% | |||||||
2383 | zafirlukast | R03DC01 | ACCOLATE tablett 20mg 1TABL N56 | AstraZeneca UK Ltd. | 50% | |||||||
2384 | zafirlukast | R03DC01 | ACCOLATE tablett 40mg 1TABL N28 | AstraZeneca UK Ltd. | 50% | |||||||
2385 | zafirlukast | R03DC01 | ACCOLATE tablett 40mg 1TABL N56 | AstraZeneca UK Ltd. | 50% | |||||||
2386 | zidovudiin | J05AB05 | RETROVIR CAPSULES 100 MG kapsel 100mg N100 | Glaxo Wellcome | 50% | 100% | (B20-B24)*; Z20.6*; Z21* | *rv patsienti jälgival ja ravival infektsionistil | ||||
2387 | zolmitriptaan | N02CC03 | ZOMIG tablett 2,5mg N18 | AstraZeneca UK Ltd. | 50% | |||||||
2388 | zolmitriptaan | N02CC03 | ZOMIG tablett 2,5mg N3 | AstraZeneca UK Ltd. | 50% | |||||||
2389 | zolmitriptaan | N02CC03 | ZOMIG tablett 2,5mg N6 | AstraZeneca UK Ltd. | 50% | |||||||
2390 | tamoksifeen | L02BA01 | NOLVADEX D tablett 20mg N30 | AstraZeneca UK Ltd. | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2391 | tamoksifeen | L02BA01 | NOLVADEX tablett 10mg N30 | AstraZeneca UK Ltd. | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2392 | tamoksifeen | L02BA01 | ZITAZONIUM 20 MG tablett 20mg N30 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2393 | tamoksifeen | L02BA01 | ZITAZONIUM 20 MG tablett 20mg N60 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2394 | tamoksifeen | L02BA01 | ZITAZONIUM 30 MG tablett 30mg N30 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2395 | tamoksifeen | L02BA01 | ZITAZONIUM 40 MG tablett 40mg N30 | Egis | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2396 | tamoksifeen | L02BA01 | TAMOFEN tablett 10mg N100 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2397 | tamoksifeen | L02BA01 | TAMOFEN tablett 10mg N30 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2398 | tamoksifeen | L02BA01 | TAMOFEN tablett 20mg N100 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2399 | tamoksifeen | L02BA01 | TAMOFEN tablett 20mg N30 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2400 | tamoksifeen | L02BA01 | TAMOFEN tablett 30mg N100 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2401 | tamoksifeen | L02BA01 | TAMOFEN tablett 30mg N30 | Leiras | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2402 | tamoksifeen | L02BA01 | TAMOXIFEN-EBEWE tablett 10mg N30 | Ebewe | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2403 | tamoksifeen | L02BA01 | TAMOXIFEN-EBEWE tablett 20mg N30 | Ebewe | 50% | 100% | (C00-D48)* | *rv hematoloogil, onkoloogil ja uroloogil | ||||
2404 | tamsulosiin | G04CA02 | OMNIC retardkapsel 0,4mg N30 | Yamanouchi | 50% | |||||||
2405 | tamsulosiin | G04CA02 | OMNIC retardkapsel 0,4mg N90 | Yamanouchi | 50% | |||||||
2406 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N14 | Boehringer Ingelheim | 50% | |||||||
2407 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N28 | Boehringer Ingelheim | 50% | |||||||
2408 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N56 | Boehringer Ingelheim | 50% | |||||||
2409 | telmisartaan | C09CA07 | MICARDIS 20 MG tablett 20mg N98 | Boehringer Ingelheim | 50% | |||||||
2410 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N14 | Boehringer Ingelheim | 50% | |||||||
2411 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N28 | Boehringer Ingelheim | 50% | |||||||
2412 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N56 | Boehringer Ingelheim | 50% | |||||||
2413 | telmisartaan | C09CA07 | MICARDIS 40 MG tablett 40mg N98 | Boehringer Ingelheim | 50% | |||||||
2414 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N14 | Boehringer Ingelheim | 50% | |||||||
2415 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N28 | Boehringer Ingelheim | 50% | |||||||
2416 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N56 | Boehringer Ingelheim | 50% | |||||||
2417 | telmisartaan | C09CA07 | MICARDIS 80 MG tablett 80mg N98 | Boehringer Ingelheim | 50% | |||||||
2418 | telmisartaan | C09CA07 | PRITOR tablett 20mg N14 | Glaxo Wellcome | 50% | |||||||
2419 | telmisartaan | C09CA07 | PRITOR tablett 20mg N28 | Glaxo Wellcome | 50% | |||||||
2420 | telmisartaan | C09CA07 | PRITOR tablett 20mg N56 | Glaxo Wellcome | 50% | |||||||
2421 | telmisartaan | C09CA07 | PRITOR tablett 20mg N98 | Glaxo Wellcome | 50% | |||||||
2422 | telmisartaan | C09CA07 | PRITOR tablett 40mg N14 | Glaxo Wellcome | 50% | |||||||
2423 | telmisartaan | C09CA07 | PRITOR tablett 40mg N28 | Glaxo Wellcome | 50% | |||||||
2424 | telmisartaan | C09CA07 | PRITOR tablett 40mg N280 | Glaxo Wellcome | 50% | |||||||
2425 | telmisartaan | C09CA07 | PRITOR tablett 40mg N56 | Glaxo Wellcome | 50% | |||||||
2426 | telmisartaan | C09CA07 | PRITOR tablett 40mg N98 | Glaxo Wellcome | 50% | |||||||
2427 | telmisartaan | C09CA07 | PRITOR tablett 80mg N14 | Glaxo Wellcome | 50% | |||||||
2428 | telmisartaan | C09CA07 | PRITOR tablett 80mg N28 | Glaxo Wellcome | 50% | |||||||
2429 | telmisartaan | C09CA07 | PRITOR tablett 80mg N280 | Glaxo Wellcome | 50% | |||||||
2430 | telmisartaan | C09CA07 | PRITOR tablett 80mg N56 | Glaxo Wellcome | 50% | |||||||
2431 | telmisartaan | C09CA07 | PRITOR tablett 80mg N98 | Glaxo Wellcome | 50% | |||||||
2432 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 200mg 1TABL N100 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2433 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 200mg 1TABL N30 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2434 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 300mg 1TABL N100 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2435 | teofülliin | R03DA04 | RETAFYLLIN retardtablett 300mg 1TABL N30 | Orion | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2436 | teofülliin | R03DA04 | TEOTARD retardkapsel 200mg N40 | KRKA, d.d. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2437 | teofülliin | R03DA04 | TEOTARD retardkapsel 350mg N40 | KRKA, d.d. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2438 | terbinafiin | D01AE15 | LAMISIL DERMGEL geel 1% 15g N1 | Novartis Consumer Health | 50% | |||||||
2439 | terbinafiin | D01AE15 | LAMISIL DERMGEL geel 1% 30g N1 | Novartis Consumer Health | 50% | |||||||
2440 | terbinafiin | D01AE15 | LAMISIL DERMGEL geel 1% 5g N1 | Novartis Consumer Health | 50% | |||||||
2441 | terbinafiin | D01AE15 | LAMISIL kreem 1% 15g N1 | Novartis Consumer Health | 50% | |||||||
2442 | terbinafiin | D01AE15 | LAMISIL lahus paikseks kasut. 1% 15 ml N1 | Novartis Consumer Health | 50% | |||||||
2443 | terbinafiin | D01AE15 | LAMISIL lahus paikseks kasut. 1% 30ml N1 | Novartis Consumer Health | 50% | |||||||
2444 | terbinafiin | D01AE15 | LAMISIL nahasprei 1% 30ml N1 | Novartis Consumer Health | 50% | |||||||
2445 | terbinafiin | D01AE15 | TERBISIL 1% KREEM kreem 1%/g 15g N1 | Richter | 50% | |||||||
2446 | terbinafiin | D01AE15 | TERBISIL tablett 250 mg N14 | Richter | 50% | |||||||
2447 | terbinafiin | D01AE15 | TERBISIL tablett 250 mg N28 | Richter | 50% | |||||||
2448 | terbinafiin | D01AE15 | TERBISIL tablett 125 mg N14 | Richter | 50% | |||||||
2449 | terbinafiin | D01BA02 | LAMISIL tablett 125mg N28 | Novartis Pharma | 50% | |||||||
2450 | terbinafiin | D01BA02 | LAMISIL tablett 250mg N14 | Novartis Pharma | 50% | |||||||
2451 | terbinafiin | D01BA02 | LAMISIL tablett 250mg N28 | Novartis Pharma | 50% | |||||||
2452 | terbutaliin | R03AC03 | BRICANYL inhal aeros 0,25mg/annuses 400annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2453 | terbutaliin | R03AC03 | BRICANYL TURBUHALER inhalatsioonipulber 0,5mg/annuses 200annust N1 | AstraZeneca UK Ltd. | 50% | 75% | J45*; J43**; J44** | *rev pediaatril ja pulmonoloogil; **rev pulmonoloogil | ||||
2454 | terfenadiin | R06AX12 | HISFEDIN SAFT suspensioon 6mg/ml 120ml N1 | Wolff | 50% | |||||||
2455 | terfenadiin | R06AX12 | HISFEDIN tablett 60mg N100 | Wolff | 50% | |||||||
2456 | terfenadiin | R06AX12 | HISFEDIN tablett 60mg N20 | Wolff | 50% | |||||||
2457 | terfenadiin | R06AX12 | HISFEDIN tablett 60mg N50 | Wolff | 50% | |||||||
2458 | terfenadiin | R06AX12 | TERIDIN FORTE tablett 120mg N20 | KRKA, d.d. | 50% | |||||||
2459 | terfenadiin | R06AX12 | TERIDIN suspensioon 6mg/ml 100ml N1 | KRKA, d.d. | 50% | |||||||
2460 | terfenadiin | R06AX12 | TERIDIN tablett 60mg N20 | KRKA, d.d. | 50% | |||||||
2461 | testosteroon | G03BA03 | PANTESTON kapsel 40mg N60 | N.V. ORGANON | 50% | 100% | (C00-D48)*; E23**; E29.1**; E89.5**; Q98** | *rv hematoloogil, onkoloogil ja uroloogil; **rv endokrinoloogil ja günekoloogil | ||||
2462 | testosteroon | G03BA03 | SUSTANON “250" süstelahus 250mgml 1ml N1 | N.V. ORGANON | 50% | 100% | (C00-D48)*; E23**; E29.1**; E89.5**; Q98** | *rv hematoloogil, onkoloogil ja uroloogil; **rv endokrinoloogil ja günekoloogil | ||||
2463 | tetratsükliin | D06AA04 | IMEX salv 3% 20g N1 | Merz+Co | 50% | |||||||
2464 | tetratsükliin | J01AA07 | TETRACYCLIN NYCOMED tablett 250mg N24 | Nycomed SEFA | 50% | 100% | (A50-A53)* | *rv dermatovene- roloogil |
||||
2465 | tetratsükliin | S01AA09 | TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT 1% silmasalv 1% 5g | Troge | 50% | |||||||
2466 | tianeptiin | N06AA80 | COAXIL tablett 12,5mg N30 | Servier | 50% | |||||||
2467 | tiboloon | G03DC05 | LIVIAL tablett 2,5mg N28 | N.V. ORGANON | 50% | |||||||
2468 | tiboloon | G03DC05 | LIVIAL tablett 2,5mg N84 | N.V. ORGANON | 50% | |||||||
2469 | tiklopidiin | B01AC05 | APO-TICLOPIDINE tablett 250 mg N30 | Apotex | 50% | |||||||
2470 | tiklopidiin | B01AC05 | APO-TICLOPIDINE tablett 250 mg N60 | Apotex | 50% | |||||||
2471 | tiklopidiin | B01AC05 | TICLOPIN tablett 250 mg N30 | Nycomed SEFA | 50% | |||||||
2472 | tiklopidiin | B01AC05 | TICLOPIN tablett 250 mg N60 | Nycomed SEFA | 50% | |||||||
2473 | tiklopidiin | B01AC05 | TAGREN tablett 250mg N30 | KRKA, d.d. | 50% | |||||||
2474 | tiklopidiin | B01AC05 | TICLID tablett 250mg N20 | Sanofi | 50% | |||||||
2475 | tiklopidiin | B01AC05 | TICLOPIDIN-RATIOPHARM tablett 250mg N30 | ratiopharm | 50% | |||||||
2476 | tiklopidiin | B01AC05 | TICLOPIDIN-RATIOPHARM tablett 250mg N90 | ratiopharm | 50% | |||||||
2477 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,25% 5 ml N1 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2478 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,25% 5 ml N3 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2479 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,5% 5ml N1 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2480 | timolool | S01ED01 | ARUTIMOL silmatilgad 0,5% 5ml N3 | ANKERPHARM | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2481 | timolool | S01ED01 | NYOLOL silmatilgad 0,25% 3ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2482 | timolool | S01ED01 | NYOLOL silmatilgad 0,25% 5ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2483 | timolool | S01ED01 | NYOLOL silmatilgad 0,5% 3ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2484 | timolool | S01ED01 | NYOLOL silmatilgad 0,5% 5ml N1 | NOVARTIS Ophthalmics | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2485 | timolool | S01ED01 | OFTAN TIMOLOL silmatilgad 0,25% 5ml N1 | Santen | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2486 | timolool | S01ED01 | OFTAN TIMOLOL silmatilgad 0,5% 5ml N1 | Santen | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2487 | timolool | S01ED01 | TIMOPTIC 0,25% silmatilgad 0,25% 5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2488 | timolool | S01ED01 | TIMOPTIC 0,5% silmatilgad 0,5% 5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2489 | timolool | S01ED01 | TIMOPTIC XE silmatilgad 0,25% 2.5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2490 | timolool | S01ED01 | TIMOPTIC XE silmatilgad 0,5% 2.5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2491 | timolool | S01ED01 | TIMOSAN silmageel 0,1% 5g N1 | Santen | 50% | 100% | (H40-H42)* | *rev oftalmoloogil | ||||
2492 | timolool+dorsolamiid | S01ED80 | COSOPT silmatilgad 2%+0,5% 5ml N1 | MSD | 50% | 100% | (H40-H42)* | *rv oftalmoloogil, kombinatsioonpreparaate kasutatakse juhul, kui monoteraapia beeta-adrenoblokaatori, lokaalse karboanhüdraasi inhibiitori või prostaglandiini analoogiga ei ole langetanud piisavalt siserõhku | ||||
2493 | tinsapariin | B01AB10 | INNOHEP 10000 ANTI-XA IU/0,5 ML SYRINGES süstelahus 20000TÜ anti Xa/ml 0.5ml N2 | Leo | 50% | 75% | O99.8 | |||||
2494 | tinsapariin | B01AB10 | INNOHEP 10000 ANTI-XA IU/ML VIALS 2 ML süstelahus 10000TÜ anti Xa/ml 2ml N1 | Leo | 50% | 75% | O99.8 | |||||
2495 | tinsapariin | B01AB10 | INNOHEP 10000 ANTI-XA IU/ML VIALS 2 ML süstelahus 10000TÜ anti Xa/ml 2ml N10 | Leo | 50% | 75% | O99.8 | |||||
2496 | tinsapariin | B01AB10 | INNOHEP 14000 ANTI-XA IU/0,7 ML SYRINGES süstelahus 20000TÜ anti Xa/ml 0.7ml N2 | Leo | 50% | 75% | O99.8 | |||||
2497 | tinsapariin | B01AB10 | INNOHEP 18000 ANTI-XA IU/0,9 ML SYRINGES süstelahus 20000TÜ anti Xa/ml 0.9ml N2 | Leo | 50% | 75% | O99.8 | |||||
2498 | tinsapariin | B01AB10 | INNOHEP 20000 ANTI-XA IU/ML VIALS 2 ML süstelahus 20000TÜ anti Xa/ml 2ml N1 | Leo | 50% | 75% | O99.8 | |||||
2499 | tinsapariin | B01AB10 | INNOHEP 20000 ANTI-XA IU/ML VIALS 2 ML süstelahus 20000TÜ anti Xa/ml 2ml N10 | Leo | 50% | 75% | O99.8 | |||||
2500 | tinsapariin | B01AB10 | INNOHEP 2500 ANTI-XA IU/0,25 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.25ml N10 | Leo | 50% | 75% | O99.8 | |||||
2501 | tinsapariin | B01AB10 | INNOHEP 3500 ANTI-XA IU/0,35 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.35ml N10 | Leo | 50% | 75% | O99.8 | |||||
2502 | tinsapariin | B01AB10 | INNOHEP 3500 ANTI-XA IU/0,35 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.35ml N2 | Leo | 50% | 75% | O99.8 | |||||
2503 | tinsapariin | B01AB10 | INNOHEP 4500 ANTI-XA IU/0,45 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.45ml N10 | Leo | 50% | 75% | O99.8 | |||||
2504 | tinsapariin | B01AB10 | INNOHEP 4500 ANTI-XA IU/0,45 ML SYRINGES süstelahus 10000TÜ anti Xa/ml 0.45ml N2 | Leo | 50% | 75% | O99.8 | |||||
2505 | tioguaniin | L01BB03 | LANVIS tablett 40mg N25 | Glaxo Wellcome | 50% | |||||||
2506 | tioridasiin | N05AC02 | MELLERIL tablett 100mg N30 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)* (F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2507 | tioridasiin | N05AC02 | MELLERIL tablett 10mg N30 | Novartis Pharma | 50% | 100% | (F00-F09)*; (F10-F19.4-7)*
(F20-F29)* (F30-F31)* (F32/33.2-3)* F60.3* (F70-F79)* |
*rev psühhiaatril | ||||
2508 | tisanidiin | M03BX02 | SIRDALUD tablett 2mg N30 | Novartis Pharma | 50% | 75% | G81; G82 | |||||
2509 | tisanidiin | M03BX02 | SIRDALUD tablett 4mg N30 | Novartis Pharma | 50% | 75% | G81; G82 | |||||
2510 | tobramütsiin | S01AA12 | TOBREX silmasalv 3% 3.5g N1 | Alcon | 50% | |||||||
2511 | tobramütsiin | S01AA12 | TOBREX silmatilgad 0,3% 5 ml N1 | Alcon | 50% | |||||||
2512 | toitained ilma fenüül- alaniinita |
V06CA80 | XP ANALOG pulber 400g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2513 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMAID (ORANGE FLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2514 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMAID (UNFLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2515 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMUM (ORANGE FLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2516 | toitained ilma fenüül- alaniinita |
V06CA80 | XP MAXAMUM (UNFLAVOURED) pulber 500g N4 | SHS International | 50% | 100% | E70.0; E70.1 | |||||
2517 | tolfenaamhape | M01AG02 | CLOTAM tablett 200mg N100 | Bristol-Myers Squibb | 50% | |||||||
2518 | tolfenaamhape | M01AG02 | CLOTAM tablett 200mg N20 | Bristol-Myers Squibb | 50% | |||||||
2519 | tolfenaamhape | M01AG02 | CLOTAM tablett 200mg N50 | Bristol-Myers Squibb | 50% | |||||||
2520 | tolterodiin | G04BD07 | DETRUSITOL 1 MG tablett 1mg N28 | Pharmacia Enterprises | 50% | |||||||
2521 | tolterodiin | G04BD07 | DETRUSITOL 1 MG tablett 1mg N56 | Pharmacia Enterprises | 50% | |||||||
2522 | tolterodiin | G04BD07 | DETRUSITOL 2 MG tablett 2mg N28 | Pharmacia Enterprises | 50% | |||||||
2523 | tolterodiin | G04BD07 | DETRUSITOL 2 MG tablett 2mg N56 | Pharmacia Enterprises | 50% | |||||||
2524 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsio- naalsetele antiepileptilistele ravimitele resistentse epilepsia näidustustel |
||||
2525 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2526 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2527 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2528 | topiramaat | N03AX11 | TOPAMAX TABLETS 200 MG tablett 200mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2529 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2530 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2531 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2532 | topiramaat | N03AX11 | TOPAMAX TABLETS 400 MG tablett 400mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2533 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2534 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2535 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2536 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2537 | topiramaat | N03AX11 | TOPAMAX TABLETS 50 MG tablett 50mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2538 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2539 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2540 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2541 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2542 | topiramaat | N03AX11 | TOPAMAX TABLETS 100 MG tablett 100mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2543 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2544 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2545 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N28 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2546 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2547 | topiramaat | N03AX11 | TOPAMAX TABLETS 25 MG tablett 25mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2548 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N100 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2549 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N20 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2550 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N50 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2551 | topiramaat | N03AX11 | TOPAMAX TABLETS 300MG tablett 300mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2552 | topiramaat | N03AX11 | TOPAMAX SPRINKLE CAPSULES 15 MG kapsel 15mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2553 | topiramaat | N03AX11 | TOPAMAX SPRINKLE CAPSULES 25MG kapsel 25mg N60 | Cilag | 50% | 100% | G40* | *rv neuroloogil alla 18-aastasele lapsele ning täiskasvanule rev neuroloogil
konventsionaalsetele antiepilepti- listele ravimitele resistentse epilepsia näidustustel |
||||
2554 | torasemiid | C03CA04 | TRIFAS 10 tablett 10mg N100 | Berlin-Chemie | 50% | |||||||
2555 | torasemiid | C03CA04 | TRIFAS 10 tablett 10mg N30 | Berlin-Chemie | 50% | |||||||
2556 | torasemiid | C03CA04 | TRIFAS 10 tablett 10mg N50 | Berlin-Chemie | 50% | |||||||
2557 | torasemiid | C03CA04 | TRIFAS 200 tablett 200mg N100 | Berlin-Chemie | 50% | |||||||
2558 | torasemiid | C03CA04 | TRIFAS 200 tablett 200mg N30 | Berlin-Chemie | 50% | |||||||
2559 | torasemiid | C03CA04 | TRIFAS 200 tablett 200mg N50 | Berlin-Chemie | 50% | |||||||
2560 | torasemiid | C03CA04 | TRIFAS COR tablett 5mg N100 | Berlin-Chemie | 50% | |||||||
2561 | torasemiid | C03CA04 | TRIFAS COR tablett 5mg N30 | Berlin-Chemie | 50% | |||||||
2562 | torasemiid | C03CA04 | TRIFAS COR tablett 5mg N50 | Berlin-Chemie | 50% | |||||||
2563 | tramadool | N02AX02 | ADAMON SR 100 MG retardkapsel 100mg N20 | Asta Medica | 50% | |||||||
2564 | tramadool | N02AX02 | ADAMON SR 150 MG retardkapsel 150mg N20 | Asta Medica | 50% | |||||||
2565 | tramadool | N02AX02 | ADAMON SR 200 MG retardkapsel 200mg N20 | Asta Medica | 50% | |||||||
2566 | tramadool | N02AX02 | ADAMON SR 50 MG retardkapsel 50mg N20 | Asta Medica | 50% | |||||||
2567 | tramadool | N02AX02 | DOLOL kapsel 50mg N20 | Nycomed SEFA | 50% | |||||||
2568 | tramadool | N02AX02 | DOLOL kapsel 50mg N30 | Nycomed SEFA | 50% | |||||||
2569 | tramadool | N02AX02 | DOLOL kapsel 50mg N60 | Nycomed SEFA | 50% | |||||||
2570 | tramadool | N02AX02 | LANALGET RETARD 150 MG TAB retardtablett 150 mg N10 | Lannacher | 50% | |||||||
2571 | tramadool | N02AX02 | LANALGET RETARD 150 MG TAB retardtablett 150 mg N30 | Lannacher | 50% | |||||||
2572 | tramadool | N02AX02 | LANALGET RETARD 200 MG TAB retardtablett 200 mg N10 | Lannacher | 50% | |||||||
2573 | tramadool | N02AX02 | LANALGET RETARD 200 MG TAB retardtablett 200 mg N30 | Lannacher | 50% | |||||||
2574 | tramadool | N02AX02 | MABRON kapsel 50mg N10 | Medochemie | 50% | |||||||
2575 | tramadool | N02AX02 | MABRON kapsel 50mg N20 | Medochemie | 50% | |||||||
2576 | tramadool | N02AX02 | PROTRADON kapsel 50mg N10 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2577 | tramadool | N02AX02 | PROTRADON kapsel 50mg N20 | PRO. MED. CS. PRAHA a.s. | 50% | |||||||
2578 | tramadool | N02AX02 | TRAMADOL 100-SLOVAKOFARMA suposiit 100mg N10 | Slovakofarma | 50% | |||||||
2579 | tramadool | N02AX02 | TRAMADOL 50 STADA kapsel 50mg N10 | Stada | 50% | |||||||
2580 | tramadool | N02AX02 | TRAMADOL 50 STADA kapsel 50mg N30 | Stada | 50% | |||||||
2581 | tramadool | N02AX02 | TRAMADOL 50 STADA kapsel 50mg N50 | Stada | 50% | |||||||
2582 | tramadool | N02AX02 | TRAMADOL 50-SLOVAKOFARMA kapsel 50mg N10 | Slovakofarma | 50% | |||||||
2583 | tramadool | N02AX02 | TRAMADOL 50-SLOVAKOFARMA kapsel 50mg N20 | Slovakofarma | 50% | |||||||
2584 | tramadool | N02AX02 | TRAMADOL kapsel 50mg N20 | KRKA, d.d. | 50% | |||||||
2585 | tramadool | N02AX02 | TRAMADOL ALPHARMA CAPSULES 50 MG kapslid 50 mg N30 | ALPHARMA | 50% | |||||||
2586 | tramadool | N02AX02 | TRAMADOL LANNACHER retardtablett 100mg N10 | Lannacher | 50% | |||||||
2587 | tramadool | N02AX02 | TRAMADOL LANNACHER retardtablett 100mg N30 | Lannacher | 50% | |||||||
2588 | tramadool | N02AX02 | TRAMADOL LANNACHER SOL. tilgad 100mg/ml 10ml N1 | Lannacher | 50% | |||||||
2589 | tramadool | N02AX02 | TRAMADOL LANNACHER SUPP. suposiit 100mg N5 | Lannacher | 50% | |||||||
2590 | tramadool | N02AX02 | TRAMADOL LANNACHER tablett 50mg N1000 | Lannacher | 50% | |||||||
2591 | tramadool | N02AX02 | TRAMADOL LANNACHER tablett 50mg N1100 | Lannacher | 50% | |||||||
2592 | tramadool | N02AX02 | TRAMADOL LANNACHER tablett 50mg N20 | Lannacher | 50% | |||||||
2593 | tramadool | N02AX02 | TRAMADOL RETARD retardtablett 100mg N30 | KRKA, d.d. | 50% | |||||||
2594 | tramadool | N02AX02 | TRAMADOL- SLOVAKOFARMA suukaudne lahus 100mg/ml 10ml N1 | Slovakofarma | 50% | |||||||
2595 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 100ml N1 | Stada | 50% | |||||||
2596 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 10ml N1 | Stada | 50% | |||||||
2597 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 20ml N1 | Stada | 50% | |||||||
2598 | tramadool | N02AX02 | TRAMADOL STADA lahus 100mg/ml 50ml N1 | Stada | 50% | |||||||
2599 | tramadool | N02AX02 | TRAMADOL suposiit 100mg N5 | KRKA, d.d. | 50% | |||||||
2600 | tramadool | N02AX02 | TRAMADOL tilgad 100mg/ml 10ml N1 | KRKA, d.d. | 50% | |||||||
2601 | tramadool | N02AX02 | TRAMADOL tilgad 100mg/ml 96ml N1 | KRKA, d.d. | 50% | |||||||
2602 | tramadool | N02AX02 | TRAMAL kapsel 50mg N20 | Grünenthal GmbH | 50% | |||||||
2603 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N10 | Grünenthal GmbH | 50% | |||||||
2604 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N20 | Grünenthal GmbH | 50% | |||||||
2605 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N30 | Grünenthal GmbH | 50% | |||||||
2606 | tramadool | N02AX02 | TRAMAL lahustuv tablett 50mg N50 | Grünenthal GmbH | 50% | |||||||
2607 | tramadool | N02AX02 | TRAMAL RETARD 100 MG retardtablett 100mg N10 | Grünenthal GmbH | 50% | |||||||
2608 | tramadool | N02AX02 | TRAMAL RETARD 100 MG retardtablett 100mg N30 | Grünenthal GmbH | 50% | |||||||
2609 | tramadool | N02AX02 | TRAMAL RETARD 100 MG retardtablett 100mg N50 | Grünenthal GmbH | 50% | |||||||
2610 | tramadool | N02AX02 | TRAMAL RETARD 150 MG retardtablett 150mg N10 | Grünenthal GmbH | 50% | |||||||
2611 | tramadool | N02AX02 | TRAMAL RETARD 150 MG retardtablett 150mg N30 | Grünenthal GmbH | 50% | |||||||
2612 | tramadool | N02AX02 | TRAMAL RETARD 150 MG retardtablett 150mg N50 | Grünenthal GmbH | 50% | |||||||
2613 | tramadool | N02AX02 | TRAMAL RETARD 200 MG retardtablett 200mg N10 | Grünenthal GmbH | 50% | |||||||
2614 | tramadool | N02AX02 | TRAMAL RETARD 200 MG retardtablett 200mg N30 | Grünenthal GmbH | 50% | |||||||
2615 | tramadool | N02AX02 | TRAMAL RETARD 200 MG retardtablett 200mg N50 | Grünenthal GmbH | 50% | |||||||
2616 | tramadool | N02AX02 | TRAMAL suposiit 100mg N5 | Grünenthal GmbH | 50% | |||||||
2617 | tramadool | N02AX02 | TRAMAL tilgad 100mg/ml 10ml N1 | Grünenthal GmbH | 50% | |||||||
2618 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N10 | Mundipharma Austria | 50% | |||||||
2619 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N20 | Mundipharma Austria | 50% | |||||||
2620 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N30 | Mundipharma Austria | 50% | |||||||
2621 | tramadool | N02AX02 | TRAMUNDIN RETARD retardtablett 100mg N50 | Mundipharma Austria | 50% | |||||||
2622 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N100 | Abbott GmbH & Co. KG | 50% | |||||||
2623 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N20 | Abbott GmbH & Co. KG | 50% | |||||||
2624 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N28 | Abbott GmbH & Co. KG | 50% | |||||||
2625 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2626 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N60 | Abbott GmbH & Co. KG | 50% | |||||||
2627 | trandolapriil | C09AA10 | GOPTEN kapsel 0,5mg N98 | Abbott GmbH & Co. KG | 50% | |||||||
2628 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N100 | Abbott GmbH & Co. KG | 50% | |||||||
2629 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N20 | Abbott GmbH & Co. KG | 50% | |||||||
2630 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N28 | Abbott GmbH & Co. KG | 50% | |||||||
2631 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N50 | Abbott GmbH & Co. KG | 50% | |||||||
2632 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N60 | Abbott GmbH & Co. KG | 50% | |||||||
2633 | trandolapriil | C09AA10 | GOPTEN kapsel 2mg N98 | Abbott GmbH & Co. KG | 50% | |||||||
2634 | traneksaam- hape |
B02AA02 | CYKLOKAPRON süstelahus 100mg/ml 5ml N10 | Pharmacia Enterprises | 50% | |||||||
2635 | traneksaam- hape |
B02AA02 | CYKLOKAPRON tablett 500mg N100 | Pharmacia Enterprises | 50% | |||||||
2636 | traneksaam- hape |
B02AA02 | CYKLOKAPRON tablett 500mg N20 | Pharmacia Enterprises | 50% | |||||||
2637 | traneksaam- hape |
B02AA02 | CYKLOKAPRON tablett 500mg N50 | Pharmacia Enterprises | 50% | |||||||
2638 | travoprost | S01EX80 | TRAVATAN silmatilgad 40mcg/ml 2.5ml N3 | Alcon UK | 50% | |||||||
2639 | tretinoiin | D10AD01 | RETIN-A kreem 0,05% 30g N1 | Cilag | 50% | |||||||
2640 | triamtsinoloon | D07AB09 | FTOROCORT 0,1% OINTMENT salv 0,1% 15g N1 | Richter | 50% | 75% | L20*; L23*; L40**; M07** | *rv dermatovene- roloogil; **rv dermatovene- roloogil ja reumatoloogil |
||||
2641 | triamtsinoloon | H02AB08 | KENALOG 40 süstesuspensioon 40mg/ml 1ml N5 | KRKA, d.d. | 50% | |||||||
2642 | triamtsinoloon | H02AB08 | LEDERSPAN süstesuspensioon 20mgml 1ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2643 | triamtsinoloon | H02AB08 | LEDERSPAN süstesuspensioon 20mgml 5ml N1 | WYETH LEDERLE PHARMA GmbH | 50% | |||||||
2644 | triamtsinoloon | R01AD80 | NASACORT ninasprei 55mcg/annuses 120annust N1 | Aventis Pharma Ltd. | 50% | |||||||
2645 | triamtsinoloon+ekonasool | D07BB81 | PEVISONE kreem 0,1%+1% 15g N1 | Cilag | 50% | |||||||
2646 | triheksüfe- nidüül |
N04AA01 | CYCLODOL tablett 2mg N50 | TFT | 50% | |||||||
2647 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 2 tablett 2mg N100 | Hexal AG | 50% | |||||||
2648 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 2 tablett 2mg N50 | Hexal AG | 50% | |||||||
2649 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 5 tablett 5mg N100 | Hexal AG | 50% | |||||||
2650 | triheksüfe- nidüül |
N04AA01 | PARKOPAN 5 tablett 5mg N50 | Hexal AG | 50% | |||||||
2651 | trimetasidiin | C01DX17 | PREDUCTAL tablett 20mg N60 | Servier | 50% | |||||||
2652 | trimetoprim | J01EA01 | TRIMETOP tablett 100mg N100 | Vitabalans | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
2653 | trimetoprim | J01EA01 | TRIMETOP tablett 100mg N200 | Vitabalans | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
2654 | trimetoprim | J01EA01 | TRIMETOP tablett 100mg N30 | Vitabalans | 50% | 100% | T86* | *rv patsienti jälgival ja ravival arstil | ||||
2655 | triptoreliin | L02AE04 | DECAPEPTYL DEPOT mikrokapslid süstimiseks 3,75mg N1 | Ferring GmbH |